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"Those early weeks, when Campbell had spent hours 
waiting about in what Hadden had called the kebab squad, 
hanging about ghoulishly for operations that rarely 
delivered the goods, were not to be repeated. "
Colin Douglas, "Ethics Made Easy"
SUMMARY
1. Although much clinical research has been carried out in the last 14 years to 
examine the postoperative function of patients undergoing ileal pouch-anal 
anastomosis (IPAA), little is known about the small bowel which is used to create 
the reservoir in this procedure. This thesis has therefore examined the preoperative 
small bowel motility characteristics of patients with ulcerative colitis (UC) 
undergoing EPAA using in vivo and in vitro techniques. The in vitro studies were 
compared against control subjects of whom most were undergoing elective right 
hemicolectomy for non-obstructing neoplasms. During part of the research project 
access to ileal tissue from patients with idiopathic slow transit constipation (ISTC) 
undergoing subtotal colectomy and ileorectal anastomosis (SC+IRA) enabled a 
study of this interesting subgroup o f patients to be made. A review of the IPAA 
operation performed at Glasgow Royal Infirmary between 1988 and 1995 i.e. 
totally stapled restorative proctocolectomy (TSRP), was also carried out.
2. An ambulatory manometry catheter assembly with 6 solid-state transducers, 
straddling the small bowel from duodenojejunal flexure to ileocaecal junction, was 
used to assess fasting patterns of small bowel motility in 9 UC patients and 2 
patients with familial adenomatous polyposis (FAP) awaiting EPAA. In the 9 UC 
patients (7 intact; 2 staged i.e. previous subtotal colectomies) nocturnal recordings 
were possible in 8. In 1 staged UC patient, catheter advancement to terminal ileum 
was impossible and with hindsight, following IPAA, this was thought to have been 
caused by previous postoperative adhesions. The second staged UC patient had 
catheter migration into the stoma bag following insertion and recordings were 
therefore invalid. The 7 intact UC patients and 1 FAP patient were studied for a
total of 81 hours in the nocturnal period. The 7 UC patients (6 males) had trace 
recordings analysed for migrating motor complex (MMC) characteristics including 
total number, cycle length, mean duration and mean velocity. Non-propagating 
MMCs, discrete clustered contractions (DCCs) and prolonged propagating 
contractions (PPCs) were also noted. The median recording period was 8.7hours 
(h), (range 6.5-9.5h) and the nocturnal stool frequency 2 (range 0-7). Other 
propagating contractions per subject included 1 PPC (0.9-2) and 2.1 DCCs (0-6). 
Calculation of Spearman's rank correlation coefficient failed to show any 
statistically significant associations between these motility parameters and 
nocturnal stool frequency. In particular the MMC pattern failed to show any 
relationship to nocturnal stool frequency. Recordings made in 5 UC patients during 
the diumal period were considered "too noisy" to show any meaningful relationship 
between stool frequency and motility parameters because of intense postprandial 
motor activity. On the basis o f this pilot study, ambulatory small bowel manometry 
was considered to be uncomfortable for the patient, the data obtained time- 
consuming to analyse, unsuitable for assessment of patients who had previously 
undergone subtotal colectomy and limited by expensive equipment which was too 
easily damaged. While possible, the technique did not seem to be a practical way of 
assessing small bowel motility routinely in prospective EPAA patients. Albeit on 
the basis of 7 nocturnal recordings, the technique also failed to show any 
relationship between gross patterns of small bowel motility and stool frequency in 
intact UC patients.
3. When isolated mucosal-free strips of human ileum were suspended in 
conventional jacketed organ baths, bursts of rhythmic oscillations in tone 
(spontaneous activity) were noted in 59 control strips (60%) and 73 UC strips
(49%). Analysis of this activity, in horizontally orientated strips, in a Golenhofen 
apparatus to enable synchronous measurement of both extracellular electrical and 
mechanical activity showed marked differences in the results from the 2 
techniques. In 3 groups of patients i.e. control subjects, UC and ISTC patients, the 
Golenhofen measurements showed that spontaneous mechanical contractions were 
faster, stronger and of shorter duration than those measured in conventional organ 
baths. These differences reached statistical significance in 6 of the 9 comparative 
measurements among the recording techniques in the 3 patient categories. When 
the electrical and mechanical characteristics of UC (n=7) and ISTC (n=7) patients 
were compared with controls (n=10), significant differences were noted in terms of 
the number of electrical spike bursts and the duration of electrical spike bursts 
between ISTC patients and controls: 3.86+0.14 versus 9.71+1.78 electrical spikes 
per spike burst, P=0.03; 0.66+0.12 versus 2.18+0.62s duration of electrical spike 
bursts, P=0.04. Although trends emerged in the results from UC strips, suggesting 
the opposite in terms of greater numbers o f electrical spikes per spike burst and 
longer duration of electrical spike bursts these differences did not reach statistical 
significance. These results suggest that, although the intestinal pacemaker is 
functional in the small bowel of ISTC patients, it generates spontaneous 
mechanical activity as a result o f less intense, shorter duration electrical activity 
than controls. This supports the concept of ISTC being a panenteric disorder which 
is not solely confined to the colon. In UC patients undergoing EPAA no statistically 
significant differences were observed in spontaneous electrical and mechanical 
parameters when compared with control subjects.
4. The effects o f cooling/ rewarming and certain drugs (potassium chloride, 
carbachol, atropine, diltiazem, sodium nitroprusside and metronidazole) were
iv
examined using the Golenhofen apparatus in control, UC and ISTC samples of 
ileum (3 patients, 3 muscle strips per category). Stepwise cooling from 37.5°C to 
27.5°C reduced the frequency and amplitude o f slow wave activity and the 
preceding spike bursts of electrical activity. Neither the resting tone nor the 
maximum amplitude of isometric contraction was affected by these temperature 
changes in the 3 patient groups. Rewarming produced reversal of these effects with 
visible recovery of electrical activity.
5. The presence of voltage-operated and receptor-operated channels were 
demonstrated in ileal tissue from the 3 patient groups using potassium chloride, 
carbachol, atropine, diltiazem and sodium nitroprusside (SNP). No differences 
were observed amongst the 3 patient groups in terms of the pattern of tissue 
reponse to each o f these spasmogens and relaxants. Metronidazole, an antibiotic 
commonly used to treat pouchitis, an idiopathic inflammatory condition which can 
affect up to 31% of EPAA patients with UC, had no effect on extracellular electrical 
or mechanical activity.
6. In carbachol-induced tone, both control and UC samples of ileum 
responded to electrical field stimulation (EFS, l-64Hz, 0.05ms, supramaximal 
voltage) with a relaxation response followed by a rebound contraction. There were 
no statistically significant differences between control and UC tissues in terms of 
frequency/ response curves. The nitric oxide synthase (NOS) antagonist N^-nitro- 
L-arginine methyl ester (L-NAME, 10'^M) inhibited nerve-mediated relaxations in 
control tissues (10 patients, 17 muscle strips) by 60-90%. A more heterogeneous 
group of responses were noted in 18 UC patients (58 muscle strips, 11 synchronous 
EPAA procedures, 7 staged IPAA procedures). Thus, only 5 (10 muscle strips)
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behaved in a similar fashion to control ileum i.e. L-NAME effectively inhibited 
nerve-mediated relaxations by 60-90%. L-NAME was only weakly effective in a 
further 3 patients (11 muscle strips) and ineffective in 5 patients (12 muscle strips). 
A further 5 UC patients (25 muscle strips) undergoing IPAA showed no evidence 
of functioning enteric neurons with EFS failing to elicit relaxation responses. NO 
would therefore seem to be the main inhibitory transmitter in control ileum but, in 
patients with UC, whilst some may behave in a comparable fashion to control 
tissue others have relaxation responses which suggest a possible alteration in the 
relative potencies of other inhibitory neurotransmitters. This may be due to the 
systemic effects of UC, to the medications used to treat this condition or both. 
Those patients, with in vitro absence of neuronal relaxations to EFS may exhibit 
features o f a more aggressive form of UC. Alternatively, these tissues may have 
been traumatised by resection and therefore less likely to have responded to stimuli 
. in the organ bath.
7. The NO-donor SNP in strips of control human ileum (n=30, 6 patients) 
produced a TTX-insensitive and therefore not neuronally mediated relaxation. The 
SNP-induced relaxation was independent on K+-channel opening as demonstrated 
by the ineffectiveness of K+-depolarising solution or apamin to modify its effect. 
The compound oxyhaemoglobin (HbO) which has a high affinity for NO and 
scavenges it from extracellular media did not appreciably prevent or reverse the 
relaxant responses to SNP in control human ileum. SNP-relaxation in human small 
bowel did not appear to be mediated by nerves or affected by K+-channel opening. 
The ineffectiveness of HbO on SNP-induced relaxation suggests that, contrary to 
belief, this NO-donor relaxes smooth muscle in human ileum by mechanisms 
which are independent of extracellular NO generation.
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8. Histochemical staining for reduced nicotinamide adenine dinucleotide 
phosphate (NADPH)-diaphorase which colocalizes with NOS was carried out in 4 
control and 11 UC patients. In the control group, 2 individuals were undergoing 
reverse ileal onlay grafts for postvagotomy diarrhoea. One of the UC patients had 
fulminant disease whilst one had pouch dysfunction requiring formation of a 
defunctioning ileostomy. Strong uptake of the stain was noted in the intestinal 
mucosa and myenteric plexus of all tissues studied. Nerve fibres showing strong 
NADPH-diaphorase activity were evenly distributed throughout the inner circular 
and outer longitudinal layers. There were no visual differences amongst the 2 
patient groups in terms of intensity or distribution of staining.
9. A retrospective audit o f 103 attempted TSRP procedures at Glasgow Royal 
Infirmary between 1988 and 1995 (87 UC; 9 FAP; 6 ISTC; 1 hereditary non­
polyposis colorectal cancer, HNPCC), revealed no operative mortality, minimal 
operative morbidity and a pouch excision rate of 8%. In 60 patients with a 
maximum of 12 months established function, mean stool frequencies were x5 by 
day and x l by night. Fifty-three patients (88.3%) were satisfied with overall long­
term function. Of the 7 FAP pouches and 39 UC pouches undergoing detailed 
functional assessment the FAP subgroup had superior day and night stool 
frequencies as well as continence scores. The long-term functioning UC pouches 
showed a wider spectrum of function. The clinical impression of a difference in 
function o f the small bowel in the UC and FAP patients undergoing IPAA, as 
reported in other pouch series in the surgical literature, was borne out by this audit. 
Moreover, the contribution of small bowel motility problems to pouch dysfunction
was clinically apparent with some individuals showing pouch dysfunction in the 
absence of pouchitis, pouch-anal outlet problems or anal sphincter defects.
10. These preliminary studies show that perioperative assessment of small 
bowel motility in prospective LPAA patients with a diagnosis of UC is possible 
using ambulatory small bowel manometry, although the technique itself is 
restricted by the difficulties associated with catheter insertion and data analysis. No 
association between small bowel motility and nocturnal stool frequency was 
evident in 7 intact UC patients. In vitro studies of small cuffs of ileum obtained at 
the time of IPAA were easier to perform and yielded more data than the small 
bowel manometry studies. Examination of spontaneous activty in control and UC 
tissues was influenced by the orientation of the muscle strip and the apparatus used 
to assess pacemaker activity. Golenhofen apparatus measurements, compared with 
conventional jacketed organ bath recordings gave data which showed spontaneous 
mechanical activity in control and UC strips to be faster, stronger and of shorter 
duration. No statistically significant differences in spontaneous activity parameters 
were noted between UC and controls. In contrast, the chance to study similar 
muscle strips from patients with ISTC revealed the unexpected finding that the 
latter group have differences in their spontaneous extracellular electrical activity 
characteristics. These suggest that in ISTC, the disease process is not confined 
exclusively to the colon and that differences in pacemaker activity may suggest 
differences in the number andJ or function of the interstitial cells of Cajal (ICC), 
which are believed to act as pacemakers for most of the gastrointestinal tract. 
Differences exist in the inhibitory nerve-mediated responses of UC and control 
tissues. In UC, alternative neuronal mechanisms appear to be utilised in relaxation 
in some patients whilst in others there are no demonstrable nerve-mediated
responses. Some UC patients do, however, have responses which are affected by L- 
NAME in the same way as control tissues, implying that NO is the main inhibitory 
neurotransmitter in these UC individuals. The classic NO-donor SNP produced its 
relaxant effects in human ileum by mechanisms which were not nerve-mediated, 
not dependent on K+ channel opening and not prevented or reversed by HbO. The 
latter observation challenges the traditional concept that SNP produces its smooth 
muscle relaxation by liberating extracellular NO. NADPH-diaphorase staining 
showed that the facility to generate NO is present in the ileal smooth muscle of 
control and UC tissues. The heterogeneous reponses to L-NAME seen in UC 
patients implies that whilst NO can be generated in inhibitory ileal neurons, the 
cascade of events bringing about the relaxation response seen in control ileal 
smooth muscle is either modified, with other inhibitory transmitters playing a 
greater role in the process or alternatively abolished in some UC patients. These 
changes are presumably a direct legacy of the systemic effects of chronic UC 
and/or long-term drug treatments used to treat this condition. Collectively, these 
data support the concept that the ileum in UC patients undergoing IPAA is 
different from that of control counterparts, or indeed the ileum of FAP patients 
undergoing IPAA. The significance of these differences in terms of long-term 
pouch function will require further investigation.
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CHAPTER 1
WHY STUDY SMALL BOWEL MOTILITY 
IN PATIENTS WITH ULCERATIVE COLITIS 
UNDERGOING RESTORATIVE 
PROCTOCOLECTOMY WITH 
ILEAL POUCH-ANAL ANASTOMOSIS?
1.1 INTRODUCTION
Ulcerative colitis (UC) is an inflammatory disorder of the colonic mucosa 
which spontaneously relapses and remits. The pathogenesis of UC is 
multifactorial and probably results from a complex interaction among genetic, 
endogenous and exogenous modifying factors (Lowes & Jewell, 1990). Since 
predisposing and trigger factors have not been clearly identified, current 
therapeutic strategies for UC are targetted to the immunopathogenic mechanisms 
mediating the inflammatory process which produce tissue injury in this condition. 
A significant proportion of patients with chronic UC will, however, require 
surgical intervention, particularly if  the inflammation involves the entire colon 
and rectum.
Traditionally, the surgical procedure of choice for patients with chronic 
UC was panproctocolectomy (removal of the entire colon and rectum). This 
operation entails a permanent abdominal end ileostomy and patients are totally 
incontinent of faeces and require to wear continuously an external stoma 
appliance. Although most patients with an ileostomy adjust to having a stoma and 
return to a relatively normal lifestyle, approximately 50% of patients, despite a 
well constructed ileostomy, suffer chronic appliance-related problems (Becker, 
1993). There are also significant psychological and social implications for such 
patients. Not surprisingly, therefore, surgeons have, for many years, sought 
alternative strategies, the most recent of which has been the modem restorative 
proctocolectomy with ileal pouch-anal anastomosis (Parks & Nicholls, 1978). 
This operation is now the preferred surgical treatment for UC (Williams, 1989a). 
Restorative proctocolectomy involves excising the diseased colon and rectum 
with the creation of a pouch or reservoir from the remaining terminal ileum which 
is then either sutured or stapled to the anal sphincter mechanism (see Fig 1.1).
In spite of the potential advantages of EPAA, with over 90% of patients 
having satisfactory preservation of faecal continence (Pemberton et al, 1987)
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Fig 1.1 Totally stapled restorative proctocolectomy.
Shaded area represents excised colon and rectum.
some individuals develop persistent and excessive stool frequency following 
restorative proctocolectomy. In the absence of sphincter impairment this suggests 
that factors, already present in the ileum used to construct the pouch, may be 
involved in these continence difficulties (dyscontinence) (Dozois et al, 1989). 
Measurement of small bowel motility in established BPAA patients with a 
spectrum of pouch activity has shown that small bowel motility may indeed be a 
determinant of pouch function (Groom et al, 1994).
Although the human terminal ileum is one of the major anatomical 
components used in EPAA to treat chronic UC, its in vitro and in vivo motility 
characteristics are unknown. Indeed, little is known about the motility of the 
human terminal ileum in health. Work in laboratory animals has, however, shown 
that enteric neural and smooth muscle functions are altered in non-inflamed areas 
of the gastrointestinal tract as a consequence of distal inflammation (Marzio et al, 
1990; Jacobson et al, 1993a-b). Whether the same holds true for patients with 
chronic UC undergoing EPAA is, as yet, unestablished.
In an attempt to clarify why small bowel motility should be investigated in 
UC patients undergoing IPAA this chapter reviews the development of modem 
restorative proctocolectomy with IPAA; discusses the factors used to assess pouch 
functional outcome; and looks at current practice in terms of preoperative clinical 
and physiological assessment of prospective UC patients.
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1.2 RESTORATIVE PROCTOCOLECTOMY WITH ILEAL-POUCH 
ANAL ANASTOMOSIS (IPAA) IN THE MANAGEMENT OF 
ULCERATIVE COLITIS
1.2.1 HISTORICAL BACKGROUND
The role of surgery in the management of UC has evolved over the last 
100 years in tandem with developments in surgical practice, anaesthesia and 
resuscitation. Surgical treatment of UC has developed from the early, life-saving 
technique of colonic irrigation, through diversion of the faecal stream to enable 
complete physiological rest of the inflamed colon, to surgical excision of diseased 
colon and rectum either with or without restoration of intestinal continuity. These 
important developments in the surgical management of UC are summarised 
below.
The first case report of successful surgical intervention in UC described 
irrigation of the inflamed mucosa via a left iliac sigmoid colostomy to treat severe 
UC (Mayo Robson, 1893). Thereafter, the technique evolved from irrigation via a 
colostomy to irrigation with various fluids through the appendix stump 
(appendicostomy), which minimised the leakage of excoriating ileal contents onto 
the abdominal wall. This remained the surgical treatment of choice in UC until the 
1940's (Corbett, 1945). However, one m ajorl imitation with colonic irrigation was 
that the colon was defunctioned inadequately.
Failure to improve symptoms by colonic irrigation alone in some patients 
with severe UC led to the introduction of the concept of diverting the faecal 
stream to rest completely the inflamed colonic mucosa (Brown, 1913). This was 
achieved by dividing the ileum and bringing the end out on to the abdominal wall 
as a flush ileostomy. A tube caecostomy was then used to irrigate the colon. While 
diversion by ileostomy with colonic irrigation remained central to the treatment of
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severe UC for the first half of this century, it was regarded as a salvage procedure 
designed for the treatment of almost moribund patients with UC.
By the Second World War, general improvements in resuscitation and 
anaesthetic techniques enabled proctocolectomy with formation of a permanent 
end ileostomy to become the recognised operative procedure for the management 
of severe UC (Strauss & Strauss, 1944). However, major morbidity associated 
with ileostomy formation such as stomal stenosis and excessive effluent output 
persisted until techniques were introduced to create everted ileostomies (Brooke, 
1952; Turnbull, 1953). By everting the stoma, large losses of nutrients and fluid 
were avoided and serositis, which leads to stricture formation, effectively 
abolished. Further advances in adhesives and lightweight stoma appliances 
minimised problems with skin excoriation and enabled patients to lead active 
lifestyles after colectomy.
Because of problems relating to the perineal dissection in proctocolectomy 
such as sexual dysfunction (Stahlgren & Ferguson, 1959) and perineal sinus 
formation (Watts et al, 1966), methods were devised to excise the diseased rectum 
whilst retaining some or all of the anus and the sphincter mechanism. Of these, 
conservative proctocolectomy with retention of both the internal and external anal 
sphincters along with the mucosa of the lower anal canal avoided a perineal 
wound and preserved the perineum with its important supportive function. Doubts 
about the efficacy of this procedure, in terms of providing uncomplicated perineal 
healing (Talbot et al, 1989) resulted in it failing to gain widespread acceptance. 
Intersphincteric proctectomy, on the other hand, preserved both an intact external 
anal sphincter with levator ani muscles (Lyttle & Parks, 1977). This form of rectal 
excision resulted in improved perineal wound healing and allowed easier 
eradication of any perineal sepsis which might develop.
Despite these improved techniques o f rectal excision and ileostomy 
formation, considerable interest had focussed on preserving intestinal continuity 
following colonic excision in UC. Ileorectal anastomosis following colectomy
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was the initial alternative sphincter-sparing procedure to attract attention (Devine 
& Devine, 1957). This procedure, still used by some surgeons to treat UC and 
FAP, represents a compromise between preserving anorectal and sexual function 
on one hand, with the putative risk of leaving diseased rectal mucosa on the other. 
Over 90% of patients undergoing this procedure return to full health with an 
operative mortality as low as 5% in some series (Aylett, 1960). In a review of 17 
studies on ileorectal anastomosis for the treatment of UC, 1206 patients were 
found to average 4-5 bowel motions per day and 99% of these individuals had 
normal continence (Parc et al, 1985). Fifteen percent of these patients, however, 
eventually underwent bypass procedures or completion proctectomy. However, 
neoplastic transformation in the retained rectal mucosa is a real risk, occurring in 
2-20% of reported series. Colectomy with ileorectal anastomosis is certainly an 
attractive option in patients with minimal rectal involvement but close 
surveillance is mandatory to minimise the possibility of developing rectal cancer 
and to monitor disease progression or exacerbation in the remaining rectal 
segment, which often requires further medical or surgical intervention.
In an attempt to overcome the total incontinence associated with a 
permanent ileostomy, the concept of an intra-abdominal reservoir was introduced 
(Kock, 1969). This created an abdominal ileostomy which required no stoma 
appliance, with the added advantage for the patient of being able to evacuate the 
stoma when socially convenient. Further modification of the continent ileostomy 
occurred with the introduction of a nipple valve to create a leak-proof one-way 
valve system (Faren et al, 1973), but failure required valve revision in over 50% 
of patients. Subsequent technical improvements in valve construction reduced this 
revision rate to a reported 10% of patients (Dozois et al, 1980; Gerber et al, 
1983). The Kock continent ileostomy procedure is both technically demanding 
and associated with high complication rates. While still carried out at specialised 
institutions, modem restorative proctocolectomy with DPAA has completed the 
evolution of the continent ileostomy procedure to the end of its evolution.
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1.2.2 EVOLUTION OF THE MODERN OPERATION OF ILEAL POUCH- 
ANAL ANASTOMOSIS
The risks associated with the retention of a potentially diseased rectum 
following total colectomy and ileorectal anastomosis, together with the technical 
aspects of constructing a continent permanent ileostomy led to the evolution o f the 
procedure of modem restorative proctocolectomy with IPAA (Parks & Nicholls, 
1978). This operation evolved from the fusion of two concepts: the ileoanal pull- 
through, which consisted o f total colectomy, rectal mucosectomy and pull-through 
o f the distal ileum with anastomosis to the anus; and the ileal reservoir.
Ileoanal anastomosis was first attempted at the beginning of this century 
(Hochenegg, 1900), but poor functional outcome and high morbidity prevented its 
widespread acceptance as a standard surgical technique. Similar problems were 
observed when ileoanal anastomosis was performed in Germany on a 10 year-old 
boy with FAP (Nissen, 1933), and some 10 years later in Minnesota, USA when 
Wangensteen attempted to duplicate this operation in a young adult male with 
chronic UC (Wangensteen, 1943). Disappointing results were also noted in studies 
of mucosectomy prior to ileoanal anastomosis both in dogs (Ravitch & Sabiston, 
1947) and in a limited number of humans with severe UC (Ravitch, 1948). 
Coloanal anastomosis, following mucosal stripping of the distal rectum and a 
colonic pull-through procedure was first described in the treatment of megacolon 
(Yancey et al, 1952) and later applied to the management o f Hirschsprung's 
disease with good results (Soave, 1962). However, increased stool frequency and 
erratic continence limited the use of the Soave procedure in adult patients. Distal 
rectal mucosal stripping combined with a total colectomy and a straight ileoanal 
anastomosis was first applied in the treatment of FAP (Safaie-Shirazi & Soper, 
1973) and later in young patients with UC (Martin et a l, 1977). However, 
urgency, nocturnal incontinence and excessive stool frequency dogged initial 
efforts at performing straight ileoanal anastomosis in adults.
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The concept of constructing a reservoir to increase neorectal capacity, in 
an effort to address the problem of excessive stool frequency following ileoanal 
anastomosis was first explored in animal studies. A triple limb ileal pouch 
combined with an ileoanal anastomosis was studied in dogs (Valiente & Bacon, 
1955), as was the effectiveness of a double-barrelled isoperistaltic pouch (Karlan 
et al, 1959). In humans, the first acceptable results following restorative 
proctocolectomy were achieved by combining a triplicated ("S") ileal pouch with 
distal rectal mucosectomy and handsewn pouch-anal anastomosis (Parks & 
Nicholls, 1978).
Since 1978, several reservoir designs have been advocated in restorative 
proctocolectomy procedures. These include the "J" pouch (Utsunomiya et al, 
1980), the lateral side-to-side ileal pouch (Fonkalsrud & Ament, 1978) and the 
"W" reservoir (Nicholls & Lubowski, 1987). Each of these reservoir 
configurations appear to have similar functional results provided that they are of 
sufficient capacity, are positioned in the true pelvis with a short outflow tract and 
that the constructed pouch-anal anastomosis is tension-free.
As the modem IPAA procedure has evolved, the length of the remaining 
rectal muscular cuff has been shortened (Grant et a l, 1986) or completely excised 
(Chaussade et al, 1989; Slors et al, 1989) by many surgeons. The role of 
mucosectomy has also generated considerable debate (O'Connell & Williams,
1991). While some surgeons begin proximal stripping of the mucosa at the dentate 
line (Parks & Nicholls, 1978; Parks et al, 1980; Nicholls, 1987) arguing that this 
removes all the diseased mucosa and prevents any chance of recurrent UC, FAP or 
neoplastic transformation, others strip above the anal transitional zone (ATZ) 
(Martin et al, 1985). Advocates of the latter technique claim superior functional 
results in terms of continence (Miller et a l, 1990; Lavery et al, 1990).
Recently, surgeons have avoided mucosectomy by constructing stapled 
pouch-anal anastomoses (Heald & Allen, 1986; Johnston et al, 1987; Williams, 
1989; Kmiot & Keighley, 1989; Sugerman et al, 1991), l-2cm above the dentate
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line. Those workers have argued that the excellent functional results obtained with 
these techniques outweigh the putative risk of leaving a small cuff of potentially 
diseased mucosa. Nevertheless, if a stapled pouch-anal anastomosis is performed 
without mucosectomy then regular surveillance of the retained cuff is mandatory 
(Schmitt et al, 1992; Seow-Choen et al, 1991).
Controversy persists over which operative technique of restorative 
proctocolectomy with EPAA is superior. In an important prospective randomised 
study from St Mark's (Seow-Choen et al, 1991), anal function was compared after 
handsewn ileoanal anastomosis with mucosectomy versus stapled ileoanal 
anastomosis without mucosectomy. No functional advantage was conferred by use 
of the latter. Subsequent studies have also supported these findings (Gozzetti et al, 
1994; Becker & Raymond, 1986). At present, surgeons adopt their own technique 
of choice: at our Institution we perform a totally stapled "J" EPAA procedure (see 
Appendix and Fig 1.1). From the literature to date there seem to be few 
differences in functional results between a well-sewn EPAA and a well-stapled 
one.
EPAA now represents an acceptable alternative to conventional 
proctocolectomy and ileostomy, in selected patients with UC and FAP. Indeed, 
some consider that EPAA should be the elective operation of choice for young UC 
patients requiring surgical intervention (Williams, 1989a). In most large series of 
patients undergoing EPAA, the overall functional results have been encouraging 
(Pemberton et al, 1987; Wexner et al, 1989; Keighley et al, 1993; Mortensen, 
1988; Stryker et al, 1986). Improvements in technique have lowered operative 
morbidity and improved overall functional outcome so that a patient undergoing 
EPAA can expect a stool frequency of 4 to 6 motions per 24 hour period, complete 
continence, and spontaneous defaecation with the ability to defer defaecation for 
more than 30 min (Mortensen, 1988). There is, however, considerable variation in 
clinical results and 10% of pouch patients are estimated to have a poor outcome 
with respect to their preoperative condition (Stryker et al, 1986). The factors
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which have been established as contributing to the determination of long-term 
pouch function are reviewed below.
1.2.3. FUNCTIONAL DETERMINANTS
For an ileoanal pouch to function well as a substitute rectum (neorectum), 
the ileum which is used to create the reservoir must adapt to its new role and 
environment. In clinical practice, IPAA performance is assessed by monitoring 
four variables (Levitt & Lewis, 1991). These are summarised in Table 1.1.
SPONTANEITY OF DEFAECATION
The majority of IPAA patients can empty their reservoirs spontaneously. 
However, failure of spontaneous defaecation, with patients requiring to self- 
catheterise the pouch to achieve defaecation was formerly associated with a 
defective "S" pouch design. This has since been eliminated, largely by 
modification of the "S" pouch to shorten its efferent limb (Hallgren et al, 1989).
ABILITY TO DEFER DEFAECATION
Most ileoanal pouch patients can postpone defaecation voluntarily for at 
least fifteen minutes (Stryker et al, 1985). The minority who cannot are defined as 
having pouch urgency. The factors causing this unusual phenomenon are poorly 
understood. Although some workers have identified patients with poor external 
anal sphincter function who experience symptoms of urgency (Nasmyth et al, 
1986a), this has not been encountered by others (Scott et al, 1989). While 
exclusion of patients with poor preoperative sphincter function reduces the 
incidence of urgency, other contributing factors, as yet undetermined, must exist.
CONTROL OF FAECAL CONTINENCE
Poor postoperative continence following IPAA has been most commonly 
associated with impaired internal anal sphincter (IAS) function, which itself is
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FUNCTIONAL PARAMETER
Spontaneous defaecation 
Ability to defer defaecation for at least 30 min 
Faecal continence 
Stool frequency (day and night)
Table 1.1: Clinical determinants of function in established IPAA patients,
(after Levitt & Lewis, 1991)
reflected in a reduction in resting anal canal pressure (Chaussade et al, 1989; 
Johnston et al, 1987; Nasmyth et al, 1986a; Scott et al, 1989; Primrose et al, 
1987; O'Connell et al, 1988). Other factors such as the effectiveness of pouch 
evacuation (Nasmyth et al, 1986a) and stool consistency (Beart et al, 1985) have 
also been implicated.
Irrespective of the surgical technique used to construct the ileoanal pouch, 
a reduction in anal pressure is a common sequel of IPAA. Patients, however, 
generally report satisfactory continence in the early postoperative period which 
would imply considerable functional sphincter reserve (Stryker et al, 1986; 
Pescatori & Parks, 1984; Williams et al, 1989). In addition, both continence and 
IAS function improve postoperatively and gradually return to preoperative levels 
(Becker et al, 1985; Kmiot et al, 1989).
Poor continence following IPAA seems more likely to reflect poor patient 
selection rather than sphincter injury related to operative technique. Individuals 
with limited functional sphincter reserve because of advanced age or previous 
sphincter injury are most likely to experience incontinence problems following 
IPAA (Chaussade et al, 1989; Kmiot et al, 1989; Nicholls & Pezim, 1985; 
McHugh et al, 1987).
STOOL FREQUENCY
Pouch volume appears to be the single most important influence on stool 
frequency. Thus, a larger pouch is often associated with a lower stool frequency 
(Nasmyth et al, 1986b; Becker et al, 1985; O'Connell et al, 1987; Nicholls & 
Pezim, 1985; Neal et al, 1982). Moreover, pouch capacity tends to increase with 
time and this is mirrored by a reciprocal fall in stool frequency (Becker et al, 
1985; Williams, 1986). It is unclear as to how pouch capacity influences the 
pattern of defaecation. Work which has questionned the view that the pouch acts 
purely as a reservoir includes scintigraphic analysis of IPAA patients. This 
technique showed that the actual reservoir area included ileum immediately above
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the pouch (O'Connell et al, 1986). Comparative studies of patients with straight 
ileoanal anastomoses and IPAA patients showed no significant difference in the 
respective capacity of each type of neorectum (Dozois, 1986; Taylor et al, 1983 ).
Pouch capacity is also related to compliance with the larger pouch proving 
the more compliant. In turn, compliance is linked with stool frequency (Nasmyth 
et al, 1986a; Scott et al, 1989). Indeed, large pouches have less active motility 
profiles and have greater threshold volumes (O'Connell et al, 1987). The latter 
term refers to the volume of pouch material which triggers propulsive wave 
activity associated with the desire to defaecate. How variations in pouch capacity 
influence pouch compliance and motility are unknown (Levitt & Lewis, 1991). 
Intrapouch pressure measurements, during continuous water distension, have been 
used to characterise compliance and pouch motor activity in patients with good 
and poor functional outcomes (Levitt et al, 1992). Using this provocative test of 
pouch performance, those individuals with poor function had a reduced pouch 
compliance and primary disorders of pouch motility.
Other factors which influence stool frequency are total daily stool volume 
(O'Connell et al, 1987) and the degree of pouch emptying (Stryker et al, 1986; 
O'Connell et al, 1987; Dozois, 1986). Higher stool volumes are associated with a 
greater frequency of defaecation following IPAA (O'Connell et al, 1987). The 
former are directly related to dietary intake. The factors which result in poor 
pouch emptying are not fully understood, but outlet obstruction is one of the most 
important (Pescatori & Parks, 1984; O'Connell et al, 1986).
Two other factors which have an adverse effect on overall pouch function 
are postoperative sepsis (Beart et al, 1985; Keighley et al, 1988) and pouchitis 
(Madden et al, 1990; Hulten, 1989). Postoperative sepsis may result in a smaller, 
less compliant pouch but this is unproven (Keighley et al, 1988). Pouchitis results 
in increased stool frequency and increased urgency; pouchmetrography has been 
used to characterise the pouch motility profile in patients with this condition 
(Levitt et al, 1992).
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1.3 PREOPERATIVE ASSESSMENT OF THE ULCERATIVE COLITIC 
PATIENT UNDERGOING ILEAL POUCH-ANAL ANASTOMOSIS- 
CURRENT SURGICAL PRACTICE
1.3.1 PATIENT SELECTION
While IPAA may seem to be, at least in theory, the ideal operation for the 
elective management of UC, each case has, nevertheless, to be assessed 
individually. The implications of IPAA on the patient’s lifestyle must be 
considered along with technical factors and the advantages o f this operation 
weighed against alternative surgical strategies for UC.
The relative advantages and disadvantages of IPAA (see Table 1.2) have to 
be carefully discussed with each patient and a joint decision reached on whether 
IPAA or an alternative operation, most commonly proctocolectomy and end 
ileostomy, is most appropriate for that particular individual.
Technical aspects often determine whether or not IPAA is appropriate. For 
example, the length o f the small bowel mesentery is very important in determining 
the ease with which a terminal ileal reservoir may be led into the pelvis to enable 
pouch-anal anastomosis. Both the short obese patient and the very tall patient can 
have restricted lengths of small bowel mesentery. Likewise, previous surgery may 
restrict the length of available small bowel for pouch construction. Dense 
adhesions after previous surgery for acute UC may also cause technical difficulties 
in the pelvic dissection prior to pouch-anal anastomosis. Careful consideration of 
these factors is mandatory before attempting ileoanal pouch surgery. The 
potentially difficult patient has to be informed preoperatively o f the possibility of 
technical failurewhich would necessitate permanent end ileostomy formation.
The main indication for ileoanal pouch surgery in chronic UC is the case 
which is refractory to medical therapy or complicated by frequent attacks of 
severe acute colitis. Patients with longstanding disease which interferes with 
physical, social or employment factors are also strong candidates for elective
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ADVANTAGES DISADVANTAGES
Improved body image
Improved social life
Less interference with occupation
No occupational barriers
Psychosocial advantages
Less odour during/between
emptying
Less time to manage
More extensive operation 
Longer convalescence 
Requires greater motivation 
Perianal leakage 
Perianal irritation 
Pouchitis
More frequent visits to toilet 
Long-term surveillance necessary 
10% failure rate requiring pouch 
excision
Table 1.2: Advantages and disadvantages of IPAA. The above quality of life
factors should be considered for each UC individual requiring elective surgery. 
IPAA is considered against the traditional operation of panproctocolectomy and 
permanent ileostomy formation (see Pezim & Nicholls, 1985).
pouch surgery. Another large subgroup of patients who undergo IPAA at Glasgow 
Royal Infirmary are those who have been treated at other institutions by initial 
subtotal colectomy with rectal stump preservation for toxic megacolon or 
complications of acute UC. Individuals with severe or high-grade dysplastic 
lesions biopsied on colonoscopic surveillance for chronic total UC, or low-grade 
dysplastic changes on raised lesions are also advised to undergo ileoanal pouch 
surgery as prophylaxis against developing colorectal carcinoma. In certain patients 
with toxic UC refractory to medical therapy, urgent BPAA within 48 hours of 
admission is performed in selected cases at Glasgow Royal Infirmary, providing 
the histological diagnosis is established, perforation has not occurred and the 
patient does not require intensive preoperative parenteral nutrition. This last 
indication for ileoanal pouch surgery is a local policy and although encouraging 
results have been obtained at Glasgow Royal Infirmary and at other institutions 
(McCourtney & Finlay, 1993; Mowschenson et al, 1993), one must acknowledge 
that in this clinical situation it is traditional colorectal practice to perform subtotal 
colectomy, rectal stump preservation and end ileostomy (O'Kelly & Mortensen, 
1992).
Table 1.3 lists the absolute and relative containdications to ileoanal pouch 
surgery respectively. The relative contraindications must be assessed on an 
individual basis. Clearly, elderly patients must be considered for pouch surgery 
only after a thorough clinical and physiological evaluation to identify latent anal 
sphincter weakness has been made. Paediatric patients and their parents require 
careful counselling, but excellent long-term functional results in carefully 
selected, well-motivated children (McCourtney et a l, 1996; Romanos et al, 1997) 
have been obtained. Patients with major psychiatric disorders should probably not 
be offered the procedure. Likewise, those individuals who are educationally 
subnormal should also be carefully evaluated before embarking on ileoanal pouch 
construction, which even if technically succesful, may fail because the impact of 
the surgery and subsequent period of pouch adaptation is too great and the patient
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RELATIVE ABSOLUTE
Age
Psychological factors 
Poor nutritional status 
General inanition 
Indeterminate colitis
Crohn's disease 
Distal rectal/anal carcinoma 
Anal sphincter damage 
Faecal incontinence 
Obstetric trauma 
Immobility/infirmity
Table 1.3: Contraindications to IPAA.
cannot cope (Mortensen, 1993). The diagnosis o f "indeterminate colitis" accounts 
for 10-15% of all cases of idiopathic inflammatory bowel disease (Pezim et al, 
1989). This entity reflects the absence of characteristic features which enable 
either UC or CD to be diagnosed. Problems can ensue, when faced with this 
diagnosis, in trying to decide the most appropriate surgical procedure. Further 
clinical and radiological assessment can often lead to a firm decision being made 
regarding the question of ileoanal pouch surgery. The majority of cases of 
indeterminate colitis can undergo pouch formation with satisfactory functional 
results (Pezim et al, 1989). Nevertheless, where serious concern over occult CD 
exists a preliminary subtotal colectomy with rectal stump preservation should be 
performed. Thereafter the rectum should be biopsied, on a serial basis if 
necessary, to confirm or refute the diagnosis o f CD, though in the defunctioned 
state, rectal histology can be difficult to interpret and may have features which are 
hard to distinguish from CD (Shepherd, 1991).
1.3.2. PREOPERATIVE PREPARATION- GENERAL ASPECTS
Several clinical aspects must be assessed before a patient with UC 
undergoes ileoanal pouch surgery. These are broadly similar to those evaluated in 
the preoperative preparation of patients undergoing other major elective colorectal 
procedures and include a complete examination of the colon, if still present, by 
barium enema or colonoscopic examination, histology to exclude CD and identify 
UC cases with dysplastic changes, preoperative asessment of the patient's 
cardiorespiratory function and general fitness, correction of anaemia and 
electrolyte disturbances and evaluation by a stomatherapist. At Glasgow Royal 
Infirmary the patient is generally admitted 48h prior to operation to enable these 
tests to be completed and a full bowel preparation commenced the day before 
surgery. This preoperative "work-up" is also carried out at other pouch centres, 
both in the United Kingdom (Thomas & Taylor, 1991; O'Kelly & Mortensen,
1992) and in North America (Pemberton, 1993). The preoperative assessment of
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the two functional components of the ileoanal pouch viz. the anal sphincter 
mechanism and the small bowel are discussed below.
1.3.3 ANORECTAL PHYSIOLOGY
Most centres perform anorectal physiology tests on prospective IPAA 
patients routinely. Although used largely as a research tool, these provide 
important objective information about basic characteristics such as resting and 
squeeze pressure, anal canal length and sensitivity and the presence or absence of 
a rectoanal inhibitory reflex (RAIR). Many papers (see review by Bartolo & 
Duthie, 1993) have reported the pre- and postoperative changes in anorectal 
measurements with various IPAA techniques. In conjunction with the more recent 
introduction of endoanal ultrasonography, these tests yield useful data on the pre­
pouch functional and structural characteristics o f the anal sphincter mechanism. 
Table 1.4 summarises the most common anorectal physiology tests which are 
routinely performed in pouch centres.
In practical terms, however, anorectal physiological tests are useful only as 
clinical research tools. Few, if any, patients are rejected from IPAA on the basis of 
an abnormal anal canal pressure profile (O'Kelly & Mortensen, 1992). 
Furthermore, an experienced surgeon can obtain just as much information 
regarding anal sphincter function from digital examination (Hallgren et al, 1989).
1.3.4 SMALL BOWEL ASSESSMENT
In the clinical situation, where doubt exists over a diagnosis of UC, 
Crohn's disease (CD) may be excluded, to some extent, by small bowel 
radiological investigations i.e. small bowel enema or follow-through studies. 
Occasionally, radiolabelled white cell scans may be performed to identify 
inflammatory changes in the terminal ileum which are suggestive of CD. 
Currently, however, UC patients who undergo IPAA do not have preoperative 
small bowel functional assessment, either at Glasgow Royal Infirmary or at other
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ANORECTAL ASSESSMENT
^Digital examination
*Anal canal manometry
Resting pressure (internal anal sphincter) 
Squeeze pressure (external anal sphincter) 
RAIR testing 
Anal canal motility
*Anal canal length
Anal canal sensation
External anal sphincter 
electromyography
Pudendal nerve terminal motor latency
Table 1.4: Preoperative anorectal assessment of prospective IPAA patients.
RAIR= rectoanal inhibitory reflex.
*= tests commonly used in practice at Glasgow Royal Infirmary.
(see Thomas & Taylor, 1991).
centres specialising in this operation. Indeed, the motility characteristics of the 
small bowel in patients with UC have never been assessed. This is a surprising 
statistic when one considers that several thousand patients with UC have 
undergone IPAA since the modem operation was first described (Parks & 
Nicholls, 1978).
1.4 AIMS OF THESIS
Currently the best "chance" of a successful result following IPAA lies in 
the creation of a "large volume reservoir" in patients who have good preoperative 
anal sphincter function (Levitt & Lewis, 1991). However, poor clinical outcome 
with excessive stool frequency is seen in some patients following ileoanal pouch 
surgery despite having normal anal sphincter function, a good capacity reservoir 
and no pouchitis (Stryker et al, 1986). Differences in small bowel motility 
characteristics in patients with high and low stool frequencies following IPAA 
may explain this phenomenon (Groom et al, 1994). Further, the functionally 
superior results reported in some series o f FAP patients undergoing EPAA, as 
compared with UC counterparts, has led to the suggestion that the remaining 
small bowel is functionally different in these two conditions (Dozois et al, 1989). 
Clearly, pre- and postoperative studies of small bowel motility characteristics in 
patients with UC undergoing IPAA would be necessary to resolve these questions.
Although some workers have examined the relationship of small bowel 
motility to EPAA function after reservoir construction (see section 2.5.3), 
surprisingly there has yet to be a study of small bowel motility prior  to pouch 
surgery. This deficiency is compounded by the fact that the in vitro motility 
characteristics of the terminal ileum used to construct the pouch have never been 
assessed in UC and only examined briefly in control subjects (see section 4.2).
Two basic questions regarding small bowel motility therefore need to be 
answered in EPAA for UC:
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1. Do inter-individual differences in patterns of small bowel motility 
correlate with individual preoperative stool frequencies in patients with UC before 
IPAA is performed?
2. What are the in vitro characteristics of human terminal ileum in health 
and UC?
This thesis attempted to answer these questions by studying, in vivo and in 
vitro, the small bowel motility characteristics of UC patients undergoing IPAA. 
Solid state ambulatory manometry was used to assess, in vivo, the preoperative 
patterns of human small bowel motility in patients undergoing EPAA. In resected 
specimens from control and IPAA patients with UC, specific interest was 
focussed on two areas of smooth muscle function. These areas comprised the 
characteristics of and effects of drugs on spontaneous myogenic activity in the 
human terminal ileum and the role o f nitric oxide (NO) as a mediator of inhibitory 
neurotransmission in this region of the gut in control and UC patients.
The background literature to these two areas of research and the in vivo 
and in vitro experimental work which was carried out are reported in the 
following chapters.
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CHAPTER 2 
SMALL BOWEL MOTILITY- IN  VIVO ASPECTS
2.1 INTRODUCTION
A study of small bowel motility in preoperative patients with UC would 
help to establish whether inter-individual differences in small bowel motility 
patterns correlated with respective preoperative stool frequencies before IPAA is 
performed. However, the term "motility" covers a diverse range of smooth muscle 
functions matched only by the wide variety of techniques used to investigate them. 
Clinical techniques used to assess small bowel motility are listed in Table 2.1.
Clearly, studies of small bowel motility can focus at different functional 
levels such as the single smooth muscle cell, whole tissue preparation or intact 
animal. This chapter examines the properties of small bowel which determine its 
motility characteristics, assesses the recording techniques which can be used to 
investigate human small bowel motility and reviews the data obtained from small 
bowel manometry studies in healthy individuals, in patients with motility 
disorders and in those who have undergone IPAA.
2.2 BACKGROUND
2.2.1 FUNCTIONS SERVED BY SMALL BOWEL MOTILITY
Contractions of the small bowel are complex. They carry out several 
important functions in both the fed state, when nutrient assimilation takes place 
and in the fasting state, when nutrients are absent (different contraction patterns in 
both fed and fasting states are discussed in section 2.4.1). During the fed state, 
small bowel contractions may assist in the control of gastric emptying, mix 
intraluminal contents with pancreatic, biliary and enteric secretions, bring 
intraluminal contents into contact with the absorptive surface of the mucosa and 
bring about an overall net caudad (downstream) movement. In the fasting state, 
muscle contractions may prevent disuse atrophy of the smooth muscle cells in the 
wall of the small bowel. Contractions are also coupled to intestinal secretory
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SMALL BOWEL MOTILITY INVESTIGATION TECHNIQUES
SMALL BOWEL MOTOR/ MYOELECTRIC ACTIVITY 
Intraluminal manometry 
Serosal electromyography 
Transluminal electromyography
SMALL BOWEL TRANSIT 
Breath hydrogen analysis 
Scintigraphy
Table 2.1: Clinical techniques used to investigate small bowel motility.
events and occur periodically, propelling the secretions caudad. Along with 
digestive secretions, small bowel contractions in the interdigestive phase maintain 
a low microbial count in the proximal gut. Furthermore, these contractile patterns 
may also be altered or be absent in certain disease states where clinical signs and 
symptoms suggest disrupted gut motility. To date two studies have shown that 
alterations in fasting motility patterns can lead to small bowel bacterial 
overgrowth (Vantrappen et al, 1977; Scott & Cahall, 1982).
2.2 PHYSIOLOGICAL ASPECTS OF SMALL BOWEL MOTILITY
Several basic physiological phenomena underlie contractile activity in the 
small bowel. These include electrical "slow waves", action potentials, 
coordination or propagation of motility, the migrating motor complex (MMC) and 
postprandial motility. Appreciation of these aspects of intestinal smooth muscle 
activity is important when attempts are made to interpret motor events in the small 
bowel.
ELECTRICAL "SLOW WAVES"
Slow waves (also referred to as pacemaker potential, basic electrical 
rhythm or electrical control activity) are rhythmic oscillations of membrane 
potential of smooth muscle cells. They can be detected by several in vitro and in 
vivo techniques. The electrical signals can be recorded by intracellular 
microelectrodes in single smooth muscle cells in vitro, or from groups of smooth 
muscle cells using extracellular electrodes in vitro (see section 4.4) or in vivo (see 
section 2.3). In the small bowel, the intrinsic frequency of the slow wave 
decreases in a caudad direction. This gradient is thought to enable propulsion of 
gut contents in all mammals (Phillips, 1988). In humans, the gradient was first 
documented using electrical recording techniques (Christensen, 1966). The 
mechanism by which a faster proximal pacemaker in the small bowel captures and 
drives the more distal small bowel is thought to involve a series of relaxation
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oscillators (Sama et al, 1971; Sama, 1984). However, the cellular mechanisms 
which regulate this gradient of spontaneous myogenic activty remain unknown.
ACTION POTENTIALS AND SLOW WAVES
The maximum rate at which contractions in different areas of the small 
bowel occur is governed by the slow wave. When smooth muscle membrane 
depolarisation occurs, in association with a slow wave, an action potential is 
recorded. Furthermore, when depolarisation takes place in association with all 
slow waves in a particular region of the small bowel, this area will contract at its 
maximum frequency. Indeed, this frequency gradient of small bowel contractions 
shows the same frequency gradient as the slow wave. However, the small bowel 
may also contract in response to only some or none of the slow waves. This 
capacity for the membrane potential (slow wave) to either trigger an action 
potential or not, enables intestinal muscular contractions to vary in intensity and 
underlies the subtle motility patterns which exist in small bowel. These aspects 
are discussed more fully in Chapter 4, Section 4.1. The varying patterns of 
contractile activity or inactivity in the small bowel are determined by the balance 
of local factors such as gut contents, extrinsic and intrinsic innervation, as well as 
neurotransmittters.
COORDINATION OR PROPAGATION OF MOTILITY
As well as a gradient for slow waves along the length of the small bowel 
there is also a "phase-lag" which results in the slow waves appearing to move in a 
caudad direction. Slow waves not only determine the pace of contractile events at 
sites in the small bowel as they pass downstream but also enable mechanical 
events to be propagated. Stationary contractions in the small bowel move gut 
contents in both directions simultaneously, whereas propagated mechanical 
activity causes propulsion of contents. The mechanisms which regulate the 
degrees of coordination in intestinal smooth muscle are unknown, but
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undoubtedly contribute to the wide range of transit rates seen in small bowel. The 
variations in degrees of coordination and propagation of small bowel motility are 
most notable in the digestive (postprandial) state.
THE MIGRATING MOTOR COMPLEX
Periodic activity in the stomach and small bowel was first described by 
Boldyreff in Pavlov’s laboratory in 1905 (Wingate, 1981). However, it was not 
until Szurszewski identified a regular motility cycle in fasting small bowel, using 
electromyography in conscious dogs (Szurszewski, 1969) that this phenomenon 
was clearly identified. In the latter study a migrating burst o f intense spike activity 
lasting 90-120 min was detected by a series of electrodes positioned along the gut 
from duodenum to ileum. A phase lag between each sensor corresponded to the 
time required for motor pattern propagation and the intense spike activity was 
noted to alternate with phases of inactivity (quiescence). This phenomenon is now 
recognised as a universal feature of mammalian small bowel. In electrical terms 
the interdigestive myoelectrical complex (EDMEC) is a short burst of spiking 
activity over several minutes during which every slow wave leads to an action 
potential. The IDMEC migrates along the small bowel with a velocity and 
periodicity such that when one burst reaches the ileum, another starts in the 
duodenum. This cycle of 90-120 min has been divided into four phases in the dog 
small bowel (Code & Marlett, 1975). Human interdigestive motility was classified 
into four phases in a similar manner to that of Code and Marlett, by Vantrappen 
and colleagues in 1977 (Vantrappen et al, 1977); in recent years Phase IV 
designation has largely been abandoned since it is often poorly developed. These 
phases of mechanical activity are summarised in Table 2.2. Phase III of 
interdigestive motility is known as the migrating motor complex (MMC). For 
examples see Chapter 3.
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FASTING (INTERDIGESTIVE) MOTOR ACTIVITY
PHASE I 
Motor quiescence
PHASE II
Persistent but irregular motor activity 
PHASE III
Regular contractions superimposed on every electric 
depolarisation
Table 2.2: Normal fasting (interdigestive) motor activity. Phase IE (migrating
motor complex, MMC) lasts about 1 Omin and migrates slowly down the small 
intestine before recurring after a period of about 90min.
POSTPRANDIAL MOTILITY
In the postprandial (fed) pattern of small bowel contractions replacement 
of the MMC occurs with an almost continuous low level of contractile activity 
(for example see Chapter 3). This makes detailed analysis difficult, and in many 
cases, impossible. The random patterns of spiking and contractility can persist for 
several hours and are influenced by both the calorific value of the meal and the 
nutrient constituents. After a meal the human MMC usually first reappears in the 
mid-jejunum. At present, little else is known about the organisation of human 
postprandial motor activity. Unfortunately, many patients with clinical signs of 
disturbed small bowel motility experience their symptoms after eating.
2.3 METHODS OF RECORDING HUMAN SMALL BOWEL 
MOTILITY
Human gastrointestinal motor activity can be evaluated using one or more 
of three basic techniques. These comprise cutaneous recordings of myoelectric 
activity, postoperative serosal myoelectric recordings and intraluminal 
monitoring.
Electrodes placed on the skin surface to obtain recordings of myoelectric 
activity are the least invasive of these recording methods. However, in reality their 
application is limited to the measurement of gastric antral myoelectric activity 
(electrogastrography, EGG) (Abell & Malagelada, 1988). This technique has no 
useful role in assessing small bowel motility.
Implantation of serosal electrodes at the time of open surgery enables 
accurate postoperative recordings of myoelectric activity but is largely restricted 
in humans because of its invasive nature (Richter & Kelly, 1986; Miedema et al, 
1992).
Recordings of intraluminal myoelectric and/or contractile activity 
represent a semi-invasive compromise between the two previously described 
techniques. Indeed, this is the most widely used technique to evaluate motor
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function along the entire length of the human gut. In the upper gastrointestinal 
tract the subject can be intubated either orally or nasally with a flexible recording 
catheter; in the colon the recording device is usually positioned with the aid of a 
colonoscope, while intraluminal measurements in the anorectum are easily 
obtained from catheters inserted under direct vision. Transluminal 
electromyography with bipolar electrodes has been used to investigate human 
small bowel (Fleckenstein, 1978). However, concerns over the safety and 
reliability of suction, wick and mucosal clip electrodes have limited the 
application of this technique. Moreover, the myoelectric tracings obtained from 
intraluminal bipolar electrodes are difficult to interpret and are used less 
commonly than recordings of contractile activity obtained either with manometric 
tips or solid state transducers.
The principles underlying manometric assessment of the human small 
bowel and the manometry techniques which are available to study this region of 
the gut are discussed below.
2.4 MANOMETRIC TECHNIQUES
2.4.1 PRINCIPLES OF MANOMETRY
The technique of manometry records gastrointestinal tract mechanical 
activity by detecting and measuring changes in intraluminal pressure caused by 
gut wall contractions. In basic physics terms, however, a manometer is a device 
which measures the pressure of fluid or gas in an enclosed chamber. The 
instrument consists of a U-shaped tube filled with liquid. The unknown pressure 
of the fluid or gas in the chamber is applied to one limb of this tube and the height 
of the column of liquid in the other limb above the equilibrium level equals this 
unknown pressure. To record gut contractility this method has been modified by 
the use of low compliance open-tip perfiised-tube (pneumohydraulic) systems. An 
alternative and more modem manometry recording technique involves
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intraluminal pressure measurements using tube-mounted electronic transducer 
strain gauges (solid state).
2.4.2 PNEUMOHYDRAULIC MANOMETRY
Pneumohydraulic manometry relies on the perfusion of distilled water at a 
constant pressure through one or more side openings in an intraluminal recording 
catheter. When gastrointestinal smooth muscle contracts sufficiently to occlude 
the lumen at the level of the opening, the flow of water is restricted. Such 
resistance to perfusate outflow causes an increase in pressure inside the catheter 
tubing which is in turn measured by a resistive transducer mounted on a 
diaphragm. The pressure amplitude which is generated in this way is proportional 
to the resistance to perfusate outflow. This, in turn, depends on the force with 
which the smooth muscle contracts and on the length of gut segment affected by 
this contraction. Pneumohydraulic manometry therefore records the force with 
which the contraction occurs. Contractions which fail to occlude the manometric 
tip are not recorded with this technique. Similarly, a contraction at one site will 
produce little or no alteration in intraluminal pressure at adjacent non-contracting 
sites.
Pneumohydraulic manometry catheters for small bowel recording are 
multilumen enabling recordings to be made at several different levels. The tubing 
itself is made of polyvinylchloride which permits bonding of several tubes and 
also retains flexibility for passage along the gut. The tube dimensions range from 
inner diameters of 0.75mm to outer diameters of 2.0mm. As a result, perfusion of 
distilled water through these small lumens is very restricted, with typical infusion 
rates of 0.5-3ml/min. Such a hydraulic capillary system achieves high fidelity 
recording of intraluminal pressure at a low infusion rate. A reservoir of water is 
maintained at a high constant pressure (1 OOmmHg), and is reduced to atmospheric 
presure by the narrow calibre capillary tubing which has a high resistance to flow. 
The flow rate is largely unaffected by gut contractions since the pressure in the
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manometry tube lumen is always low in comparison with the reservoir pressure. 
As the infusion system compliance is therefore minimised, the manometer itself 
becomes the main source of compliance in the pneumohydraulic system. Water- 
perfused manometry catheters have proved to be reliable and accurate but the 
accompanying cumbersome apparatus limits this technique to bedside studies. A 
recent advance, which has overcome this drawback, is the ability to record 
contractile activity over 24 hour periods with ambulatory solid state manometry 
systems.
2.4.3 SOLID STATE MANOMETRY
Solid state manometry catheters comprise a fine tube (2.0mm outer 
diameter) on which are mounted pressure-sensitive electronic strain gauge 
sensors. Measurements of pressure are relayed from the sensors to a portable 
electronic recorder. Data from the latter can be downloaded at the end of the study 
period to a computer for storage, replay and analysis.
Since many motility abnormalities become more apparent during routine 
activities or over several hours, ambulatory techniques enable important 
measurements of gut contractile activity to be made in subjects who are under "as 
near normal" environmental conditions. However, these solid state ambulatory 
catheters are more expensive than their water-perfused counterparts and are less 
robust. In recent years they have, nevertheless, been used with increasing 
frequency in motility studies.
2.4.4 MULTICHANNEL MANOMETRIC RECORDINGS
The small bowel motor functions of mixing and propulsion depend on 
both contractions at a given location and their spatial relationship with 
contractions at adjacent sites. Pneumohydraulic and solid state manometry 
catheters are therefore generally equipped with multiple recording channels in 
order to obtain meaningful recordings over several sites in the gut. With
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multichannel manometry the recording tip/sensors can be spaced far apart to 
measure motor activity over one or more distinct areas, or instead spaced close 
together to measure contractions from a short gut segment. Although these two 
strategies give different types of information on gut motiltity they each record the 
temporal and spatial organisation of contractions. Temporal organisation refers to 
the characteristics of contractions at a given anatomical site; these vary with time 
and include frequency, amplitude and duration. Spatial organisation, on the other 
hand, refers to the relationship between contractions which occur at adjacent gut 
sites. The specific characteristics of spatial organisation which are commonly 
noted in manometry studies include propagation (or non-propagation) of 
contractions, as well as their direction, velocity and length of propagation.
The temporal and spatial organisation characteristics which have been 
established in certain patterns of human small bowel motility are reviewed below. 
These include studies of asymptomatic individuals o f patients with certain disease 
states associated with abnormal small bowel motility and of patients who have 
undergone IPAA.
2.5 HUMAN SMALL BOWEL MANOMETRY PATTERNS 
2.5.1 HEALTH
The spatial and temporal organisation of small bowel contractions may 
change in response to different ingested nutrients and different motility 
requirements. For the majority of time, the small bowel mixes ingested food with 
enteric and exocrine secretions, moving gut contents in a caudad direction. 
However, occasionally, under certain circumstances, the small bowel has to move 
luminal contents rapidly in either orad or caudad directions, such as vomiting and 
mass movements respectively. In addition, the small bowel has to keep its lumen 
free of residual debris between meals. Each of these functions is carried out by a
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different type of contraction. Three categories of small bowel contraction are 
recognised (see Table 2.3).
INDIVIDUAL PHASIC CONTRACTIONS
The basic unit of contractile activity in the fasted and fed state is the 
individual phasic contraction. In the human jejunum, individual phasic 
contractions are spatially and temporally discoordinated when measured from 
recording sites just 2cm apart (Sama, 1989). The term "discoordination" refers to 
the fact that most of the individual phasic contractions in the jejunum vary both in 
amplitude and frequency and that few, if any, propagate distances of 2cm or more. 
Although these contractions cause very slow distal propulsion, they enable mixing 
of the luminal contents to occur with exposure of nutrients to the absorptive 
surface area of the jejunal mucosa. Occasionally, larger amplitude and longer 
duration single contractions which sweep over several centimetres are detected in 
the jejunum. This "individual migrating contraction" may have a role in propelling 
jejunal contents rapidly over short distances in a caudad direction.
The spatial and temporal organisation of individual phasic contractions in 
healthy and diseased human small bowel have not been fully characterised. 
However, this type of contraction may dictate small bowel mixing characteristics 
and transit rates. Any organisational changes to these contractions may therefore 
produce absorptive and transit disorders.
ORGANISED GROUPS OF CONTRACTIONS
Two organised groups of contractions are recognised in the human small 
bowel. These are the migrating motor complex (MMC) and discrete clustered 
contractions (DCCs)
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CATEGORIES OF SMALL BOWEL CONTRACTION
INDIVIDUAL PHASIC CONTRACTIONS
ORGANISED GROUPS OF CONTRACTIONS 
Migrating motor complex 
Discrete clustered contractions
SPECIAL PROPULSIVE CONTRACTIONS 
Prolonged propagating contractions 
Giant retrograde contractions 
Mini-activity front
Table 2.3: Categories of small bowel contraction.
Migrating motor complex
As discussed in section 2.2.2, the MMC is the mechanical activity front in 
phase EH of fasting motility. In the human small bowel the MMC is a periodically 
occurring band of contractile activity which normally originates in the proximal 
duodenum and migrates caudad to the ileocaecal junction (ICJ). It normally occurs 
only in the fasting state with a cycle length of 150 min. Cycle length is defined as 
the time interval between two successive MMCs passing the most proximal 
manometry port/sensor. At any given site the MMC lasts for a period of 6-10 min 
and migrates caudad with a velocity of 1-4 cm/min. The effects of eating on the 
MMC cycle are discussed in section 2.2.2.
Discrete clustered contraction
Discrete clustered contractions (DCCs) are groups of contractions lasting 
l-2min which migrate over short distances in a caudad direction. Unlike MMCs, 
DCCs may occur in both the fasting and fed states, and are characterised by their 
irregularity and occur in an unpredictable sequence. For this reason DCCs have 
been difficult to investigate in health and disease states.
SPECIAL PROPULSIVE CONTRACTIONS
In certain physiological circumstances the small bowel is required to 
propel gut contents in orad or caudad directions. This is achieved by prolonged 
propagating contractions (PPCs); giant retrograde contractions (GRCs); and mini­
activity fronts (MAFs).
Prolonged propagating contractions
The prolonged propagating contraction (PPC) is a large amplitude, 
sustained contraction which migrates rapidly down the small bowel (>60cm/min). 
It is about 1.5-2 times larger in amplitude and 4-6 times longer in duration than 
the phasic contractions seen in the MMC (Sama, 1987). PPCs are caused by
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profound smooth muscle depolarisation which removes it from the control of the 
slow wave. Once initiated, PPCs migrate uninterruptedly into the terminal ileum 
and often across the ICJ into the proximal colon. The PPC is highly propulsive as 
a result of its characteristic large amplitude, long duration and unimpeded caudad 
propagation. In health, these contractions can occur normally in the terminal ileum 
where they propel semi-solid material into the colon. PPCs can also be induced by 
the presence of short-chain fatty acids (SCFAs) in the small intestine. This may 
act as a reflex control mechanism to prevent reflux of colonic contents into the 
lower small bowel, since SCFAs are normally found in the colon. At present, the 
precise function of PPCs in health is unknown. However, they may have a 
pathophysiological role in abdominal pain and diarrhoea (Kellow & Phillips, 
1987).
Giant retrograde contractions
The gaint retrograde contraction (GRC) is one of the motor correlates of 
vomiting (Sama, 1989). It originates, just prior to vomiting, in the upper small 
bowel and is 1.5-2 times larger in amplitude and 2-4 times longer in duration than 
the phasic contractions of the MMC. The GRC migrates orad at a velocity of 8- 
lOcm/s. In this fashion it evacuates the contents of the upper small bowel into the 
stomach in preparation for vomiting.
Mini-activity front
A third type of special propulsive contraction can be associated with 
nausea and vomiting. The mini-activity front (MAF) consists of regular 
contractions lasting for short periods of 2-3min. Unlike the MMC, the MAF may, 
instead of migrating caudad, either remain stationary or propagate orad.
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2.5.2 MOTILITY DISORDERS
Small bowel motility in humans is affected by a spectrum of conditions. 
Alterations to the spatial and temporal organisation of specialised small bowel 
contractions as a result o f disease are reviewed below.
MMC patterns in motility disorders
Manometry has been used to correlate MMC characteristics with such 
motility disorders as diarrhoea or constipation but has failed to define a consistent 
relationship. The MMC is present in diabetes mellitus (Malagelada et al, 1980), 
Chaga's disease (Oliveira et al, 1983), peptic ulcer disease (Miranda et al, 1985; 
Thompson et al, 1982), myotonic dystrophy (Nowak et al, 1984) and irritable 
bowel syndrome (Kellow & Phillips, 1987). During prolonged small bowel 
manometry measurements in IBS, abnormalities in the MMC cycle length and 
abnormal motor patterns have been noted which correlate with symptoms (Kellow 
et al, 1990; Kellow et al, 1992). More recently, in patients with diarrhoea- 
predominant IBS, manometry has failed to show any abnormalities of fasting 
small bowel motility (Gorard et al, 1994).
In some studies the MMC is always present while in others it is absent in 
some patients. These studies included investigation of idiopathic intestinal 
pseudo-obstruction (Sama et al, 1978; Summers et al, 1983), scleroderma (Rees 
et al, 1982), and small bowel overgrowth (Code & Marlett, 1975). Attempts to 
correlate specific MMC characteristics, such as cycle length, duration, direction of 
migration, velocity and distance of propagation, with motility disorders in certain 
disease states have been unsuccessful. It seems likely that alterations in these 
MMC characteristics would have a significant impact on small bowel motility. 
Indeed, in contrast to animal studies, MMC characteristics are highly variable in 
normal human subjects (Kellow et al, 1986; Kerlin & Phillips, 1982). Further, 
since MMC are only present in the fasting period, extrapolation of changes in 
MMC characteristics to small bowel motility in the fed state would be difficult.
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Nevertheless, motility disorders of neural or chemical origin may manifest 
manometrically as failure to disrupt the MMC following a meal or early return of 
MMC in the postprandial period. In addition, MMCs appearing in the digestive 
state could alter small bowel transit times.
Discrete clustered contractions in motility disorders
DCCs have been associated with symptoms of abdominal discomfort in 
patients with IBS (Kellow & Phillips, 1987). These patients were also found to 
have DCCs which occurred in the fasting period for a greater percentage of time 
and at a greater amplitude than DCCs in control subjects. DCCs have also been 
observed in cases of pseudoobstruction and can be induced by administration of 
both mannitol and cisapride (Read, 1986).
Prolonged propagating contractions in motility disorders
The occurrence of PPCs in proximal small bowel is abnormal and can be 
associated with abdominal pain (Sama, 1989; Kellow & Phillips, 1987) while the 
incidence of PPCs and their site of origin relative to the ileocaecal junction are 
both increased significantly during nematode infection (Trichinella spiralis), 
(Cowles & Sama, 1988), and abdominal irradiation (Otterson et al, 1988). Both of 
these factors may contribute to the diarrhoea experienced by patients in such 
circumstances (Sama & Otterson, 1989).
2.5.3 ILEAL POUCH- ANAL ANASTOMOSIS
To date three groups of workers have studied small bowel motility in 
patients following  IPAA (see Table 2.4). There were, however, considerable 
differences in both the configurations and types of manometry catheters used in 
each of these studies, as well as in study design. Nevertheless, interesting data 
have emerged concerning the motility of the small bowel after IPAA. The findings 
are described below.
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The Mayo Clinic study
Stryker and colleagues used small bowel manometry to assess 8 IPAA 
patients with a preoperative diagnosis of UC (Stryker et al, 1985). The patients 
had a variable clinical outcome ranging from 2-17 stools per 24 hours, and were 
compared with 6 healthy volunteers. Follow-up occurred at 4-24 months after 
pouch surgery. Using a pneumohydraulic manometry system, both small bowel 
and pouch contractile activity were recorded simultaneously. Small bowel motility 
was measured with a nine-channel catheter with side-ports at 
10,20,30,40,50,75,100 and 125cm from the tip while a second separate three- 
lumen assembly was placed transanally into the pouch to monitor propagation of 
proximal small bowel motility. Fasting and fed recordings were made over 
periods of 20 hours and 6 hours respectively and analysed for the presence of 
MMCs, PPCs and DCCs.
There were no differences between the patient groups in terms of MMC 
frequency, duration or velocity of propagation. PPCs had similar durations and 
velocities in each group. However, PPC distribution differed; in controls, PPCs 
occurred only in the terminal ileum, but in 3 EPAA patients they were noted at the 
most proximal recording port at 125cm proximal to the pouch. DCCs occurred in 
all controls and in over half of the EPAA patients, with similar frequency, duration 
and velocity values. The Mayo Clinic group failed to show any correlation 
between motility patterns and frequency of pouch evacuation. Further, no 
temporal association was found between motility patterns and individual 
defaecation events.
The French study
Motility of the jejunum was examined in 11 patients and 6 control subjects 
to investigate whether small bowel motility was altered after EPAA because of 
mechanical obstruction and/or bacterial overgrowth (Chaussade et a l, 1989). 
Pneumohydraulic manometry and D-glucose breath tests were performed in 6
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patients with 6 months of pouch function and in 5 patients with 12 months of 
pouch function. The manometry catheter consisted of four side-holes located at 
0,30,60 and 90cm from the tip, with the most proximal port positioned under 
radiological control at the duodenojejunal flexure. Recordings were made in 11 
patients during fasting (4 hours) and in 7 patients after a liquid meal (1 hour). 
Using D-glucose breath testing, only 2 patients had bacterial overgrowth. MMC 
frequencies in the fasting period were unchanged between the 2 groups; PPCs 
were infrequent in the 6 control subjects and were never recorded in the fed period 
of the study. Four IPAA patients however, had numerous PPCs and 2 of these had 
evidence of jejunal bacterial overgrowth. Three of these 4 patients had triplicated 
"S" pouches and 2 required to catheterise the reservoir to achieve defaecation. In 
the fasting state, DCCs appeared with equal frequency between patients and 
controls. However, postprandially DCCs were recorded in all 7 IPAA patients (6 
of whom had no evidence of bacterial overgrowth), but were not seen in the 
control group.
The authors concluded that the presence of DCCs could have arisen from a 
functional obstruction as a result of small bowel anastomosis due to the high 
pressure zone of the anal sphincters since the same motility pattern was noted in 
the jejunum of patients with proximal or distal partial small bowel obstruction 
(Summers et al, 1983).
The St Mark’s study
The St Mark's group used a solid state ambulatory technique to determine 
whether small bowel motility was important in determining the frequency of 
defaecation following EPAA and to examine whether small bowel motility was 
propagated into the pouch (Groom et al, 1994). Both small bowel and pouch 
motility were compared in 2 groups of patients prospectively selected as having 
low or high stool frequencies. Twelve patients were studied with a range of 9-108 
months pouch function (5 with good functional outcome, 7 with poor functional
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outcome). Functional outcome in these patients was inversely related to their 24 
hour stool frequencies. The ambulatory small bowel manometry catheter 
comprised 5 solid state pressure transducers at 20,40,60,80 and 100cm from the 
distal tip, which was screened fluoroscopically to a position 20-30cm orad from 
the pouch. Once positioned, a second manometry catheter, with a solid state 
pressure transducer 1cm from the tip was inserted transanally into the pouch. 
Patients were studied whilst fully ambulant on an unrestricted diet. At the end of 
the ambulatory study, anal manometry, pouch-pressure volume and video 
evacuation pouchography studies were performed to assess anal sphincter 
function, pouch compliance and reservoir size respectively.
The major finding was that EPAA patients with poor pouch function had a 
significantly greater number of MMCs than those with good pouch function, 
during the fasting nocturnal period. Only 2 out of a total of 120 MMCs in the 12 
patients studied were propagated from the small bowel into the pouch. DCCs did 
not propagate into the pouch but in 1 patient PPCs were found to pass into the 
reservoir. Whilst stool volume over a 24 hour period and radiological pouch size 
were not significantly different between the patient groups, those with poor pouch 
function had a reduced maximum reservoir capacity. It was concluded that the 
differences in the maximum tolerated volume may have been related to changes in 
pouch sensitivity rather than to reservoir size. Such an alteration in pouch 
sensitivity in patients with poor functional outcome may have coexisted with the 
disturbances in nocturnal small bowel motility. Thus, although propagation of 
coordinated small bowel motility into the reservoir was rare, the results from this 
study suggested that small bowel motility orad  to the pouch was related to pouch 
functional outcome and 24 hour stool frequency.
Although each of the above studies examined postoperative patterns of 
small bowel motility, preoperative manometry has never been performed to study 
small bowel motility in patients awaiting IPAA. The following chapter describes a
36
pilot study which examined small bowel manometry patterns in prospective IPAA 
patients who suffered from UC.
37
CHAPTER 3
SMALL BOWEL MANOMETRY PATTERNS 
IN ULCERATIVE COLITICS 
UNDERGOING 
ILEAL POUCH-ANAL ANASTOMOSIS
3.1 INTRODUCTION
Given that EPAA has been used in the surgical management of UC for some 
fifteen years, it is surprising that only three small bowel manometry studies of 
IPAA patients have been reported. The most recent study on this subject and 
arguably the one which produced the most clinically relevant data was carried out 
by the St Marks' group who used ambulatory solid state manometry to measure 
small bowel motility in EPAA patients (Groom et al, 1994). This study 
demonstrated that small bowel motility parameters orad to the pouch were related 
to the pouch functional outcome and 24h stool frequency, but concluded that 
further studies were required to determine whether these existed before reservoir 
creation.
The main aim of the present study was therefore to assess differences 
between individuals in terms of small bowel motility patterns in prospective UC 
patients awaiting EPAA using ambulatory solid state manometry and to establish 
whether individual small bowel motility profiles correlated with defaecation 
patterns prior to removal of the inflamed colon and formation of IPAA. A second 
aim was to evaluate ambulatory small bowel manometry as a potential tool for 
preoperative investigation of IPAA patients.
3.2 PATIENTS AND METHODS
Patients
The patients investigated by small bowel manometry fell into two 
categories which are detailed below.
1. Preliminary study
Since small bowel manometry had never been previously used at Glasgow 
Royal Infirmary a preliminary series of small bowel intubations and manometry
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recordings were carried out in three patients with known gastrointestinal motility 
problems. Their clinical details are listed in Table 3.1.
2. Prospective IPAA patients
Eleven of 12 consecutive EPAA patients consented to undergo ambulatory 
small bowel manometry over a 10 month period. The preoperative diagnosis was 
UC in 9 and FAP in 2 patients. Clinical details for these patients are listed in Table 
3.2. Two patients with UC had undergone previous subtotal colectomy and 
preservation of rectal stump for toxic megacolon. Access to age- and sex-matched 
control subjects was not possible.
Equipm ent
A 3mm diameter pliable catheter 250cm in length was used to record small 
bowel motility (Gaeltec Limited, Dunvegan, Isle of Skye, Scotland). The catheter 
contained six solid state pressure transducers located at 5, 25, 45, 65, 95 and 
125cm from the distal tip (Fig 3.1). A central lumen allowed inflation/ deflation of 
a 7ml balloon tied on to the tip.
Subjects were intubated via the nasointestinal route following an overnight 
fast. Radiological screening was used to confirm the passage of the catheter 
through the pylorus. At this point, the balloon was inflated to facilitate caudad 
migration of the catheter. Regular radiological screening was used to monitor the 
progress of the catheter and the time taken for it to reach its final tip position in the 
terminal ileum noted (Fig 3.2). Once in the terminal ileum, the balloon was 
deflated and the catheter taped to the nostril to maintain its final position (Fig 3.3). 
The manometry catheter was then connected to a 7-channel portable recorder with 
512kBite digital memory (7-MPR recorder, Gaeltec Ltd, Isle of Skye, UK). 
Pressures were sampled in each channel at a frequency of 8Hz. The recorder was 
carried in a shoulder holster and had a patient-initiated event marker.
Note: The displays o f transducer recordings from these small bowel 
manometry studies (see Figs 3.5-9) are orientated in the opposite direction to
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Fig 3.1 Small bowel manometry catheter specifications: diagram shows positioning 
o f  six pressure transducers.
mm
Fig 3.2 Abdominal x-ray showing satisfactory final position with catheter tip in 
terminal ileum.
.3 Patient undergoing ambulatory small bowel manometry study.
conventional displays of such recordings, due to problems with the initial set-up of 
the system. The same trace orientation was, however, maintained for the duration 
of the study period. Data storage and trace analysis were unaffected by this display 
problem. Fig 3.5 illustrates the orientation of the small bowel manometry traces 
obtained in this pilot study.
Study conditions
Recording started once the tip was in its final position. Patients were fully 
ambulant during the study and on an unrestricted diet. Diaries of activities were 
kept by each individual. The patients were also asked to record times of eating and 
drinking, defaecation, passage of flatus and micturition. Topical pharyngeal 
anaesthesia was applied in a few situations where the patient complained of throat 
discomfort.
Data analysis
The data were downloaded to a Viglen IV/25 personal computer for 
analysis which was performed manually by reviewing all records in their entirety 
on the monitor screen. For analysis, each study was divided into diumal and 
nocturnal study periods. The diumal period was defined as the interval between 
waking and going to bed (usually 2200h). The nocturnal period was taken from 
2200h to 0700h, and during this period the subjects fasted.
Small bowel manometric activity was analysed to define the following 
periods:
1. phase I- quiescence (absence of motor activity),
2. phase II- motor activity characterised by irregular contractions,
3. phase EH- regular contractile activity at a frequency of 11-13/min, 
lasting at least three min. Phase IE activity represents the migrating motor complex 
(MMC). Propagation of motor activity was defined as caudad progression as 
measured in at least 3 transducers. Non-propagating motor activity was defined as
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contractile events recorded at only 1 transducer (acknowledging, however, that 
these may have propagated over a short distance).
During phase II activity, the traces were analysed for the presence of DCC 
(rhythmic bursts of phasic contractions of duration shorter than three minutes and 
occurring with a much greater periodicity than phase HI contractions. The presence 
of PPCs were also noted. These were defined as single pressure waves, propagated 
over at least three sites, and lasting 20-30s or more with pressures up to lOOmmHg.
In the nocturnal study, the durations of phases I, II and III were measured, 
in addition to the MMC cycle length. The latter was defined as the interval between 
2 successive phase III activity fronts passing the most proximal transducer. The 
duration and extent of caudad propagation of each MMC activity front was also 
measured.
3.3 RESULTS
1. Preliminary study
Several technical problems were encountered during the learning phase of 
small bowel manometry and these are summarised in Table 3.3.
A total of 29h o f recording (14h nocturnal, 15h diumal) were obtained from 
patients 2 and 3. Because of the position of the catheter tip in patient 1 recording 
was abandoned. Although a satisfactory terminal position of the small bowel 
manometry catheter was achieved in patient 2 , her disease process (systemic lupus 
erythematosis, SLE) made identification of MMC activity impossible. This in itself 
was an interesting feature which would merit further investigation. Conclusive 
evidence of MMC activity and caudad progression was seen in patient 3. However, 
because this individual required intravenous metoclopramide, itself a prokinetic 
agent which facilitates gastric emptying, to enable passage of the catheter through 
the pylorus after 24 hours of unsuccessful intubation, the traces were declared 
unsuitable for meaningful analysis. A further problem with this recording was the
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failure of the sixth transducer to detect pressure changes (see trace in Fig 3.5). 
Subsequent testing by the manufacturer confirmed the presence of water in the 
catheter assembly.
2. Prospective IPAA patients
One technical problem arose during small bowel intubation in the 
prospective ileoanal pouch patients. This occurred because of catheter impaction at 
the duodenojejunal flexure in study 4 which precluded further advancement. 
Interestingly, at subsequent laparotomy and IPAA, dense adhesions were noted 
around this area which were related, presumably, to this patient's previous 
emergency subtotal colectomy for fulminant UC.
The median length of time required to negotiate the catheter to its final 
resting position in the terminal ileum in the remaining 10 patients was 7.5h (range 
6-48h). Unfortunately, patient 11 demanded the catheter to be withdrawn shortly 
after successful intubation. Successful ambulatory small bowel manometry 
recordings were made in the remaining nine patients (8 UC, 1 FAP). The total 
recording period for these patients was 140h (8 lh  nocturnal); in four cases (patients 
10,11,13,14), diumal recording was not carried out at the request of the individuals, 
who were uncomfortable and felt unable to continue with the study following the 
nocturnal recording period. Diumal small bowel manometry recordings were made, 
however, in the other five subjects (patients 5-9) for a total of 59h.
The small bowel manometry pilot study is summarised in Fig 3.4. Trace 
orientation and examples of motility patterns are shown in Figs 3.5- 3.9.
Fasting nocturnal small bowel motility (2200h-0700h)
The data for the nocturnal study are summarised in Tables 3.4 and 3.5. 
Clearly, a spectrum of small bowel activity was noted during the fasting period in 
the nine patients studied.
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Small Bowel Manometry Studies
n=14
Preliminary Studies 
n=3
Completed Studies 
n=9
I---------------
Ulcerative Colitis 
n=8
1
FAP
n=l
I--------
Intact UC 
n=7
Staged UC 
n=l
Analysis o f small bowel motility 
and nocturnal stool frequency
Failed Studies 
n=2
Fig 3.4 Flow chart o f ambulatory small bowel manometry studies
in 14 patients.
FAP, familial adenomatous polyposis; UC, ulcerative colitis.
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Fig 3.5 Anatomical orientation and interpretation o f  manometry recording. Note 
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Fig 3.6 Compressed 24 hour small bowel manometry recording.
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Fig 3.9 Postprandial small bowel manometry trace (diurnal study).
NOCTURNAL SMALL BOWEL M OTILITY 
PARAMETERS
UC
n=8
FAP
n=l
MMCs
Propagating MMCs 54 5
Non-propagating MMCs 18 0
Total num ber of MMCs 72 5
N um ber of MMCs per subject 8(4-15) 5
D uration of MMC cycle (min) 62 (18-190) 27
Velocity of MMC cycle (cm/min) 3 (1-5) 3
INTERDIGESTIVE PHASE DURATION
Phase I (min) 80 (26-139) 33
Phase II (min) 19 (7-33) 10
Phase III (min) 10 (6-15) 9
Table 3.4: Nocturnal small bowel motility in prospective EPAA patients. UC,
ulcerative colitis; FAP, familial adenomatous polyposis; MMC, migrating motor 
complex. Values expressed as median (range).
NOCTURNAL MMC FEATURES UC
n=8
FAP
n=l
Propagating M MCs 54 5
Num ber of MMCs reaching distal transducer 50 0
Most proximal sensor at which MMC was 
first detected:
P I- Term inal ileum 0 0
P2 0 0
P3 8 0
P4 11 0
P5 18 2
P6- Duodenojejunal flexure 17 3
Total number o f  non-propagating M M Cs 17
Location and num ber of non-propagating 
MMCs recorded 
P I- Term inal ileum 4
P2 3
P3 2
P4 5
P5 1
P6- Duodenojejunal flexure 2
Table 3.5: Features of nocturnal migrating motor complexes (MMCs) and
other propagating contractions in prospective IPAA patients. UC, ulcerative colitis; 
FAP, familial adenomatous polyposis; PPC, prolongred propagating contraction; 
DCC, discrete clustered contraction.
There was no evidence of non-propagating MMCs in study 10 (FAP, 
female, age 15yrs). Otherwise, the motility parameters measured for this patient fell 
within the ranges encountered in the UC patients.
Interestingly, the highest total number of MMCs were in study 13 (UC- 
previous subtotal colectomy, age 30yrs), which had the only patient in the series 
with an end ileostomy.
Diumal small bowel motility (0700h- 2200h)
The diumal motility recordings for the five UC patients are summarised in 
Table 3.6.
Much of the recording time was spent in the postprandial state (see Fig 3.9). 
Consequently, trace analysis to determine MMC cycle length was impossible.
Relationship of small bowel motility with nocturnal defaecation patterns
Evaluation of the relationship between nocturnal defaecation patterns and 
motility was possible in the seven intact UC patients. The patient in study 3 was 
excluded from these calculations since it was not possible to document accurately 
the defaecation events from his end ileostomy. Data for these patients are 
summarised in Table 3.7.
There were no statistically significant relationships amongst the nocturnal 
defaecation patterns with respect to the total number o f MMCs, propagating 
MMCs, non-propagating MMCs, MMC cycle length, MMC mean duration , MMC 
mean velocity, number of PPCs, or number of DCCs and nocturnal stool 
frequency. Individual relationships between motility parameters and nocturnal stool 
frequency were calculated using Spearman's rank correlation, rs (Kirkwood, 1988). 
The respective correlation coefficients for each motility parameter are listed in 
Table 3.8. The phase IE motility parameters of the 7 intact UC patients studied 
noctumally and the distribution of stool frequency are shown in Table 3.9.
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DIURNAL MMC CHARACTERISTICS
Total d iurnal recording period (h) 
Hours per patient
59
12 (10-13)
Total number o f  M MCs 19
Num ber per patient
Velocity of propagation (cm/min)
Time to establishment of MMC post-cibal (min)
3.8 (1-7) 
2.64 (1.09- 3.65) 
314 (212-370)
Other propagating contractions
PPC
DCC
2 (0.7-3.5) 
7(5-11)
Table 3.6 Migrating motor complex (MMC) and other propagating contraction 
characteristics of 5 patients in the diumal study. PPC, prolonged propagating 
contraction; DCC, discrete clustered contraction. Values expressed as median 
(range).
NOCTURNAL M OTILITY PARAMETERS
Nocturnal stool frequency 2 (0-7)
Total MMCs 
Propagating MMCs 
Non-propagating MMCs
7(4-12) 
6 (3-9) 
3 (0-3)
MMC cycle length (min) 
MMC duration (min)
MMC mean velocity (cm/min)
41 (9.5-190.5) 
8.8 (5.9-15.3) 
2.64 (0.63-4.94)
Nocturnal PPCs 1 (0.86-2)
Nocturnal DCCs 5(4-6)
Table 3.7 Nocturnal motility parameters in 7 intact patients with ulcerative 
colitis. MMC, migrating motor complex; PPC, prolonged propagating contraction; 
DCC, discrete clustered contraction. Values expressed as median (range).
SMALL BOWEL 
M OTILITY PARAMETER
CORRELATION COEFFICIENT, r s, 
W ITH  NOCTURNAL 
STOOL FREQUENCY
P
Total num ber of MMCs 0.26 n.s
Propagating MMCs 0.22 n.s.
Non-propagating MMCs 0.36 n.s
MMC cycle length -0.54 n.s.
M MC mean duration -0.50 n.s
MMC mean velocity 0.43 n.s.
Mean num ber of PPCs -0.62 n.s
M ean num ber of DCCs -0.36 n.s.
Table 3.8 Correlation coefficients for motility parameters and nocturnal stool 
frequency in 7 intact patients with ulcerative colitis. rs, Spearman's rank correlation 
coefficient; P, probability; n.s., not significant.
NOCTURNAL INTERDIGESTIVE 
M OTILITY PARAMETERS 
AND STOOL FREQUENCY
Interdigestive Cycle
Phase I duration (min) 
Phase II duration (min) 
Phase III duration (min)
81.7 (26.4-139) 
13 (6.8-52.5) 
8.78 (5.9-15.3)
Total number o f  stools 14
N um ber of defaecations during each motility 
phase (%  total)
Phase I 
Phase II 
Phase III
12 (86%) 
1 (7%)
1 (7%)
Table 3.9 Interdigestive motility parameters of the 7 intact ulcerative colitics 
studied noctumally and the distribution of stool frequency during the study period. 
Results expressed as median (range).
The nocturnal small bowel motility parameters recorded for the 2 other 
patients (studies 10 and 13), are summarised in Table 3.10.
3.4 DISCUSSION
Ambulatory small bowel manometry is not easy to perform; several factors 
contribute to the difficulty of this technique. Firstly, intubation of the entire length 
of the small bowel, relying on gravity and peristalsis to negotiate the catheter into 
position, is a tedious and unpleasant process which may be affected by catheter- 
related or anatomical problems. In the preliminary study, looping of the catheter 
through the pylorus prevented further caudad migration and intubation of the small 
bowel had to be abandoned (study 1). Similarly, in the study of prospective IPAA 
patients 1 individual (study 4) had a failed intubation because the catheter would 
not pass the duodenojejunal flexure. This was later discovered to be due to dense 
adhesions.
Another problem with the technique is the fragility of the catheter. The two 
most common types of damage caused during intubation are crushing of the 
transducers by the patient's teeth if looping occurs in the mouth during insertion; 
and lacerations, again by inadvertent biting during catheter insertion, to the silicone 
sleeving of the assembly which enables water to seep into both the tubing and 
transducers (as experienced in study 3). Necessary catheter repairs are also 
expensive.
In addition to the costs of the catheter (in this sudy one catheter at 
discounted 1993 prices cost £3000), further expense is incurred with the need for 
radiological screening. An average of 8 sessions of screening (range 3-12) were 
required for the 11 prospective EPAA patients. This also carries a small amount of 
radiation exposure to both the patient and clinical staff. While ambulatory small 
bowel manometry could be performed on an out-patient basis, in practice patients
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NOCTURNAL M OTILITY 
PARAMETERS
Study 10: 
FAP
Study 13: 
Staged UC
Total MMCs 5 15
Propagating MMCs 5 12
Non-propagating MMCs 0 3
MMC cycle length (min) 26.8 21
MMC mean duration (min) 8.8 8.83
MMC mean velocity (cm/min) 2.82 4.34
Nocturnal PPCs 1 6
Nocturnal DCCs 2 5
Table 3.10 Motility parameters of other patients studied during nocturnal 
period. FAP, familial adenomatous polyposis coli; UC, ulcerative colitis. MMC, 
migrating motor complex; PPC, prolonged propagating contraction; DCC, discrete 
clustered contraction.
prefer to remain in hospital during the recording period. The cost of hospitalisation 
for periods of up to 3 days must also be taken into account when assessing this 
technique.
Interpretation of the data from small bowel manometry studies can be time- 
consuming. Analysis of 10 traces in this study took 60 hours. Although computer 
programmes have been devised to assist with the analysis, the traces in the present 
study and in all the other published series of small bowel manometry in DPAA 
patients were analysed manually.
Because of the associated difficulties with small bowel manometry large 
numbers of patients have not been recruited to this or previous EPAA patient 
studies. The lack of patient numbers compromises the validity of statistical tests 
applied to study data.
In the present study, a control group of patients, or more prospective FAP 
patients awaiting IPAA would have been helpful to permit comparisons with the 
UC recordings. Access to control (volunteer) subjects, which would have entailed 
remuneration, was not an available option. Furthermore, the number of FAP 
patients awaiting IPAA, who were studied, represent the total number of FAP 
pouches which were constructed in a 12 month period at a tertiary referral centre. 
Thus, in practical terms, recruitment of either control subjects or more FAP 
patients was not possible during the study period.
The main area of investigation in the present study was the nocturnal 
period. This was useful for two reasons. Firstly, it has been validated as a reliable 
time period to assess fasting motility patterns (Kumar et al, 1990). Secondly, the 
overnight stool pattern is a major determinant of long-term functional outcome (see 
Appendix). It was therefore important to investigate whether a relationship existed 
between patterns of fasting motility and nocturnal stool frequency in prospective 
IPAA patients. What conclusions can therefore be drawn from the data obtained? 
Clearly, the measured motility parameters showed no correlation with stool 
frequency in the 7 UC subjects studied. This answers in part, the main question
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raised by the St Mark's study (Groom et al, 1994), i.e. do small bowel motility 
profiles which correlate with postoperative stool patterns in IPAA patients with 
good and poor functional outcomes exist before pouch surgery?
The differences in the number of MMCs generated between individuals as 
well as cycle duration and MMC velocity are well documented (Groom et al, 
1994). However, in the present study the lack of correlation between motility 
parameters and nocturnal stool frequency may be due to the fact that the colon was 
in situ. Thus, any variation in small bowel activity may be dampened by the 
absorptive and reservoir capacity of the colon. When the colon is excised and 
IPAA performed, this may reveal the effect of inter-individual variation in small 
bowel behaviour with respect to stool frequency.
Prior to the St Mark's study (Groom et al, 1994) small bowel motility 
patterns had been implicated with different patterns of defaecation. In 1990, 
Kellow and colleagues performed 24 hour small bowel ambulatory manometry 
studies in 12 patients with irritable bowel syndrome (IBS) and compared these 
results with those from 8 healthy controls (Kellow et al, 1990). Diarrhoea- 
predominant IBS patients had significantly more frequent small bowel MMCs than 
control subjects.
Since, in the present study, no statistically significant correlations have 
been demonstrated to exist between small bowel motility parameters and stool 
frequency in preperative EPAA patients, the motility changes noted in patients with 
good and poor functional outcomes may have been related to functional differences 
in the actual pouches. These differences in frequency of pouch evacuation could in 
turn feed back to the small bowel proximal to the pouch via intrinsic neural 
pathways to modify its behaviour. Unfortunately, in the St Mark's patient group 
(Groom et al, 1994), reservoir design varied. Although the total volume and 
radiological size of the reservoirs in the good and poor functional groups were 
similar on performing pouch pressure-volume studies and video evacuation 
pouchography, differences were noted in the respective maximum tolerated pouch
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volumes. Those authors concluded that such differences were possibly related to 
altered pouch sensitivity rather than pouch size. A postoperative investigation of 
the 7 intact UC patients used in the present study, with further small bowel 
manometry combined with pouch-pressure volume measurements, stool volume 
and pouch sensitivity recordings would be helpful in establishing whether this 
postulated modification of small bowel motility by the pouch actually takes place. 
The 7 patients in this study would have the added advantages of having been 
standardised in terms of diagnosis, pouch design and absence of the effects of 
previous abdominal surgery. In the St Mark's study (Groom et al, 1994), however, 
the reservoirs of the 12 patients (10 UC, 2 FAP) comprised five "W" and six "J" 
pouches, with one ileoanal Kock reservoir.
While the two other studies o f small bowel motility in patients following 
IPAA failed to show any difference in MMC frequency, neither categorised the 
pouch subjects in terms of clinical function. In the French study (Chaussade et al, 
1989) only jejunal motility was considered and the study period lasted only 4 
hours. This was an inadequate time period in which to detect differences in small 
bowel motility (Groom et al, 1994). This study also looked at a heterogeneous 
group of pouch patients comprising 11 patients (10 UC, 1 FAP) with a mixture of 4 
"S" and 7 "J" reservoirs. Stryker et al recorded both jejunal and ileal motility for a 
longer time period, although non-ambulant water-perfused manometry was used 
(Stryker et al, 1985). In this study the periodicity and other parameters of the MMC 
were not significantly different between patients and control healthy sunjects. The 
Mayo Clinic study (Stryker et al, 1985), was also superior to the French study 
(Chaussade et al, 1989), since it examined patients with the same original disease 
(8 UC), who underwent a standardised pouch operation (Beart et al, 1982).
If one assumes that IPAA formation modifies proximal small bowel 
motility, it would be helpful to investigate the motility characteristics of the 
terminal ileum used to fashion the pouch. This could be achieved by looking at the 
in vitro characteristics of a small portion of ileum at the time of pouch
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construction. Alternatively, pouch motility could be investigated in an animal 
model. However, this has the disadvantage that there is no satisfactory animal 
model which reproduces the local and systemic effects of chronic UC.
While manometry has been used to investigate the motility characteristics 
of the terminal ileum (Hammer et al, 1993), the costs of manufacturing special 
catheters and problems intubating the most inaccessible area of the gastrointestinal 
tract made this an unattractive option, within the financial and practical constraints 
of this thesis. From the outset, in vitro analysis of ileum obtained at the time of 
pouch construction seemed to be a more useful and cheaper way of studying small 
bowel motility in UC patients undergoing IPAA.
The second section of this thesis deals with a series of experiments which 
were carried out in an attempt to characterise certain aspects of ileal motility. As a 
prelude, the following chapter reviews the literature relating to the aspects of 
motility which were investigated in vitro in samples o f ileum obtained at the time 
of IPAA formation.
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CHAPTER 4 
SMALL BOWEL MOTILITY - IN  VITRO ASPECTS
4.1 INTRODUCTION
From the concluding remarks of the preceding chapter in vitro motility 
studies may represent a more practical and cheaper way o f studying human small 
bowel motility characteristics in UC patients undergoing IPAA. However, unlike 
the vast amount of literature which exists on the in vitro small bowel motility 
characteristics o f various laboratory animals (see Furness & Costa, 1987) there is 
very little information available on the in vitro motility characteristics of human 
small bowel. This is, in part, due to ethical constraints regarding human tissue 
research. Any work which is undertaken on human small bowel in vitro must 
therefore target specific areas which are both suitable and practical to investigate. 
With these factors in mind, preliminary in vitro studies were undertaken in UC 
patients undergoing IPAA (see Chapter 5).
As a precursor, this chapter therefore reviews the relevant background areas 
which underpin the in vitro motility experiments described in Chapter 5. These 
areas include: the properties of spontaneous gastrointestinal pacemaker activity, the 
pharmacological characteristics of the human small bowel in health and 
inflammatory bowel disease, the nonadrenergic, noncholinergic (NANC) inhibitory 
control of gastrointestinal motility and the role of the L-arginine-nitric oxide 
pathway in NANC transmission in gastrointestinal smooth muscle.
4.2 SPONTANEOUS PACEMAKER ACTIVITY IN SMALL BOWEL
Small bowel manometry can determine gross patterns of fasting motility 
(see Chapter 3), but cannot accurately document segmental or peristaltic activity. 
For practical and ethical reasons it would be impossible to assess in vitro the 
motility characteristics of the human small bowel. Thus, the only segment of small 
bowel which is potentially available for study in patients with UC undergoing 
EPAA is the most distal edge of terminal ileum. One way to examine motility, in 
such a limited quantity of tissue would be to use either extra- or intracellular 
recording techniques to measure both these electrical and mechanical events which
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characterise the oscillatory contractions seen in mammalian intestinal smooth 
muscle (see Bolton, 1989). Indeed, this would be an obvious starting point in 
examining the basic in vitro motility characteristics of any intestinal smooth 
muscle preparation before proceeding to studies o f nerve-evoked and receptor- 
evoked responses, The following is a brief overview of the electrophysiology, 
origin and function of spontaneous activity in the small bowel of several species, 
including human.
The two transient electrical phenomena which are seen in gastrointestinal 
smooth muscle are the action potential and the slow wave (see Fig 4.1). While the 
action potential (spike burst) generally lasts for, at most, several milliseconds the 
slow wave can persist for several seconds and does not carry the membrane 
potential to such positive values as the action potential does. Spike bursts of action 
potentials are generally superimposed on the crests of slow waves and are not 
usually discharged in the intervals between slow waves when the membrane 
potential is at its most negative. The action potential consisits of an upstroke 
(depolarizing phase) followed by repolarization to a potential that may be more 
negative than the level at which it originally arose (afterhyperpolarization). The 
nature o f the ionic species responsible for the upstroke and downstroke of the spike 
have been investigated in several species (see Bolton, 1989). In general, the 
upstroke of the action potential is caused by potential-sensitive voltage dependent 
Ca++ channels operating i.e conducting Ca++. The downstroke (repolarization) is 
probably due to a vigorous increase in K+ conductance. The ionic basis of slow 
waves, on the other hand, is less clear and various hypotheses suggesting both 
voltage-dependent and metabolic components have been proposed. Regular 
spontaneous contractions observed in intestinal smooth muscle are presumed to 
indicate action potentials and/or slow wave discharge, but slow wave discharge 
alone, or in the absence of action potential discharge may be associated with weak 
or no contractions (Bolton, 1989).
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Fig 4.1 Transient electrical phenomena seen in gastrointestinal smooth muscle.
Anatomically, the upper duodenum has the highest intrinsic slow wave 
discharge frequency and this appears to decline caudad (Diamant & Bortoff, 1969). 
In this way a gradient of slow wave frequencies exist in the small intestine from 
duodenum to ileum in vivo. The origin of the slow wave has in recent years been 
re-examined. Originally slow waves were thought to originate in the longitudinal 
muscle (Bortoff et al, 1981) and to spread passively to the circular muscle where 
they either decayed electrotonically (Bortoff et al, 1981), or propagated by 
regenerative amplification (Connor et al, 1977). However, intracellular recordings 
in the longitudinal, inner and outer circular muscle layers o f several species, 
including human, showed that spontaneous slow waves were generated in non- 
neural cells located between the longitudinal and outer circular muscle layer and by 
non-neural cells located between the outer and inner circular muscle layers (Hara et 
al, 1986).
Recently, the interstitial cells of Cajal (ICCs), a group of cells in the 
gastrointestinal tract redescribed in 1893 by the Spanish neuroanatomist Santiago 
Ramon y Cajal (Cajal, 1893), have been proposed as the cells from which slow 
waves originate and therefore may act as the pacemakers of gut motor activity (see 
reviews by Hagger et al, 1997; Thuneberg, 1982). They have also been proposed as 
the intermediaries of the neural control of gut muscular activity. Extensive studies 
of human small bowel have enabled the locations of ICC to be mapped in the gut 
wall using a variety of histochemical staining techniques (see sections 5.4.1 and
5.4.3 for discussion). It is interesting to compare the work which located slow wave 
generation in the muscle layers of human jejunum (Hara et al, 1986) with more 
recent work which has mapped human small bowel ICC location (Hagger et al, 
1997), (see Fig 4.2). Although the work of Hara and colleagues did not provide 
direct confirmation, it did at least support the hypothesis that the ICCs generate 
slow waves in human small bowel.
The slow waves, thought to be generated by ICCs, are thought to determine 
the segmental contraction pattern of the gut and contribute to peristalsis. Excitatory
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Fig 4.2. Comparative diagrams showing location o f slow wave activity 
in human jejunum muscle layers with immunohistochemical 
localisation of human small bowel interstitial cells o f Cajal 
(ICC).
Adapted from Hara et al, 1986 and Hagger et al, 1997.
and inhibitory transmitters and hormones appear to regulate whether slow waves 
carry spike bursts, and if so, how many. Generally the spike rather than the slow 
wave is associated with muscle contraction. In some way ascending and descending 
neural pathways must control whether contraction associated with spike bursts on 
the crest of a slow wave remains localised (segmental) or is propagated 
(peristaltic). Although the small bowel of most species shows regular and 
continuous slow wave activity, peristaltic activity is less evident than segmental 
contractions (Bolton, 1989). As yet, the involvement of nervous activity in 
determining this pattern remains unestablished. Whilst slow wave activity in 
human small bowel has been studied by Hara and colleagues (Hara et al, 1986), the 
spontaneous activity characteristics of ileum in patients with UC remains unknown.
4.3 PHARMACOLOGY OF HUMAN ILEUM
A careful review of the literature has revealed 2 abstracts, a brief report and 
5 papers which have been published on the pharmacological characterisitics of 
human ileum in the last 30 years (1964-1994), see Table 4.1.
Fishlock reported the contractile effect of 5-hydroxytryptamine (5HT) on 
the circular muscle of the human ileum which was abolished by lysergic and 
diethylamide (LSD) and partially blocked by hexamethonium and morphine 
(Fishlock, 1960). One year later, Bennett demonstrated that ACh elicited 
contraction of both the longitudinal and circular muscle layers of the human ileum 
via muscarinic receptors, while the sympathomimetic amines (phenylephrine, 
noradrenaline, adrenaline and isoprenaline) relaxed both muscle layers and 
inhibited spontaneous contractions (Bennett, 1965). The contractile effects of 
exogenously applied histamine were also noted.
In 1980 Shirazi and colleagues published an abstract reporting the in vitro 
mechanical activity of transverse and longitudinal muscle strips from human 
terminal ileum (Shirazi et al, 1980). They found no differences in mechanical 
activity between the two muscle layers in terms of amplitude, frequency or resting
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YEAR AUTHOR(S) TOPIC PATIENT
STATUS
1964 Fishlock
(abstract)
Effects of 5HT on circular 
muscle
Control
1965 Bennett
(paper)
Basic characteristics of circular/ 
longitudinal muscle layers
-
1980 Shirazi et al, 
(abstract)
Mechanical activity of circular/ 
longitudinal strips
Control
1986 Hara et al, 
(paper)
Slow wave properties Control
1989 Maggi et al, 
(paper)
Effects of EFS and exogenous 
neuropeptides on longitudinal 
muscle
Control
1990 Maggi et al, 
(paper)
Effects of EFS and exogenous 
neuropeptides on circular 
muscle
Control
1991 Maggi et al, 
(paper)
Effects of NOS inhibitors on 
NANC relaxation in circular 
muscle
Control
1992 Maggi et al, 
(paper)
Inhibition of nerve-mediated 
contractions in circular muscle 
by tachykinin antagonists
Control
Table 4.1: Published work on the smooth muscle pharmacology of human
ileum. 5HT, 5 hydroxytryptamine; EFS, electrical field stimulation; NOS, nitric 
oxide synthase; NANC, non-adrenergic, non-cholinergic. For references see 
Bibliography.
tension. However, the mechanical responses of each muscle layer to electrical field 
stimulation (EFS) were generally opposite to one another, with the circular muscle 
tending to relax and the longitudinal layer contracting to EFS.
The work by Hara and colleagues on slow wave activity in human small 
bowel has been reviewed in the previous section (Hara et al, 1986).
Undoubtedly the greatest contribution to the study of human ileal smooth 
muscle pharmacology has been made by Maggi and co-workers (see Table 4.1) 
who focussed on the contractile effects of tachykinins- a family of peptides which 
include substance P (SP), neurokinin A (NKA) and neurokinin B (NKB). Maggi 
and colleagues showed that in the longitudinal muscle o f the human ileum both 
cholinergic excitatory and non-adrenergic, non-cholinergic (NANC) nerves 
affected motility and that several neuropeptides (NKA and SP) produced potent 
motor effects mediated by activation of NK-2 receptors (Maggi et al, 1989). VEP 
and calcitonin gene-related peptide (CGRP) each inhibited motility analogous to 
NANC stimulation. In circular muscle of human ileum cholinergic excitatory and 
non-cholinergic inhibitory nerves each affected motility while tachykinins exerted 
a potent contractile effect, independently of cholinergic nerves, via NK-1 and NK-2 
receptors (Maggi et al, 1990). Subsequent work with newly developed tachykinin 
antagonists showed that the circular muscle o f human ileum had NK-2 receptors as 
well as NK-1 receptors (Maggi et al, 1992). When activated, the former were 
largely responsible for the non-cholinergic rebound contraction to nerve 
stimulation.
The effects of nitric oxide synthase (NOS) inhibitors on NANC relaxation 
elicited by EFS in human ileal circular muscle were also studied (Maggi et al, 
1991). NOS inhibitors abolished the NANC-mediated relaxation in this tissue 
implicating NO as the inhibitory transmitter of these nerves.
Clearly only a handful of papers have been published on human ileal 
smooth muscle pharmacology. The data described above refer only to specimens 
obtained from patients undergoing colorectal and urological resections for
55
neoplasm i.e. control subjects. There are no previous studies on ileum from 
patients with UC. While a few other workers have performed in vitro research on 
human jejunum (Bauer et al, 1991; Stark et al, 1993), their findings cannot be 
extended to another anatomically distinct region of the gut, nor indeed applied to 
the ileum of UC patients undergoing IPAA.
An investigation of the smooth muscle pharmacological characteristics of 
UC pouch ileum must therefore rely on using the limited cuff of ileum discarded at 
the time of reservoir construction. For obvious reasons this places immediate 
restraints on any attempts at a systematic study to characterize all the aspects of 
spontaneous and nerve-mediated motility mechanisms.
In recent years there has been increased interest in both the role of NO as a 
NANC inhibitory transmitter in the mammalian gut and in its possible pathogenic 
role in UC and CD (see Chapter 6). A study of this aspect of inhibitory control in 
ileal motility would be interesting in UC patients undergoing IPAA. The 
background to NANC inhibitory transmission in the gut, as well as the literature 
concerning NO in gastrointestinal function and disease are reviewed in the 
following section.
4.4 NITRIC OXIDE (NO) AND NONADRENERGIC, NONCHOLINERGIC 
(NANC) INHIBITORY TRANSMISSION IN GASTROINTESTINAL 
SMOOTH MUSCLE
4.4.1 INTRODUCTION
The quest to identify the neurotransmitter from NANC nerves has stemmed 
from observations made over the last 100 years. Whilst sympathetic nerves were 
regarded as releasing only noradrenaline while parasympathetic nerves released 
only acetyl choline, several independent pieces of research suggested that this was 
an oversimplification of the peripheral autonomic nervous system. Electrical 
stimulation of the sacral parasympathetic outflow via the pelvic nerves led to penile
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erection that was unaffected by atropine (Langley & Anderson, 1895). Shortly 
thereafter, electrical stimulation o f the vagus was shown to elicit both motor and 
inhibitory responses from the stomach (Langley, 1898). Several workers also 
reported that atropine only partially blocked motor responses of mammalian 
urinary bladder preparations following parasympathetic nerve stimulation (Langley 
& Anderson, 1895; Henderson & Roepke, 1934; Ambache, 1955). Of these 
workers, only Henderson and Roepke concluded that the nerves were releasing a 
transmitter other than acetyl choline. With the introduction of selective adrenergic 
neurone blocking drugs, some smooth muscles were shown to be innervated by 
nerves which were neither adrenergic nor cholinergic. Electrical evidence for the 
distinct existence of non-adrenergic inhibitory nerves was first provided by 
Bumstock and colleagues using guinea-pig taenia coli (Bumstock et al, 1964). The 
following year vagal stimulation in the cat elicited relaxations which were resistant 
to both atropine and guanethidine (Martinson, 1965).
Over the last three decades NANC nerves have been shown to supply the 
smooth muscle of the upper, middle and lower regions of the alimentary tract of all 
mammals investigated (For reviews see Furness & Costa, 1987; Bumstock, 1981; 
Gillespie, 1982; Gillespie, 1990). NANC inhibitory neurones reflexly regulate 
smooth muscle relaxation during stomach filling and the subsequent movement of 
food and debris along the length of the gut. NANC nerves are also involved in 
sphincteric smooth muscle relaxation at the lower oesophageal sphincter (LOS), 
(Code & Schlegel, 1968), pylorus (Vanderwinden et al, 1993), ICJ (Boeckxstaens 
et al, 1990) and in the IAS (Rayner, 1974). They are responsible for the receptive 
relaxation and accommodation of both the stomach (Abrahamson, 1973) and gall 
bladder (Al-Hassani & Davidson, 1979; McKirdy & Johnson, 1991), as well as the 
descending inhibition of peristalsis (Hirst & McKirdy, 1974; Jule, 1980).
NANC nerves do not, however, comprise a homogeneous population with a 
single neurotransmitter. Several putative transmitters have been implicated in 
NANC neurotransmission or in cotransmission with "classical" transmitters in the
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gut. These other neurotransmitters have included ATP (Bumstock et al, 1970, 
Bumstock et al, 1972, Bumstock, 1981), 5-hydroxytryptamine (5HT), (Gershon, 
1979), vasoactive intestinal peptide (VIP), substance P and neuropeptide Y 
(Cuello, 1982; Lundberg & Hokfeldt, 1983; Bartfai et al, 1988). However, smooth 
muscles such as the bovine retractor penis muscle or rat anococcygeus the putative 
NANC inhibitory transmitter did not resemble any of the above substances. A 
novel smooth muscle inhibitory factor was isolated from both of these tisssues in 
the 1970s (Ambache et al, 1975; Gillespie & Martin, 1978). Further studies of this 
smooth muscle inhibitory factor over the last 15 years culminated in providing the 
first evidence that nitric oxide (NO) was released from NANC nerves (see Section 
4.4.3).
In recent years NO has been the topic of much research. Its role in the 
central nervous system, the cardiovascular system, in immunology and 
haematology, as well as smooth muscle has been investigated extensively. The 
following section reviews the role of the L-arginine-nitric oxide pathway in 
gastrointestinal function and disease.
4.4.2 THE L-ARGININE- NITRIC OXIDE PATHWAY: BACKGROUND
In the gastrointestinal tract NO has important physiological and 
pathological roles (see reviews by Moncada, 1992; Rand, 1992; Sanders & Ward, 
1992; Stark & Szurszewski, 1992; Moncada & Higgs, 1993). The following 
discussion reviews the background to the discovery o f NO and considers its roles 
in NANC neurotransmission in gastrointestinal smooth muscle.
The gas NO is a labile molecule, synthesised from the semiessential amino 
acid L-arginine (L-ARG) by a family of enzymes, the NO synthases, through the L- 
arginine-nitric oxide pathway (Moncada, 1992). NO is endogenous and stimulates 
soluble guanylate cyclase in a number of tissues, including the brain, the adrenal 
gland and platelets (see Fig 4.3). NO is also cytotoxic being released by activated 
macrophages following immunological challenge; it may function as an effector
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Fig 4.3 Schematic diagram of nitric oxide (NO) synthesis and action. Nitric
oxide synthase (NOS) is shown to be inhibited in the source cell by the 
stereospecific antagonists L-NAME, L-NMMA and L-NNA (see text). 
Extracellular NO is inhibited by oxyhaemoglobin (HbO), superoxide anion (0"2) 
and oxygen (O2). On entering the target cell NO activates guanylate cyclase. NO 
may also have effects in source cell.
(diagram modified from Stark & Szurszewski, 1992)
molecule mediating cytotoxicity in immune reactions against tumour cells and 
intracellular parasites (Hibbs et al, 1988; Stuehr et al, 1989; Salvemini et al, 1989; 
Liew et al, 1990). NO therefore has two diverse biological properties i.e. 
intercellular communication and cytotoxicity. Underlying these properties are two 
different classes of NO synthase (NOS). One is constitutive, cytosolic, Ca++ 
calmodulin-dependent (cNOS) and generates picomoles (10"12M) of NO in 
response to receptor activation. Constitutive means that it is present and active 
without exposure to inducing agents. The other class o f NO is cytosolic Ca++ 
calmodulin-independent (iNOS) and produces nanomoles (10-9M) of NO over long 
periods following induction by immunological stimuli. Importantly, iNOS 
induction is inhibited by glucocorticoids. Both cNOS and iNOS enzymes are 
NADPH- and tetrahydrobiopterin-dependent. Induction of cNOS by bacteria or 
lipopolysaccharide (LPS) in gut tissue, including smooth muscle has also been 
reported; this may have pathophysiological significance (Oguchi et al, 1992). 
Endothelial NOS may differ from the neuronal forms, thus distinguishing three 
forms of the enzyme (Schmidt et al, 1992).
NO has unique properties making it quite unlike any other biological 
mediator (Ignarro, 1989). NO is a colourless gas which is slightly water-soluble. In 
dilute solution, NO has a half-life of<10 seconds because it is rapidly oxidised to 
inorganic nitrite and nitrate. NO is also destroyed by superoxide anion. Superoxide 
dismutase protects NO from breakdown by the latter (Rubanyi, 1986; Gryglewski,
1986). NO binds to oxyhaemoglobin (HbO) which rapdily terminates its biological 
actions (Palmer et al, 1987; Ignarro et al, 1987; Martin et al, 1986), and in 
biological systems NO has a half-life of <5 seconds (Palmer et al, 1987). The 
enzymatic synthesis of NO is competitively antagonised by stereospecific 
analogues of L-arginine such as N^-monomethyl-L-arginine (L-NMMA), N03- 
nitro-L-arginine (L-NNA), and N^-nitro-L-arginine methyl ester (L-NAME). 
When NO is produced by vascular endothelial cells it diffuses into the cytosol of 
the adjacent vascular smooth muscle cells where it binds to soluble guanylate
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cyclase, a cytosolic haem-containing protein (Wolin et al, 1982). When NO binds 
to this enzyme production of 5'-cyclic guanosine monophosphate (cGMP) is 
activated with subsequent relaxation o f smooth muscle (Gruetter et al, 1981; 
Katsuki et al, 1977).
In the human, endothelium-dependent relaxation has been demonstrated in 
rings of vascular tissue (Thom et al, 1985; Luscher et al, 1988), and is more 
pronounced in arteries than in veins. This phenomenon suggests that arteries 
generate more NO than veins. The NO produced in the cardiovascular system 
contributes to the regulation of basal and stimulated regional blood flow (Vallance 
et al, 1989a; Vallance et al, 1989b). Endothelium-derived NO can also diffuse into 
nearby adhering platelets in the blood vessel lumen to inhibit platelet aggregation 
by a cGMP-dependent mechanism and acts in synergy with prostacyclin to inhibit 
the aggregation of platelets by increasing their levels o f cyclic adenosine 
monophosphate (cAMP), (Radomski et al, 1987). NO inhibits platelet adhesion 
and platelets themselves generate NO which acts as a negative-feedback 
mechanism to inhibit platelet activation (Radomski et al, 1990; Radomski & 
Moncada, 1991). NO derived from vascular endothelium may therefore have an 
important role in hypertension, shock and atherosclerosis.
Endogenous NO is also produced in nonvascular tissues including 
neutrophils, macrophages, brain, adrenal gland, renal epithelial cells, mast cells and 
peripheral neurones in gut, lung and penis. In the gastrointestinal system NO 
mediates relaxation of the muscularis extema and may play an important role in 
gastrointestinal mucosal blood flow, mucosal protection, haemodynamic response 
to liver disease, mediation of liver toxicity and regulation of hepatocyte function 
(Stark & Szurszewski, 1992).
The discovery that NO was an important messenger molecule came about 
more as a product of gradual evolution rather than through instant realisation. 
Review of the literature shows that several unrelated areas o f research each moving
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towards the common conclusion that NO plays an important physiological role in 
gastrointestinal function.
The identification of nitrosamines as potent carcinogens and their 
biosynthesis from nitrates led concerned workers to establish that nitrates could be 
synthesised by mammalian tissues. In addition, work revealed that the level of 
production of nitrates was increased under conditions o f infection or insult by 
inflammatory agents (Green et al, 1981; Wagner et al, 1983).
Research into macrophage activity showed that when macrophages are 
activated by bacterial toxins, cytokines or lipopolysaccharides, they produce nitrite 
and nitrate from the precursor L-arginine (Stuehr & Marietta, 1985; Iyengar et al,
1987). NO is an intermediate compound in the process of macrophage oxidation of 
L-arginine (L-ARG) to nitrite and nitrate (Marietta et al, 1988). More recently, NO 
has been identified as an important cytotoxic activated macrophage effector 
molecule (Hibbs et al, 1988; Nathan & Hibbs, 1991).
Workers studying the mechanisms of control of cardiovascular smooth 
muscle showed in 1980 that blood vessel endothelium was essential for the 
vasorelaxant effects of acetylcholine, and also demonstrated that this effect was 
mediated by the release of an endothelial substance that relaxed vascular smooth 
muscle (Furchgott & Zawadzki, 1980). The latter was termed endothelium-derived 
relaxant factor (EDRF). Over the next five years many studies were devoted to the 
characterisation of the pharmacological and chemical properties of EDRF. The 
well-known effects of the nitrovasodilators (i.e. nitroglycerin, amyl nitrite and 
sodium nitroprusside, SNP) to relax cardiovascular smooth muscle led to the 
suggestion that NO may indeed be EDRF. In 1987, this was confirmed by two 
groups working independently who using chemical assay and bioassay proved that 
NO was released from vascular endothelium and that the effects of NO and EDRF 
were indistinguishable (Palmer et al, 1987; Ignarro et al, 1987). NO is, however, 
not the sole agent responsible for causing hyperpolarization in vascular smooth 
muscle. More recently, other types of agonists in addition to EDRF have been
61
found to hyperpolarize the vascular smooth muscle membrane in an endothelium- 
dependent manner. These include endothelium-derived hyperpolarizing factor 
(EDHF, Chen et al, 1988) and prostanoids (Parkington et al, 1993)
Having discovered that NO was EDRF, it was logical to study its role on 
other smooth muscles. By 1989, three independent groups had reported that NO 
was the major NANC inhibitory neurotransmitter in the anococcygeus muscle, an 
accessory gut muscle in the rat and mouse (Gillespie et al, 1989; Li & Rand, 1989; 
Ramagopal & Leighton, 1989) and subsequently in gut preparations (Bult et al, 
1990; Hata et al, 1990; Li & Rand, 1990; Toda et al, 1990; Will et al, 1990; see 
review by Rand & Li, 1995). The research findings over the last 7 years which 
implicated NO as a mediator o f inhibitory NANC transmission are reviewed below.
4.4.3 EVIDENCE SUPPORTING THE L-ARGININE-NO PATHWAY AS A 
MEDIATOR OF INHIBITORY NANC TRANSMISSION
Unlike striated muscle, gastrointestinal smooth muscle is under both 
inhibitory and excitatory neuronal control. Excitation of smooth muscle results in 
contraction; in smooth muscle aligned in a circumferential manner this produces 
constriction and movement of gut contents. Inhibition, on the other hand, causes 
relaxation and a reduced resistance to movement o f contents. The "law of the 
intestine", viz. physiological stimulation of the intestinal wall causes contraction 
orally and relaxation anally has been evident since the work of Bayliss and Starling 
at the end of the last century (Bayliss & Starling, 1899). Indeed, those workers 
reported that in dog small intestine, vagal stimulation caused relaxation followed 
by a powerful contraction and that neither component was abolished by atropine. 
The orientation of these reflexes are essential to normal gut motility. 
Trendelenburg reported in 1917 that peristalsis could be recorded in isolated whole 
gut lengths of animal intestine, thus demonstrating that the enteric nervous system 
was the primary control mechanism of motility (Trendelenburg, 1917). Not 
surprisingly the polarity of the reflexes evoked by local stimulation is mirrored by
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the orientation of excitatory and inhibitory motor neurones. Thus excitatory motor 
neurones project orad and inhibitory motor neurones project caudad (Brookes et al, 
1991). Using atropine and a variety of selective adrenergic antagonists it became 
evident in the early 1960's that inhibitory neurotransmission to enteric smooth 
muscle was mediated by transmitters that were nonadrenergic, noncholinergic 
(NANC) in nature. Although strong electrical stimulation of mesenteric nerves 
activated postganglionic sympathetic nerve fibres and evoked adrenergic inhibition 
(Finkleman, 1930), it was shown that in the taenia coli intrinsic inhibitory motor 
neurones appeared to use a NANC transmitter (Bumstock et al, 1963) which was 
resistant to adrenergic blocking dmgs and therfore non-sympathetic. By 1972, 
adenosine triphosphate (ATP) or a related compound was implicated as the NANC 
transmitter released by inhibitory motor neurones in the taenia coli o f the guinea- 
pig and in other regions o f the gut, since exogenous application of ATP mimicked 
the relaxation elicited by electrical stimulation of motor nerve fibres (Bumstock, 
1972). Almost in tandem with the proposal of ATP as a putative NANC 
neurotransmitter, came the discovery of vasoactive intestinal polypeptide (VDP) and 
the demonstration that it caused a powerful relaxation of enteric smooth muscle 
(Said & Mutt, 1970). Further support came when it was shown that this peptide 
could be released by nerve stimulation (Fahrenkrug et al, 1978). Over the 
intervening years considerable controversy existed over whether the inhibitory 
neurotransmitter to gastrointestinal smooth muscle was ATP (purinergic theory) or 
VIP (peptidergic theory), (see review by Stark & Szurszewski, 1992). In both cases 
support was incomplete while in some gastrointestinal smooth muscles neither 
seemed to be involved (Manzini et al, 1986; Goyal et al, 1980; Biancani et al, 
1984; Behar et al, 1989; Furness & Costa, 1987; Niel et al, 1983; Costa et al, 
1986). In retrospect, considerable data showed that ATP and VEP, neither 
separately nor together, could account for all the types of NANC inhibitory 
transmission to gut smooth muscle. NO, a potent relaxant of vascular smooth 
muscle and the anococcygeus muscle was therefore an obvious choice as the third
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candidiate. Recent work has indicated that a nonpurinergic, nonpeptidergic system 
involving NO may mediate NANC neural inhibition of gastrointestinal smooth 
muscle (see review by Stark & Szurszewski, 1992).
Early work carried out in Glasgow by Gillespie and colleagues on the 
innervation of rodent and bovine genitalia-associated smooth muscle (well before 
the identification of EDRF as NO), indicated that a nonpurinergic, nonpeptidergic 
neurotransmitter was involved in NANC neurotransmission (Gillespie, 1972; 
Bowman & Drummond, 1984; Bowman et al, 1982). In these preparations, NANC 
inhibition was apparently independent of any established neurotransmitter, cGMP 
appeared to be the second messenger mediating relaxation and the effect of NANC 
nerve stimulation was antagonised by oxyhaemoglobin (HbO) which binds NO. 
The mediator of NANC inhibition in these tissues had chemical properties and 
actions similar to those of EDRF. Later work revealed that NO is the mediator of 
NANC neurotransmission in these muscles (Gillespie et al, 1989; Gibson et al, 
1990; Gillespie & Sheng, 1990). In 1990, Bult and colleagues reported that NO 
was released on stimulation of enteric NANC nerves (Bult et al, 1990). Since then 
an increasing body of evidence has accumulated to support the concept that NO 
acts as an inhibitory NANC neurotransmitter in the gut.
Before a substance can be classed as a neurotransmitter it must meet a 
number of criteria. Release of a putative neurotransmitter from neurones must be 
detectable and exogenous application of the substance should have identical effects 
on postjunctional receptors to those produced when it is released by nerve 
stimulation. Antagonists should also have the same effect on the response to 
exogenous application of the neurotransmitter and on nerve stimulation. A 
mechanism for transmitter inactivation must exist and the neurones must be shown 
to have mechanisms for neurotransmitter synthesis and storage. The evidence to 
date which shows that most of these criteria have been met for NO, supporting a 
role for NO as a neurotransmitter in the gastrointestinal tract, is summarised below. 
A role for NO in NANC transmission has been demonstrated in several animal
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preparations. For comprehensive lists of these experiments see reviews by Brookes, 
1993, and Stark & Szurszewski, 1992.
Release o f NO
In vitro animal experiments have shown that electrical field stimulation 
(EFS) o f NANC nerves released a chemical from both the canine ileocolonic 
junction and rat stomach which caused relaxation when superfused over vascular 
smooth muscle preparations (Bult et al, 1990; Fumess & Costa, 1987). The 
chemical in question was NO, or a related compound since it was inactivated by 
superoxide anion and HbO and its release was prevented by a NOS inhibitor. The 
origin of its release appeared to be neuronal since it was dependent on the 
frequency o f EFS and sensitive to tetrodotoxin (TTX), a nerve toxin which blocks 
neuronal action potential conduction. These early experiments did not, however, 
exclude the possibility that the EFS was releasing a neurotransmitter which in turn 
liberated NO from non-neuronal tissues, such as gastrointestinal smooth muscle.
Identity of action
The effects of exogenously applied NO and the effects of NANC nerve 
stimulation have been found to be similar in numerous animal and human 
gastrointestinal smooth muscle preparations. Gross similarities exist in the 
relaxation produced by application of exogenous NO with that evolved by EFS of 
NANC nerves in tissue strips from the LOS, stomach, small intestine and IAS from 
various animal species (Boeckxstaens et al, 1990; Boeckxstaens et al, 1991a; Toda 
et al, 1990; De Man et al, 1991; Stark et al, 1991; Murray et al, 1991; Rattan & 
Chakder, 1992). To mimic the effects o f endogenous NO in tissue preparations, 
exogenous NO can be applied in a variety of forms. NO in gaseous form, dissolved 
in degassed boiled water has been used by Boeckxstaens and colleagues
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(Boeckxstaens et al, 1991b). However, there are technical problems with this 
method such as the instability of pure NO gas and difficulty in assessing absolute 
concentrations. Other agents which release NO in solution, on or in target smooth 
muscle cells, such as SNP, nitroglycerin and amyl nitrite have been used to apply 
NO to tissues under experimental conditions.
Work in isolated circular muscle from segments of rat colon showed that 
relaxation evoked by exogenous NO produced the same effect i.e. descending 
relaxation, that is seen in response to intraluminal balloon distension (Hata et al,
1990). Intracellular recording techniques also revealed that exogenously applied 
NO evoked a membrane hyperpolarization that is similar to inhibitory junction 
potentials (IJP) evoked by NANC nerve stimulation, in studies of smooth muscle 
cells from canine jejunum, ICJ and colon ( Stark et al, 1991; Ward et al, 1992; 
Thombury et al, 1991; Ward et al, 1992).
Preparations o f human tissue have also been studied. Circular muscle from 
non-diseased human jejunum was used to study the mechanisms by which NO 
mediates NANC inhibition (Stark et al, 1993). In the human tissue exogenous NO 
evoked membrane hyperpolarization and inhibition of mechanical activity. 
Although this mimicked the general response to NANC nerve stimulation, analysis 
of the electrical responses revealed marked differences between the exogenous and 
endogenous NO-induced mechanisms. The workers concluded that of the two 
hyperpolarization components seen in the human jejunal NANC inhibitory junction 
potential (IJP), NO may mediate the later sustained smaller amplitude 
hyperpolarization but not the initial rapid hyperpolarization.
Effect of antagonists
As yet no competitive antagonists exist for NO. This may be because NO 
does not appear to produce its effects through a typical membrane-associated 
receptor. The role of NO in NANC inhibitory neurotransmission has however, been 
investigated by using agents such as HbO which inactivates NO (Palmer et al,
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1987; Ignarro et al, 1987; Martin et al, 1986) and L-ARG analogues which can be 
used to inhibit NO synthesis. When either NO synthesis is inhibited or exogenous 
HbO applied in vitro, the mechanical relaxation obtained by EFS of NANC nerves 
is attenuated in a variety of smooth muscle preparations including human jejunum 
(Stark et al, 1993), colon (Burleigh, 1992) and IAS (Burleigh, 1992). Intracellular 
recordings in vitro of circular muscle from human jejunum have also shown that 
HbO and NOS inhibitors attenuate or block IJP evoked by NANC nerve 
stimulation (Stark et al, 1993).
Mechanism of inactivation
A specific mechanism for the breakdown or removal of NO in 
gastrointestinal tissue has not been identified. Two factors may underlie this. 
Firstly, NO is extremely unstable and spontaneously oxidises to nitrite and nitrate, 
with a half-life of only a few seconds, thus eliminating the need for a specific 
degradation pathway. Secondly, substances that inactivate NO, including oxygen 
and HbO are present in gastrointestinal tissue and would be expected to limit the 
action of NO released from NANC nerves to a localised area for a limited time 
period.
Neural synthesis and storage of NO
While the evidence above strongly suggests that NO plays an important role 
in mediating NANC inhibitory transmission in gastrointestinal smooth muscle, 
there is no definitive proof that NO is a neurotransmitter. Moreover, NO could be 
acting alternatively in a second messenger role within smooth muscle cells. If this 
was the case, then release of an unspecified neurotransmitter from NANC nerves 
would stimulate the synthesis of NO within gastrointestinal smooth muscle cells 
(Ignarro et al, 1990). Two areas of research have supported the concept that NO is 
in fact acting as a neurotransmitter. Immunohistochemical staining in cells in the 
myenteric plexus and in neuronal processes in the circular muscle of the rat
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duodenum localised, for the first time, NOS (Bredt et al, 1990). Further work with 
HbO which showed that the effects of stimulating NANC nerves could be inhibited 
by this large cell-impermeable molecule, suggested that NO had to exist 
extracellularly at some point after its neuronal generation (Boeckxstaens et al, 
1990; Toda et al, 1990; De Man et al, 1991; Stark et al, 1991; Thombury et al, 
1991). Other studies have shown that NO can be generated in some gastrointestinal 
smooth muscle cells in response to VIP (Grider et al, 1992). Furthermore, the 
possibility that release of a putative NANC neurotransmitter initiates NO 
production in a nonneural cell, which in turn acts on neighbouring smooth muscle 
cells to produce relaxation cannot be ruled out.
Thus a mechanism for storing NO in enteric nerves has not been 
demonstrated. Free NO stored in vesicles seems unlikely since it easily permeates 
lipid membranes. Storage may in fact be unnecessary if synthesis of NO matches 
neuronal release, simply balancing supply with demand. Ignarro has suggested that 
an alternative storage mechanism may involve an acid-stabilised S-nitrosothiol 
intermediate which could be packaged and stored in vesicles, with nerve 
stimulation leading to exocytosis and spontaneous decompression of the 
intermediate to form NO on exposure to the nonacidic extracellular space. This 
would certainly be comparable with storage and release of classical 
neurotransmitters. Work in vascular endothelium has shown that NO is stored in 
thiol-bound intermediates (Mulsch et al, 1991).
In addition to the release of NO following NANC nerve stimulation 
workers have investigated whether there is a continual background synthesis and 
release of NO affecting tone in gastrointetsinal smooth muscle. Data suggest that 
ongoing release of NO may occur in sphincters or smooth muscles that show 
predominantly active tone or slow changes in tone like the gastric fundus. 
However, in smooth muscles that show predominantly phasic activity and little 
active tonic activity such as the ileum or jejunum, ongoing release of NO does not 
seem to occur. There is no evidence to date which clearly identifies the source of
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NO in smooth muscle in which there is ongoing release. Both neuronal and 
nonneuronal cells may synthesise NO. Isolated gastric muscle cells can themselves 
generate NO (Grider et al, 1992), as can white blood cells (Hibbs et al, 1988; 
Stuehr et al, 1989; Salvemini et al, 1989) and blood vessels of the gastrointestinal 
tract (Ozaki et al, 1991; Tottrup et al, 1991; Whittle et al, 1990). Work has also 
shown that NOS activity exists in rat gastric mucosa (Brown et al, 1992). The 
possibility that mucosa-generated NO may modulate the function of underlying 
gastrointestinal smooth muscle may be significant in inflammatory conditions such 
as UC and CD (see Chapter 6).
Mechanism of NO action
1. Role of cGMP
The relaxation of gastrointestinal smooth muscle produced by NO may be 
mediated by increased levels of cGMP. cGMP-dependent protein kinase has been 
found in the gastrointestinal smooth muscle of a number of species including 
humans (Miller et al, 1986). Relaxation of sphincter preparations including human 
LOS, opossum LOS and canine IAS, in response to NANC nerve stimulation is 
associated with increases in cGMP in smooth muscle (Grous et al, 1991; Torphy et 
al, 1986). Relaxation evoked in guinea-pig taenia coli is also associated with an 
increase in cGMP (Shikano et al, 1988). The mechanism through which increases 
in cGMP levels, brought about by NO, result in smooth muscle relaxation is 
unknown. Modulation of levels of intracellular C a^  may be implicated (see Stark 
& Szurszewski, 1992). Activation of cGMP-dependent protein kinases may lead to 
phosphorylation of proteins in the contractile apparatus, calcium-sequestering 
mechanisms or ion channels. Ramagopal and Leighton reported that EFS in the rat 
anococcygeus muscle led to a reduction in intracellular Ca++ that could be blocked 
by L-NMMA (Ramagopal & Leighton, 1989). In canine gastric antrum, SNP 
decreases the amplitude of the plateau potential of gastric action potentials and 
inhibits the increase in cytosolic Ca++ and tension associated with the plateau
69
potential (Ozaki et al, 1991). These results imply that NO inhibits voltage- 
dependent C a^  channels reponsible for the plateau potential. SNP had no 
significant effect on either upstroke potential of the gastric slow wave or levels of 
free cytosolic C a^. There was, however, a significant decrease in the force of 
contraction triggered by the upstroke potential, suggesting that NO may reduce in 
addition the C a^  sensitivity of the contractile elements. This effect may be 
mediated by cGMP, as cGMP inhibits Ca^-induced contraction in this tissue.
2. Role of hyperpolarisation evoked by NO
Exogenously applied NO causes a membrane hyperpolarisation in 
gastrointestinal smooth muscle which resembles the IJP seen following NANC 
nerve stimulation (Stark et al, 1991; Thombury et al, 1991; Ward et al, 1992; Stark 
et al, 1993). Whether this hyperpolarisation is caused by a direct effect o f NO on 
membrane channels, or mediated by a NO-induced increase in cGMP is unknown. 
Methylene blue, which blocks the action of NO through the inhibition of guanylate 
cyclase, attenuates NO-induced IJP in the circular smooth muscle of opossum 
oesophagus and canine small intestine, demonstrating that increased levels of 
cGMP are important in NO-evoked hyperpolarisation (Christinck et al, 1991). Of 
course NO may act through cGMP-independent mechanisms, as has been 
demonstrated in NO-induced osteoclast inhibition (MacIntyre et al, 1991) and in 
fibroblast cell lines (Garg & Hassid, 1991). However, the effectiveness of 
methylene blue in numerous gastrointestinal smooth muscle preparations suggests 
this is unlikely. Work in canine intestine has shown that the membrane potential 
during NO-evoked hyperpolarisation approaches the expected potassium 
equilibrium potential suggesting that an increase in K+ conductance mediates the 
hyperpolarisation (Stark et al, 1991; Thombury et al, 1991). In patch-clamp 
recordings from canine colonic myocytes in the cell-attached configuration NO 
enhanced the open probability of Ca++-activated K+ channels (Thombury et al, 
1991; Sanders & Ward, 1992). This evidence suggests that this type of K+ channel 
mediates hyperpolarization in response to NANC neurotransmission and
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exogenous application of NO. However, IJP in many gastrointestinal smooth 
muscles are unlikely to be mediated by such channels (Sanders & Ward, 1992). 
Apamin, a compound isolated from bee venom, has been shown to block a 
component of the IJP in many preparations, but not canine colon. This agent has 
been shown to block a small-conductance Ca^-dependent K+ channel but the 
expression of this channel, using single-channel patch-clamp studies has yet to be 
demonstrated in gastrointestinal smooth muscles. The level o f expression of these 
channels is very low in some preparations. Indeed, it is possible that they are 
expressed in a very small quantity in gastrointestinal smooth muscle (Sanders & 
Ward, 1992). Very few K+ channels need to be activated to cause hyperpolarisation 
because the input resistance of gastrointestinal smooth muscles is very high at the 
resting membrane potential (Sanders, 1989). In many sites in the gastrointestinal 
tract apamin blocks only a portion of the inhibitory response (Costa et al, 1986; 
Vogalis & Sanders, 1990; He & Goyal, 1993; Rae & Muir, 1996), suggesting that 
two or more conductances may mediate these reponses. Humphreys and colleagues 
(Humphreys et al, 1991) recently suggested that only the apamin-insensitive 
component of IJP is mediated by another transmitter. Recent data from Sanders and 
colleagues have raised the possibility that both apamin-sensitive and insensitive IJP 
exist in the canine pylorus (Sanders & Ward, 1992) and canine ileocolonic 
sphincter (Ward et al, 1992).
Physiological role of NO in NANC inhibition 
1. Relationship of NO to other putative NANC neurotransmitters
Several different NANC neurotransmitters may be involved in initiating the 
same inhibitory response and similar responses in different gastrointestinal smooth 
muscles and species may be due to different transmitters. The evidence reviewed 
above provides compelling evidence that NO functions as a NANC transmitter in 
several gastrointestinal smooth muscles. However, a role for other transmitters 
such as VIP and ATP cannot be excluded. Indeed, there is a large amount of
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evidence which supports a neurotransmitter role for these substances in NANC 
neurotransmission (Furness & Costa, 1987). Some of the work which has raised the 
possibility that more than one NANC neurotransmitter is present in gastrointestinal 
smooth muscle and that more than one NANC neurotransmitter is released on 
NANC nerve stimulation is summarised below.
In guinea-pig ileum NANC elicited IJP have two components: a rapid short 
latency hyperpolarisation that is apamin-sensitive and a slower long-lasting 
hyperpolarisation that is apamin-resistant (Niel et al, 1983). This implies that either 
more than one transmitter mediates the IJP or that a single inhibitory 
neurotransmitter may mediate two different receptors linked to K+ channels with 
different kinetics or modes of activation. Further work in the guinea-pig has shown 
that the relative contributions of apamin-sensitive and apamin-resistant 
mechanisms vary between regions of the gut (Costa et al, 1986). Further evidence 
for multiple mediators of inhibitory neurotransmisssion came from work in the rat 
intestine which showed that ATP antagonists and ATP desensitisation had differing 
effects in the duodenum and ileum (Manzini et al, 1986). Similarly, in several 
preparations, VIP antiserum blocks the response to exogenous VIP but partially 
reduces the effects of NANC nerve stimulation, supporting the hypothesis that a 
neurotransmitter in addition to VIP may be released from inhibitory NANC 
neurons (Goyal et al, 1980; Biancani et al, 1984; Behar et al, 1989).
Several NANC neurotransmitters may be released on NANC nerve 
stimulation. In experiments on the role of NO in NANC neurotransmission, 
incomplete attenuation of the inhibitory effects of NANC nerve stimulation by 
NOS inhibitors and HbO have been demonstrated in canine LOS (De Man et al,
1991), canine jejunum (Stark et al, 1991), canine ICJ and ileum (Boeckxstaens et 
al, 1990), canine colon (Dalziel et al, 1991) and rat gastric fundus (Boeckxstaens et 
al, 1991; Li & Rand, 1990).
NO may act as the final mediator of relaxation, induced by other putative 
NANC transmitters such as VEP and ATP. ATP-induced relaxations in canine
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ileum and ICJ are reduced by both HbO and NOS inhibitors, suggesting that NO is 
the final mediator for relaxation (Boeckxstaens et al, 1991). VIP-induced 
relaxations in rat gastric fundus (Li & Rand, 1990) and opossum IAS (Rattan & 
Chadker, 1992) were also observed to be reduced by NOS inhibitors. The 
mechanism by which NO acts as a final mediator for relaxation initiated by other 
putative NANC transmitters such as ATP or VIP could occur in one of several 
ways. Firstly, as a neurotransmitter released from a final effector neuron in 
response to ATP or VIP; secondly, as a mediator released from a non-neuronal cell 
in response to ATP or VIP, or as a second messenger produced in smooth muscle 
in response to ATP or VIP. In guinea-pig gastric fundus VIP release stimulates NO 
production in target smooth muscle cells (Grider et al, 1992). However, in other 
preparations such as canine LOS (De Man et al, 1991), opossum LOS (Tottrup et 
al, 1992) and rat duodenum (Irie et al, 1991), ATP- and VIP-induced relaxations 
were not affected by NOS inhibitors, indicating that ATP and VIP relaxed smooth 
muscle by NO-independent mechanisms. These findings support the theory that 
multiple inhibitory neurotransmitters can be released to act through parallel 
pathways during NANC nerve stimulation.
As yet it is unknown whether putative NANC neurotransmitters, including 
NO, are colocalized in the same neurones and if they are colocalized whether they 
are released simultaneously on NANC nerve stimulation. In vitro work, showing 
co-release of multiple NANC transmitters may simply be an artefact resulting from 
EFS of muscle strips. Electrical stimulation could activate all enteric neurones 
simultaneously. In physiological terms the relative roles o f various NANC 
transmitters may be related to their half-lives. Thus, NO would be expected to 
cause rapid transient relaxation, whereas other NANC neurotransmitters with 
longer half-lives would be responsible for prolonged relaxations. The interplay 
between neurones releasing one or more NANC neurotransmitters would determine 
the type and duration of relaxation.
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Physiological role of NO in gastrointestinal motility
An important component of the intestinal peristaltic reflex is a descending 
inhibition mediated by NANC enteric inhibitory neurons. Experiments in isolated 
segments of rat colon have shown that the descending relaxation evoked by balloon 
distension is mimicked by exogenous NO and is prevented by inhibitors of NOS. 
This suggests that NO mediates this reflex (Hata et al, 1990). Likewise, receptive 
relaxation in the isolated guinea-pig stomach is prevented by NOS inhibitors 
(Desai et al, 1991). Inhibitory modulation o f the phasic contractions in canine 
gastric antrum appears to result from the continuous spontaneous release of NO 
(Ozaki et al, 1991). From in vitro animal experiments, NO-mediated inhibition of 
gastrointestinal smooth muscle appears important for a variety of physiological 
functions. More recently, in vivo research has supported this concept by 
demonstrating that vagally-mediated relaxation o f the opossum LOS (Tottrup et al,
1991), canine stomach (Allescher et al, 1992) and rat stomach (Lefebvre et al,
1992) is mediated by NO. Thus, from animal work NO appears to have a 
physiological role in NANC inhibition. Much less is known however, about the 
role of NO in human gastrointestinal motility.
McKirdy and colleagues reported that the involvement o f NO in NANC 
relaxation of human LOS strips (McKirdy et al, 1992) and NO has been implicated 
in NANC relaxation of the circular muscle of human ileum (Maggi et al, 1991). 
More recently, Burleigh demonstrated that NO was involved in NANC relaxations 
of the human IAS (Burleigh, 1992). However, unlike the IAS, relaxations in the 
circular muscle from human sigmoid colon were only partially mediated by NO.
While a large amount of evidence supports the concept of a role for NO in 
NANC-induced relaxations of gastrointestinal smooth muscle, there are still 
unanswered questions and discrepancies over the possible mechanisms of 
inhibitory neurotransmisssion in the gut. Complex multiple mechanisms exist 
which interact to elicit NANC-mediated relaxation. No single transmitter underlies 
inhibition of tone in gastrointestinal smooth muscle. In addition, the importance of
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one transmitter relative to others varies according to anatomical location, the 
species and experimental techniques used to study the transmitter in question.
As yet the level of action and interaction between putative NANC 
neurotransmitters has not been settled. Current information suggests that NO, ATP 
and VEP are probably released from the same varicosities of inhibitory motor 
neurones. NO increases intracellular cGMP levels leading to hyperpolarisation and 
relaxation. VIP increases intracellular cAMP levels causing relaxation and possibly 
causing small hyperpolarisations in some preparations. ATP acts apparently 
through ion channels, hyperpolarising the cell membrane thus reducing Ca++ 
permeability and intracellular Ca++ concentrations leading to relaxation. This gives 
limitless possibilities for interactions between different transmitter systems. More 
work is required to establish the targets for phosphorylation by the relevant protein 
kinases and to examine the specific effects of cyclic nucleotides.
Caution is required when interpreting the effects of an agonist or antagonist 
on the activity of a putative NANC neurotransmitter in vitro. Transmitter 
interactions and the possibility that several neurotransmitters may be 
simultaneously released from the same nerve ending on stimulation, mean that 
even if a specific NOS antagonist completely blocks inhibition this does not 
preclude a major role for other neurotransmitters at this site. Such an observation 
simply means that NO release is required for muscle relaxation. Transmitters may 
not simply have additive effects. Indeed, the effects of two transmitters may 
multiply with one being permissive and synergistic with the effects of the others.
More work is also needed to investigate the causal relationship between 
hyperpolarisation and smooth muscle relaxation. At least theoretically it is possible 
for changes in coupling between intracellular Ca++ and the contractile apparatus to 
cause relaxation without altering membrane potential (Bolton & Large, 1986). 
Hyperpolarization of the muscle membrane will tend to close voltage-activated 
Ca++ channels in the muscle cell membrane and thus decrease intracellular levels of 
Ca++. However, the hyperpolarization may also serve other roles including
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"resetting" of ion channels that are rapidly inactivated at normal potentials. The 
actions of NO or VIP, mediated through second messengers (viz. cGMP and cAMP 
respectively) may cause a reduction in intracellular Ca++ concentrations through 
phosphorylation of ion channels, changes in C a^  storage mechanisms or to 
alterations in the sensitivity of the contractile apparatus to intracellular Ca++ (for a 
detailed review of C a^  homeostasis in smooth muscle see Tsien & Tsien, 1990).
At present, very little information exists about neurotransmission in human 
gastrointestinal smooth muscle. To investigate NO as a NANC neurotransmitter in 
the human gut will require much work to study different anatomical sites and the 
relative contributions which NO makes to relaxation and indeed to IJP. The 
identity of the transmitter(s) that mediates the NO-independent IJP in human and 
nonhuman muscles will also be an important area for future research. Finally, once 
control human tissue has been assessed work can be extended to disease states to 
establish whether changes in NO and other neurotransmitter functions are present 
and if they are a cause or effect of the disease process in question.
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CHAPTER 5
SMALL BOWEL MOTILITY - 
IN  VITRO STUDIES OF ISOLATED HUMAN ILEUM
5.1 INTRODUCTION
A few studies have examined, in vitro , the pharmacological properties of 
the isolated human terminal ileum from control human subjects. However, to date 
there have been no related studies on specimens from patients with UC. This is 
surprising since the terminal ileum is used to construct the reservoir in the 
procedure of EPAA. This chapter reports my in vitro investigations of the 
spontaneous myogenic activity in isolated human terminal ileum from control and 
UC patients. The role of NO in inhibitory nerve-mediated transmission and in 
SNP-induced relaxation in human ileum were also examined.
5.2 METHODS
5.2.1 PATIENTS
Between October 1992 and July 1994, 171 in vitro experiments were 
performed on human ileal smooth muscle. Five hundred and thirty-four strips from 
61 patients (25 UC, 21 control, 15 other conditions) were studied in organ bath and 
Golenhofen apparatus (see sections 5.2.3 and 5.2.4). The details for each of the 
three patient categories are shown in Tables 5.1-5.3.
Twenty-five patients with UC were investigated (17 males) with a mean age 
of 34.5years. Two patients underwent subtotal colectomies followed by staged 
TSRP and had ileal samples taken at both procedures for in vitro experiments 
(studies 1-9; studies 20-23). Four cases of fulminant UC who underwent 
emergency subtotal colectomy were included in the study. EPAA was performed in 
19 of the patients in this group, of whom 8 had been treated previously with 
subtotal colectomy (staged). One patient with quiescent chronic UC had a colonic 
carcinioma treated by right hemicolectomy.
Controls were chosen on the basis of non-inflammatory pre- or neoplastic 
conditions who were undergoing surgical procedures involving terminal ileal
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resection. For established carcinoma, which was either located in the caecum or 
right colon, the lesion had to be non-obstructing. Thus, emergency right 
hemicolectomy procedures for obstructing colonic neoplasms were excluded from 
the study. Twenty-one patients were included in this category. Seventeen patients 
were treated by right hemicolectomy for colonic carcinoma. O f the remaining 4, 3 
underwent TSRP for FAP or NHPCC. One patient had formation of a permanent 
ileostomy following excision of a coloanal anastomosis with completion colectomy 
for metachronous neoplasm. The mean age of the 21 patients (11 males) in this 
category was 60 years.
The third group comprised cases which arose during the study period. 
Although they did not fall into either the UC or control categories they were 
analysed as interesting adjuncts to the main study. They involved terminal ileal 
resections and consisted of hindgut neuropathy (n=l), Crohn's disease (n=2), 
postvagotomy diarrhoea (n=3), vaogotomised caecal neoplasm (n=l), caecal 
angiodysplasia (n=l) and ISTC (n=7). The mean age of the 15 patients (4 males) in 
this category was 41.9 years.
5.2.2 DISSECTION OF TISSUES
Samples of terminal ileum were obtained from patients undergoing surgical 
procedures at Glasgow Royal Infirmary and Hairmyres Hospital, Lanarkshire. 
Specimens were transported in Hartmann's physiological saline chilled to 4°C to 
the Department of Pharmacology, Glasgow University and all experiments carried 
out within 24h of resection. The premedication agents and intra-operative drugs 
administered were noted at the time of tissue collection and are listed in Table 5.4.
All tissues were macroscopically normal with no gross signs of tumour 
infiltration or inflammation. In particular, representative biopsies of the ileal 
specimens obtained from the UC EPAA patients were submitted for histological 
analysis. There were no instances of backwash ileitis (see discussion).
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Surrounding mesentery and fat were removed from the ileal samples and 
the specimen incised along the antimesenteric border in a longitudinal direction 
(see Fig 5.1). The bowel segment was pinned out flat with the mucosal surface 
uppermost. A mucosectomy was then performed with the aid of the dissecting 
microscope. The circular layer o f the muscle wall was preserved and strips 
measuring 10mm x 2-3mm cut along the longitudinal axis.
5.2.3 EXTRACELLULAR RECORDING OF SPONTANEOUS ACTIVITY
Simultaneous extracellular recordings of electrical and mechanical activity 
were made using the Golenhofen apparatus (Golenhofen & Loh, 1970), see Fig 5.2. 
This apparatus provides an extracellular method of recording changes in the 
membrane potential of a small number of cells together with simultaneous 
measurement of the mechanical activity of the whole specimen. The equipment 
consists of four platinum wire ring electrodes (i.d. ~2.5mm) contained within a 
narrow, water jacketed (37±0.5°C) glass capillary (i.d. ~2.3mm). These electrodes 
could be used for recording or stimulating, as required. Electrical signals were 
amplified (xlOOO, Neurolog A.C. preamplifier NL104) and filtered (Neurolog 
NL115, low frequency cut-off 10Hz, high frequency cut-off lOKHz). Mechanical 
activity was measured using an isometric force-displacement transducer (Grass 
FT03). Electrical and mechanical activity were displayed on a storage oscilloscope 
(Hitachi VC-6023) and recorded on an instrumentation tape recorder (Racal, Store 
4DS) and U.V. oscillograph (Thom EMI 6150-Mk II), see Fig 5.3. Longitudinal 
ileal strips of the same dimensions mentioned above were pulled through the 
apparatus and left to equilibrate under lg  tension. Drugs were added to the Krebs' 
solution which continually perfused the tissue chamber. Before entering the 
Golenhofen apparatus the Krebs' solution flowed through a water jacketed heat 
exchange coil to maintain it at 37±0.5°C.
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1. Whole specimen.
2. Incised over anti-mese nteric length to 
enable excision of mucosa / submucosa.
3. Preparation of longitudinally orientated 
muscle strips.
Fig 5.1 Dissection of resected human ileal specimens. Note 1 p piece for scale.
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5.2.4 RESPONSES TO NERVE STIMULATION AND DRUGS
Ileal muscle strips were attached to an electrode assembly which comprised 
two ring electrodes shielded in Araldite as shown in Fig 5.4. The assembly was 
suspended in conventional, jacketed (10ml) organ bath at 37±0.5°C, placed under 
lg  of isometric tone and allowed to equilibrate for 60min before experiments were 
commenced. The organ baths were filled with Krebs1 solution (see below). Tissues 
were gassed continuously with 95% O2, 5% CO2 at 37+0.5°C. During 
equilibration, the organ bath fluid was changed approximately every 15min. To 
examine inhibitory responses to EFS, tone was raised by the addition of carbachol 
(3xlO '6M to 10~5M) before stimulation. The effects of drugs were examined when 
a reproducible response to stimulation (l-64Hz) was obtained. Inhibitory frequency 
response curves to EFS were constructed using a fixed number of pulses (64), of 
width 0.05msec, at supramaximal voltage (60V) and at frequencies ranging 
between 1 and 64Hz. Trains of stimuli were delivered at 3-5 min intervals.
Antagonists were added to the bath and allowed 15-20min to take effect. 
All drugs were added by injection to the bath in volumes of lOpl and 30pl.
5.2.5 PHYSIOLOGICAL SOLUTIONS
Hartmann's solution (sodium lactate intravenous infusion) contained the 
following ions (mM): Na+ 131, K+ 5, Ca++ 2, HC0 3 "(as lactate) 29, Cl' 111.
The composition (mM) of Krebs' solution was as follows: NaCl 118.4, 
NaHC03 25, NaH2P041.1, KC1 4.7, MgCk 1.3, CaCk 2.7 and Glucose 11.
5.2.6. DRUGS
The following drugs were used: apamin (Sigma);' L-arginine hydrochloride 
(L-ARG; Sigma); atropine sulphate (Sigma); carbamylcholine chloride (carbachol, 
Koch Light); bovine haemoglobin (HbO; Sigma); guanethidine monosulphate 
(Ciba); metronidazole (Flagyl, Rhone-Poulenc Rorer); N^-nitro-L-arginine methyl 
ester hydrochloride (L-NAME; Sigma); nitro blue tetrazolium (NBT, Sigma); P-
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To isolated stimulator
5mm
Ag / AgCl ring electrodes 
Epoxy resin
Isolated stainless hook
Fig 5.4 Stimulating electrode assembly. The tissue was pulled gently through the 
ring electrodes; one end had a thread attached to the stainless steel hook at 
the bottom and the other end was attached by thread to a force 
displacement transducer (not shown). The entire assembly was held in a 
10ml organ bath and attached by wires to a Grass stimulator for electrical 
stimulation.
nicotinamide adenine dinucleotide phosphate diaphorase (PNADPH, Sigma); Nm- 
nitro-D-arginine methyl ester hydrochloride (D-NAME, Sigma); potassium 
chloride (KC1, Sigma); sodium hydrosulphite (Sigma); sodium nitroprusside (SNP; 
BDH); sucrose (Sigma); tetrodotoxin (TTX, Sigma). Drug concentrations in the 
bath refer to the salt, with the exception of apamin, HbO and TTX, which are 
expressed as concentrations of the base. Stock solutions of the drugs were prepared 
in distilled water before dilution with Krebs solution prior to their use. HbO was 
prepared as described by Martin and colleagues (Martin et al, 1985).
5.2.7 NADPH-DIAPHORASE HISTOCHEM ISTRY
The presence of NO in control and UC ileal specimens was detected 
microscopically using histochemistry for reduced nicotinamide adenine 
dinucleotide phosphate (NADPH)-diaphorase , which is a NOS (see Chapter 4), 
using the method described by Valtschanoff (Valtschanoff et al, 1992).
Immediately following surgical resection, ileal specimens adjacent to the 
portion obtained for organ bath experimentation were fixed in a solution containing 
4% paraformaldehyde in 0.1 M phosphate buffer solution pH 7.3 (PBS). Specimens 
were immersed in this solution for 24h at 4°C. Cryoprotection was then achieved 
by immersing the specimens in a solution containing 30% sucrose in 0.1M PBS 
until they sank to the bottom (~30 min) to prevent cells shattering on subsequent 
freezing. The tissue specimens were snap frozen in isopentane cooled by liquid 
nitrogen and placed in a cryostat (Reichert-Jung, Cryocut 1800) for subsequent 
sectioning. Transverse sections were cut at 20pm and placed on glycerine-coated 
slides which were set aside at room temperature to permit tissue adhesion. The 
slides were prepared by coating in a mixture of gelatin 0.5g, chrome alum 0.05g 
and distilled water made up to a final volume of 100ml. After dipping the slides in 
this solution they were placed in a vertical slide holder and dried at 60°C in an 
incubator overnight. Subsequent staining was carried out by immersing the lowest 
1-1.5cm of the slide, covered on the outside by aluminium foil, in a solution of
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0.1M PBS containing 0.25% Triton X-100 solution and leaving for 10 minutes. 
Into this solution 0.1M PBS containing 0.2mg/ml nitro blue tetrazolium was added 
along with 0.5mg/ml p-NADPH. The slides were then incubated at 37°C and 
examined after 1-2 hours for staining. Thereafter sections were rinsed in 1M PBS 
to stop the reaction, graded concentrations of ethanol (75%, 95% and 100%) and 
then to increasing concentrations of Histoclear (50%, 75% and 100%) for 
approximately 5min each. Because the reaction product was soluble in ethanol, 
rinses in alcohols were short (lm in for each concentration). The slides were 
allowed to dry before being mounted and were then examined using light 
microscopy. Permanent records of the NADPH-diaphorase staining were made by 
photomicrography.
Tissues were obtained from 15 patients for NADPH-diaphorase 
histochemistry. Their status and disease categories are listed in Table 5.5.
5.2.8 ANALYSIS OF RESULTS
SPONTANEOUS ACTIVITY, THE EFFECTS OF TEMPERATURE AND 
PERFUSED DRUGS
Following the equilibration period tissues developed spontaneous electrical 
and mechanical activity. The number of phasic contractions after the onset of 
spontaneous mechanical activity was determined in a steady-state 5-min period 
(Fig 5.5). Summation contractions, defined as two or more phasic contractions 
recorded without a return to baseline tonic contraction, were noted when they 
occurred. The parameters measured (as illustrated in Fig 5.6) comprised the 
frequency of contractions (mim1); the mean maximum contraction per burst of 
mechanical activity (g); and mean duration of each mechanical burst (s). These 
parameters were measured over a 5min period after the onset of spontaneous 
mechanical activity. In a preliminary study of spontaneous mechanical activity in 
strips of terminal ileum from control subjects, UC and ISTC patients, the number
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Category Condition Surgical
procedure
Num ber of 
patients
Control Postvagotomy
diarrhoea
Reverse ileal 
onlay graft
2
Caecal neoplasm Right
hemicolectomy
2
Ulcerative 
colitis (UC)
Fulminant UC Emergency
TSRP
1
Chronic UC; 
intact
Elective TSRP 5
Chronic UC; 
staged
Elective TSRP 3
Others Previous UC; 
ileoanal pouch 
dysfunction
Defunctioning of 
TSRP with 
formation of 
ileostomy
2
Table 5.5: Terminal ileum specimens submitted for NADPH-diaphorase
histochemistry- patient categories.
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of phasic contractions was determined for a 5min period following the onset of 
spontaneous activity and over a 5min period 30min after the initial measurement. 
Paired Student's t-test revealed no significant differences between the initial 
frequency of phasic contractions and the frequency of phasic contractions recorded 
after 30min for each of the patient categories (see Table 5.6).
In Golenhofen apparatus experiments the same mechanical parameters were 
measured as above, in addition to the frequency of bursts of spiking of electrical 
activity (bursts m ur1); maximum spike amplitude per burst o f electrical activity 
(mV); number of electrical spikes per burst (spikes burst’1); and duration of each 
electrical burst (s). The spontaneous activity parameters measured in a typical 
Golenhofen apparatus recording are shown in Fig 5.7.
Comparisons of spontaneous activity parameters among the patient groups 
were made using Mann-Whitney U  tests. A probability level of P<0.05 was 
considered statistically significant. ** indicates P<0.001 and * P<0.05.
INHIBITORY NERVE STIMULATION AND DRUGS
Relaxation (inhibitory) responses to EFS and to drugs were expressed as a 
percentage of tension developed by the contractile agonist (carbachol 10'6M-3xl0- 
6M). The effects of drugs on inhibitory responses to EFS were expressed as a 
percentage inhibition of nerve mediated relaxation at a given stimulation 
frequency, pulse width and supramaximal voltage. These results were then 
expressed as mean + s e m . A probability level o f P<0.05 was considered 
statistically significant. ** indicates P<0.001 and * P<0.05.
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Diagnosis n
Frequency 
(min*1) of 
mechanical 
spontaneous 
activity in 
initial 5min 
period
Frequency 
(min-1) of 
mechanical 
spontaneous 
activity in 
5min period 
30min later
P
Controls 8 3.72 + 0.69 4.05 + 0.51 0.71, n.s.
UC 8 2.78 + 0.22 3.08 + 0.16 0.29, n.s.
ISTC 6 4.9 ±1.2 4.97 + 1.2 0.97, n.s.
Table 5.6: Comparison of mean frequencies of spontaneous phasic
contractions in strips of human terminal ileum from controls, ulcerative 
colitics (UC) and patients with idiopathic slow transit constipation (ISTC), 
during an initial 5min period of stable spontaneous activity and a second 5min 
period 30min later in organ bath apparatus. 
n= number of patients (one strip analysed per subject).
Results expressed as mean + s e m ; P calculated using paired Student's t-test. 
n.s., not significant.
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5.3 RESULTS
5.3.1 SPONTANEOUS ACTIVITY, THE EFFECTS OF TEMPERATURE 
AND PERFUSED DRUGS
SPONTANEOUS MECHANICAL ACTIVITY
When strips of ileum from control subjects (16 patients, 99 muscle strips), 
UC patients (18 patients, 160 muscle strips) and ISTC patients (7 patients, 37 
muscle strips) were suspended in jacketed organ baths (Fig 5.4), and allowed to 
equilibrate under 1 g of isometric tension, the presence of spontaneous mechanical 
activity in strips from each patient group varied (controls, 60%; UC patients, 49%, 
ISTC patients, 49%). The equilibration period was set at 60min, with 15min 
washouts. The development of spontaneous mechanical activity occurred at a mean 
of 56.6min + 9.40min in control strips; at a mean of 62.2 +7.43min in UC strips; 
and at a mean of 93.3 + 16.7min in ISTC strips after organ bath suspension. When 
compared to control strips there were no significant differences in the times for UC 
and ISTC strips to develop spontaneous mechanical activity (P=0.43 and P=0.07 
respectively, Mann-Whitney U  test applied). The time taken to develop 
spontaneous mechanical activity in these preparations may have partly reflected 
equilibration, rewarming of the tissues after transport and dissection (see effects of 
temperature below). The development of spontaneous mechanical activity in 2 
strips o f control ileum from the same patient is shown in Fig 5.5.
The frequency of spontaneous mechanical activity and the mean amplitude 
of contractions (measured in g of isometric tension) were compared from controls, 
UC and ISTC patient groups. The data are summarised in Table 5.7. No significant 
differences were found.
In each of the three patient groups, after lg  of isometric tension had been 
applied to the suspended ileal strips, further increases in tension to 3g caused an 
increase in the amplitude of mechanical activity (not shown). This may have been
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SPONTANEOUS
MECHANICAL
ACTIVITY
PARAMETER
CONTROL UC ISTC
N um ber of patients 
(num ber of muscle 
strips analysed)
16 (99) 18 (160) 7(37)
Percentage of strips 
showing 
spontaneous activity
59.69+8.45 44.17+6.71
P=0.24
49+9.74
P=0.40
Frequency of 
spontaneous 
contractions (m in 1)
4.39+0.66 3.40+0.61
P=0.23
4.54+1.16
P=0.71
Isometric tension of 
spontaneous 
contractions (g)
0.66+0.14 0.84+0.16
P=0.54
0.56+0.21
P=0.92
Duration of 
spontaneous 
contractions (s)
11.7+2.33 16.12+2.77
P=0.19
18.33+4.34
P=0.20
Table 5.7: Spontaneous mechanical activity characteristics in each of the three
patient groups studied.
Mann-Whitney u tests applied to compare UC and ISTC parameters with control 
subjects.
caused by stretch-induced depolarisation, where more smooth muscle cells in the 
preparation would be at, or close to their firing threshold. Stretching above 3g, to 
limits of 5g resulted in a decrease in the frequency of spontaneous mechanical 
activity. This could have been caused by a stretch-induced form of depolarising 
block, or simply due to destruction of nexuses and close junctions resulting in 
diminished syncytial activity. Similar responses to stretch were noted in 
preparations where simultaneous measurements of spontaneous extracellular 
electrical and mechanical activity were recorded (see below).
In the organ bath studies, where tissues were suspended vertically rather 
than horizontally as in the Golenhofen apparatus, no spontaneous activity was seen 
in 40% of control strips (40 specimens); 51% of UC strips (82 specimens); and 
51% of ISTC strips (19 specimens). Although a constant feature in some subjects, 
the absence of spontaneous activity in patients was not universal. Absence of 
spontaneous activity, either in one or all o f the strips from one patient may have 
been related to the trauma of transport and dissection. None of the pre- or 
intraoperative drugs (Table 5.4) was thought likely to have caused abolition of 
spontaneous mechanical activity. In those cases where there was absence of 
spontaneous activity in every muscle strip analysed, there were no instances of 
perioperative administration of Ca++ channel blockers such as nifedipine.
SYNCHRONOUS MEASUREMENT OF SPONTANEOUS ELECTRICAL 
AND MECHANICAL ACTIVITY
GENERAL ASPECTS
Sixty-seven muscle strips from 30 patients (12 controls, 9 UC, 7 ISTC, 1 
vagotomised patient, 1 CD) were studied using the Golenhofen apparatus. The 12 
control subjects included 1 individual with FAP. Of the 9 UC patients, 3 were 
intact at the time of TSRP, 1 was intact i.e no previous colonic surgery, at the time 
of right hemicolectomy for coincidental neoplasm, 3 were staged and 2 had
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fulminant UC. Nine strips showed no evidence of spontaneous activity (13.4%). 
Tables 5.8-5.10 summarise the details of the 30 patients.
In each of the 3 groups of patients studied with the Golenhofen apparatus, 
rapid bursts of electrical activity preceded and continued during the mechanical 
contractions (Fig 5.8). Each spike-burst was accompanied by a burst of contraction 
with periods of quiescence between individual bursts. Contractions never occurred 
in the absence of electrical firing, and vice versa, thus the frequency of contractile 
bursts matched that of electrical firing in all 3 groups.
The activity parameters for control patients with evidence of spontaneously 
active muscle strips were as follows. The electrical, and mechanical events 
occurred with a frequency of 9.3 ± 0.96mm-1 (n=10) and each contained 6.80 ±
1.01 spikes (n=10). The duration of each spike-burst was 1.42 + 0.31s (n=10) and 
the amplitude of the largest spike in each was 309.4 ± 59.0 pV (n=10). Each 
mechanical event contained 1.6 ± 0.6 peaks (n=10) and lasted 8.2 ± 1.99s (n=10). 
The maximum tension developed during each was 1.88 ± 0.46g (n=10).
The activity parameters for chronic UC patients with evidence of 
spontaneously active muscle strips were as follows The electrical, and mechanical 
events occurred with a frequency of 8.6 ± 0.78mm-1 (n=7) and each contained 9.71 
± 1.78 spikes (n=7). The duration of each spike-burst was 2.18 ± 0.62s (n=7) and 
the amplitude of the largest spike in each was 352.0 ± 77.9 pV (n=7). Each 
mechanical event contained 1.14 ± 0.14 peaks (n=7) and lasted 7.9 ± 1.07s (n=7). 
The maximum tension developed during each was 1.14 ± 0.15g (n=7).
The activity parameters for the ISTC patients studied were as follows. The 
electrical, and mechanical events occurred with a frequency of 9.1 ± 1.53mm-1 
(n=7) and each contained 3.86 ± 0.14 spikes (n=7). The duration of each spike- 
burst was 0.66 ± 0.12s (n=7) and the amplitude of the largest spike in each was
304.3 ± 42.4pV (n=7). Each mechanical event contained 1 ± 0 peaks (n=7) and 
lasted 6.07 ± 0.52s (n=7). The maximum tension developed during each was 1.43 ± 
0.13g (n=7).
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Fig 5.8 The spontaneous electrical (top trace) and mechanical activity recorded in 
the Golenhofen apparatus from a control strip of human ileal muscle. Each 
burst of electrical activity was accompanied by contraction, confirming 
synchronization of electrical and mechanical activity.
Two patients were examined during the course of these experiments who 
underwent emergency subtotal colectomy for fulminant UC (see Table 5.9). Both 
individuals had received pre- and intraoperative intravenous doses of 
hydrocortisone. The first patient (JH) showed some mechanical spontaneous 
activity in organ bath experiments (4 out of 5 strips) but only weak electrical and 
mechanical responses in the Golenhofen apparatus which quickly faded and were 
unsuitable for measurement. The second patient (TD) showed mechanical 
spontaneous activity in all 3 strips studied in organ bath experiments as well as 
spontaneous electrical and mechanical activity in the Golenhofen apparatus. The 
data for TD Golenhofen recordings in 1 tissue strip were as follows. The frequency 
of spontaneous electrical and mechanical activity was 8mm-1, the number of spikes 
per burst of electrical activity was 4, the duration of each electrical spike burst was 
0.75s and the maximum amplitude o f the electrical spike burst was 820 pV. There 
was 1 peak in each mechanical event and the duration of each was 6.5s. The 
maximum tension developed during each contraction was 1.4g.
Of the remaining 2 miscellaneous subjects the patient with CD (IMcC) 
showed no evidence o f spontaneous activity in 5 strips analysed. Likewise, the 
patient with postvagotomy diarrhoea undergoing reverse ileal onlay grafting (RH) 
showed, rather surprisingly, no spontaneous activity in 1 strip analysed.
No significant differences were detected in spontaneous activity parameters 
when UC patients were compared with controls (see Table 5.11). However, the 
ISTC patients were noted to have fewer electrical spike per spike burst and shorter 
duration electrical spike bursts than control patients. Both of these differences 
reached statistical significance.
Whilst controls and ISTC patients showed a more regular pattern of 
spontaneous electrical and mechanical responses, some samples of UC ileum 
showed irregular patterns in both parameters (Fig 5.9). Such fibrillation-like 
activity may have been artefactual, caused by subtle changes in the longitudinal 
orientation of the strip to a more tangential direction. This would have enabled
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SPONTANEOUS 
ELECTRICAL/ 
MECHANICAL ACTIVITY 
PARAMETER
CONTROL UC ISTC
Number of patients/ strips 
analysed
10 7 7
Frequency of spontaneous 
electrical activity/ mechanical 
contractions (m in1)
9.3±0.96 8.6±0.78
P=0.65
9.1±1.53
P=0.46
Number of electrical spikes 
per spike burst
6.80±1.01 9.71±1.78
P=0.22
3.86±0.14
*P=0.03
Duration of electrical spike 
burst (s)
1.42±0.31 2.18±0.62
P=0.40
0.66±0.12
*P=0.04
Maximum electrical spike 
amplitude (pv)
309.4±59.0 352.0±77.9
P=0.93
304.3±42.4
P=0.92
Peaks in mechanical 
contraction
1.6±0.6 1.14±0.J4
P=0.93
1±0
Isometric tension of 
spontaneous contractions (g)
1.88±0.46 1.14±0.15
P=0.43
1.43±0.13
P=0.92
Duration of spontaneous 
contractions (s)
8.2±1.99 7.9±1.07
P=0.20
6.07±0.52
P=0.81
Table 5.11: Golenhofen apparatus recordings of spontaneous electrical and
mechanical activity in the three patient groups studied.
Mann-Whitney u tests applied to compare UC and ISTC parameters with control 
subjects.
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Fig 5.9 The spontaneous electrical (top trace) and mechanical activity recorded 
in the Golenhofen apparatus in an ileal strip from an ulcerative colitic 
undergoing IPAA.
Notice the "fibrillation" type pattern of mechanical activity.
greater amounts of inner circular smooth muscle to contribute to the electrical and 
mechanical events. Alternatively, erratic patterns of spontaneous activity may have 
reflected disruption of the myogenic pacemaker in terminal ileum by chronic UC.
Both electrical and mechanical events in human ileum were entirely 
dependent on the presence of extracellular C an n o t shown). Omission of CaCl2 
from the Krebs' solution, which happened accidentally on one occasion, or 
replacement of it with magnesium chloride abolished both spontaneous spiking and 
contraction (n=3; results not shown). The effects o f diltiazem, a Ca++-channel 
blocking drug are discussed below. The nerve toxin tetrodotoxin (TTX, 10 6M), 
which acts by blocking Na+ channels, failed to abolish spontaneous pacemaker 
activity in the human ileum. Thus, in this tissue, the myogenic pacemaker activity 
relies on the presence of Ca++- rather than Na+-spikes. The TTX results may also 
imply that the channels for Na+ in human ileum are different to those in nerve.
EFFECTS OF COOLING AND REWARMING
Control (n=3), UC (n=2) and ISTC (n=3) tissues were each sensitive to 
temperature changes in the perfusing Krebs' solution (Fig 5.10). Stepwise cooling 
from 37.5°C to 27.5°C reduced the frequency and amplitude of slow wave activity 
and the preceding spike bursts of electrical activity. In general throughout the 3 
patient groups there was no accompanying reduction in resting tone as reported in 
other spontaneously active smooth muscle preparations (Small, 1982). There was 
also no appreciable change in the maximum amplitude of isometric contraction 
produced in each temperature range. In 2 control patients, summation of 
contractions seen initially at 37.5°C disappeared on stepwise cooling but returned 
when the specimens were rewarmed to 37.5°C. Rewarming in all 3 types of ileal 
tissue restored mechanical and electrical activity.
No statistically significant differences were detected when UC and ISTC 
strips were compared to control tissues for changes in spontaneous activity in each 
temperature range (see Fig 5.11).
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Fig 5.10
Cooling Rewarming
30s
Golenhofen recording of the effects of cooling from 37.5°C- 27.5°C and 
rewarming to 37.5°C in an ileal strip from an ulcerative colitic undergoing 
IPAA.
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Fig 5.11: Graph o f the effects of cooling and rewarming on the frequency 
(min-1) o f spontaneous extracellular electrical (slow wave)/ mechanical 
activity in ileal muscle strips from control, ulcerative colitic (UC) and 
idiopathic slow transit constipation (ISTC) patients. n=3 patients, 3 muscle 
strips, each category. The curves were not significantly different (UC and 
ISTC compared with controls, Student’s t-tests).
EFFECTS OF PERFUSED DRUGS
Potassium chloride
The effects of KC1, used as a spasmogen, were studied in tissues from 9 
patients (3 controls, 2 UC, 4 ISTC: 11 strips).
In general, infusion of KC1 (0.1M) into the perfusate o f the Golenhofen 
apparatus increased the frequency and amplitude of extracellular electrical spike 
activity, corresponding with a series of summation contractions which eventually 
produced a plateau in tone (Fig 5.12; n=5). There were no obvious differences in 
the patterns of response to KC1 among each of the representative strips studied 
from the 3 patient categories.
Following infusion of KC1 (0.1M), (1 UC, 2 ISTC). infusion of carbachol 
(KHM) then caused a further rise in mechanical tone with an associated increased 
extracellular electrical activity (3 strips). Atropine (KHM) subsequently abolished 
the rise in tone (1 strip) after 3min, although there was persistent spontaneous 
extracellular electrical activity.
The spasmogenic effect of KC1 (0.1M) was abolished by SNP (KHM) in 1 
strip (control) although, despite baseline tone and no spontaneous oscillations in 
mechanical tone, some rhythmic electrical activity persisted. The reverse occurred 
in a second patient (ISTC). Thus, the abolition of spontaneous mechanical and 
electrical activity after incubation with SNP (KHM) for 5min was reversed with 
6min of incubation with 0.2M KC1. In a third patient (ISTC), pretreated with SNP 
(KHM), the relaxant effects wore off and spontaneous activity returned. Incubation 
with 0.1M KC1 failed to have any significant effect, but the spasmogenic effects 
were demonstrated with the addition of 0.2M KC1.
In one experiment (UC), 0.1M KC1 was ineffective in causing 
depolarisation after the muscle strip had been exposed to diltiazem KHM.
Two strips of tissue from a patient with ISTC showed graded responses to 
two different concentrations of KC1. Incubation with KC1 (0.05M) failed to
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Fig 5.12 The effects of carbachol (10'6M) on the extracellularly recorded (Golenhofen) 
electrical (top trace) and mechanical responses of a strip of human ileum to 
infusion of KC1 (0.1M). KC1 changed the electrical discharge pattern to a 
continuous one and raised tone. Carbachol ( •  , 10'6M) further increased 
tone without visibly altering the electrical activity.
produce any response. KC1 (0.1M), on the other hand, produced the characteristic 
intense extracellular electrical activity accompanied by a series of summation 
contractions which eventually resulted in a plateau of raised tone.
Carbachol
Carbachol (10*6M) increased the amplitude, frequency and intensity of 
extracellular electrical activity which corresponded to summation of contractions 
and a plateau in tone (see Fig 5.13). This occurred in all 6 experiments (2 controls, 
1 UC, 3 ISTC; 6 strips).
The median time to produce a plateau in contractions was 4.5min (range 
0.5-7min). Interestingly the UC strip produced a maximal response to carbachol 
(10'6M) after 0.5min; the 2 control strips produced maximal responses at 2 and 
4min; and the 3 ISTC strips produced maximal responses at 5, 6.5 and 7min 
respectively.
As noted above carbachol (10'6M) caused further increases in tone in 3 
tissues exposed to the spasmogenic effect of 0.1 M KC1 (see above).
Atropine
Infusion of atropine (KHM) reversed the spasmogenic effect of carbachol 
(1CHM) in 3 experiments (1 UC, 2 ISTC), see Fig 5.13. Spontaneous contractions 
failed to reappear once baseline tone had been reached although intense 
extracellular activity was noted in 2 strips. In these strips there were no evidence of 
discrete clusters of electrical spikes separated by periods of quiescence, as seen in 
resting spontaneous activity.
Diltiazem
The effects of diltiazem were studied in 4 experiments (1 control, 2 UC, 1 
ISTC; 4 strips), see Fig 5.14.
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Fig 5.13 The inhibitory effects of atropine (10-6M, lower trace) on the increase in
tone and electrical spike change produced by carbachol (10-6M, middle trace) 
in a strip of control ileum (Golenhofen recording).
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5.14 The inhibitory effects of diltiazem (10'5M, upper set of recordings) and SNP 
(10'6M, lower set of recordings) on the electrical (top traces) and mechanical 
spontaneous activity in samples of control human ileum. Diltiazem and SNP
each abolished electrical and mechanical activity.
In the 2 UC strips diltiazem (10'5M) caused abolition of all electrical and 
mechanical activity by lOmin in both strips. Residual tone which was negligible 
was aslo reduced by diltiazem. In 1 strip some spontaneous activity had returned 
after 12min.
In 1 ISTC strip diltiazem (10*5M) caused abolition of all electrical and 
mechanical activity after 30min. Likewise, in a control strip, diltiazem (3xlO'5M) 
took 27min to produce a similar abolition of spontaneous activity.
Sodium nitroprusside
SNP (10-6M; n=2), (3xlO’6M; n= l) and (10‘5M; n=l) abolished 
spontaneous electrical and mechanical activity in all 4 strips studied (Fig5.14).
The median time to abolish spontaneous activity using SNP (10 6M) was 
5min (range 2-8min). In 1 UC strip, abolition took 2min, while the 2 ISTC strips 
studied were relaxed 5min and 8min respectively after exposure to SNP. In one 
control strip, SNP (10'5M) initially caused a transient increase in both the electrical 
spike amplitude and the size of mechanical contractions which lasted about 30s 
before abolition of spontaneous activity occurred after 5min. As with diltiazem, 
SNP reduced resting tone.
In one experiment, during continuous perfusion o f SNP, spontaneous 
activity re-emerged lOmin after its abolition by SNP (10 5M). The mechanical and 
electrical activity were, however, approximately 70% of their pre-SNP amplitudes, 
with no change in frequency.
The effects on spontaneous activty of SNP in conjunction with KC1 are 
discussed above.
Metronidazole
Metronidazole, at an organ bath concentration (5.26x10_4M) representative 
of the concentration achieved when a standard 500mg dose is infused intravenously 
in clinical practice, was studied in 6 experiments (3 controls, 2 UC; 6 strips).
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No major effects on spontaneous electrical or mechanical activity were
noted.
5.3.2 INHIBITORY NERVE STIMULATION AND THE EFFECTS OF 
DRUGS
In carbachol-induced tone (3xl0-6M-10*5M), EFS of intramural nerves (1- 
64Hz, 0.05ms, supramaximal voltage) elicited frequency-related relaxations with 
an optimum frequency o f around 4-8Hz. (see Fig 5.15) There were no differences 
in tissue responses to inhibitory EFS between control and UC patients (see Fig 
5.16). To prevent adrenergic influence, guanethidine (10'6M) was present 
throughout. A non-cholinergic blockade would have been desirable but was not 
possible since atropine would have abolished the carbachol-induced tone. Indeed, 
for studies of the effects of drugs on inhibitory nerve stimulation, the experiments 
often lasted in excess of 120min and carbachol was the only agonist which could 
sustain tone over this period (unlike substance P; 5-hydroxytryptamine, 5HT and 
histamine). Thus, the inhibitory nerve responses examined in this series of 
experiments were non-adrenergic rather than NANC. Interestingly, 2 patients (one 
control, one UC) provided muscle strips which generated sufficient spontaneous 
tone to enable the experiments to be conducted in the presence o f atropine (10 6M) 
and guanethidine (10_6M) i.e. truly NANC conditions. These patients are discussed 
below.
When tone was raised by carbachol (3xlO_6M- 10_5M) to the organ bath, 
relaxations to EFS with rebound contractions were observed in all the tissues (see 
Fig 5.15). Frequency-response relationships in control and UC strips were similar, 
with an optimum frequency of around 4Hz (see Fig 5.16). In control strips 
relaxations at 4Hz were 70.2 + 4.82% of induced tone; in UC tissues 63.1 + 3.23%. 
All responses to inhibitory EFS were abolished by TTX (10'6M) indicating their 
neural origin.
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Colitic ileum - inhibitory nerve stimulation
16Hz8Hz2Hz 4Hz
lmin
Fig 5.15 The effects of inhibitory EFS, (2-16Hz, 64 pulses, 0.05ms, supramaximal 
voltage) on the spontaneous mechanical activity of ileum from an 
ulcerative colitic undergoing IPAA, in the presence of carbachol-induced 
(10'6M) tone. EFS produced a frequency-dependent inhibition of 
spontaneous activity.
-CONTROL
-U C
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Fig 5.16 Frequency response curves to inhibitory EFS (64 pulses, 0.05ms, 
supramaximal voltage) in control and ulcerative colitic (UC) ileum. Tissues were 
pre-contracted with carbachol (3xlO'6M). Relaxations are expressed as a 
percentage o f carbachol-induced tone. Controls: 4 patients, 11 strips; UC: 4 
patients, 9 strips. The curves were not significantly different from each other at any 
point (Student's t-test applied).
Previous preliminary work had shown that the inhibitory relaxations to EFS 
were inhibited by L-NAME in a concentration-dependent manner (Campbell, 
1993). At KHM, inhibition produced by L-NAME was 60-90% in control patients. 
This dose of L-NAME was therefore selected for study in control and UC strips. In 
17 muscle strips from 10 control patients, L-NAME (KHM) inhibited relaxation by 
a mean o f 80.2 + 3.83%. Nerve-mediated responses were present in strips tested 
from all control patients.
In 2 control subjects (2 muscle strips), and 4 UC patients (6 muscle strips), 
incubation with the stereospecific enantomer D-NAME (KHM) had no effect on 
inhibitory EFS. In 2 UC patients (3 muscle strips), the effects on inhibitory EFS of 
incubation with KHM L-NAME could be stereospecifically reversed by incubating 
with L-ARG (KHM), see Fig 5.17.
In 58 muscle strips from 18 UC patients undergoing EPAA a more 
heterogeneous group of responses was noted on repeated inhibitory EFS after 
incubation with L-NAME (see Table 5.12). Only 4 of the 11 intact UC patients 
(36.4%) undergoing EPAA showed responses to L-NAME which were similar to 
those of the control group (see Fig 5.17), with an inhibition in relaxation response 
by a mean of 85.6 + 6.93% (P=0.62, n.s.; Mann-Whitney U  test). One of the 7 
(14.3%) staged IPAA patients with UC behaved in the same manner with L-NAME 
incubation. Five of the 18 (27.8%) UC patients showed no response to either 
excitatory or inhibitory EFS. In a further 3 UC patients (33.3%; 2 synchronous, 1 
staged) L-NAME was only weakly effective i.e. 0-60% reduction in response to 
inhibitory EFS, (see Fig 5.18) whilst 5 patients (27.8%; 1 synchronous, 4 staged) 
showed no alteration in inhibitory EFS after L-NAME incubation (see Fig 5.19).
In 2 muscle strips from 2 control subjects and 6 muscle strips from 4 UC 
patients, incubation with the stereospecific enantiomer D-NAME (1(HM) had no 
effect on inhibitory EFS. In 2 UC patients (3 muscle strips) the effects of 
incubation with L-NAME (KHM) on inhibitory EFS could be stereospecifically 
reversed by incubating with L-ARG (KHM), see Fig 5.17.
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Colitic ileum - L-NAME and L-ARG
2Hz 4Hz 8Hz 16Hz
5gL
0.5min
L-NAME
4Hz 2Hz 4Hz 8Hz
L-ARG 2Hz 4Hz 8Hz 16Hz 4Hz 4Hz 1Hz 2Hz 4Hz 8Hz5sL
0.5min
Fig 5.17 The effect of L-NAME (arrow, 10'4M), alone (top trace) and after the 
addition of L-ARG (arrow, 10'4M, lower trace), on the response to 
inhibitory EFS (2-16Hz, 64 pulses, 0.05ms, supramaximal voltage) in the 
presence of carbachol-induced tone (10'6M) in UC ileum. The inhibitory 
responses to EFS were abolished by L-NAME, an effect reversed by 
L-ARG (lower trace). The responses to EFS were neuronally mediated; 
they were abolished by TTX (arrow, 10'6M).
lmin
L-NAME " •
2Hz 4Hz 8Hz 16Hz
Fig 5.18 The effects of L-NAME (arrow, 10-4M, lower trace) on the inhibitory 
responses to EFS (2-16Hz, 64 pulses, 0.05ms, supramaximal voltage) in 
UC ileum. Although present in a similar concentration L-NAME was only 
weakly effective (Cf. Fig 5.17).
Colitic ileum - L-NAME
4Hz 8Hz 16Hz2Hz
0.5min
Wv/vKmjw
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Fig 5.19 The ineffectiveness of L-NAME (arrow, 10'4M, lower trace) on the
inhibitory responses to EFS (2-16Hz, 64 pulses, 0.05ms, supramaximal 
voltage) in UC ileum. The responses to EFS were neuronally mediated; 
they were abolished by TTX (arrow, 10'6M, lower trace).
The bee venom apamin, which blocks small conductance Ca^-dependent 
K+ channels (Maas et al, 1980; Castle et al, 1989), was used in 3 controls (4 
muscle strips) and 3 UC patients (4 muscle strips) to investigate whether a second 
neurotransmitter may contribute to the process of nerve-mediated relaxation. The 
results of these studies are shown in Figs 5.20- 5.23.
5.3.3 SODIUM NITROPRUSSIDE (SNP)- INDUCED RELAXATION
The basis of these experiments lay in the apparent contradiction between 
the classical view (Ignarro et al, 1981) that SNP acts by liberating NO or a related 
substance and the observations that in the sheep urethra the effects of SNP were 
unaffected by HbO (Garcia-Pascual & Triguero, 1994). With access to human 
tissue it therefore seemed worthwhile to carry out some preliminary studies to 
assess the mechanism of SNP-induced relaxation in the ileum of control subjects.
Samples from 6 controls (30 muscle strips) were examined in conventional 
jacketed organ baths. In the presence o f CARB-induced tone (3xl0*6M), SNP 
produced dose-related relaxations (3xl0 '8M-10'4M), (not shown). As previously 
demonstrated, SNP remained effective at producing relaxation in the presence of 
TTX and also after tissue exposure to L-NAME (lO^M).
The SNP-induced relaxation of human ileum was unaffected by apamin 
(5xlO’7M) or by KC1 (0.1M). When HbO (3xl0’5M) was incubated with tissue 
strips however, SNP relaxation was neither prevented nor reversed (n=3), see Fig 
5.24.
5.3.4 NADPH-DIAPHORASE HISTOCHEMISTRY
NADPH diaphorase in the layers o f the human small bowel (see Fig 5.25) 
was demonstrated in cryostat transverse sections (20pm) o f terminal ileum from 
both control and UC patients. Many NADPH-diaphorase-positive structures were 
seen in all the sections (Fig 5.26a-d). Strong uptake of the stain was noted in the 
intestinal mucosa and the myenteric plexus. In the latter, dense blue deposits of the
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Fig 5.20 The effects of L-NAME (10-4M), alone and after the addition of apamin 
(5xl0'7M) on the inhibitory responses of control ileum to EFS (4Hz, 64 
pulses, 0.05ms, supramaximal voltage). The 4Hz response was reduced by 
L-NAME alone, was further diminished by apamin and abolished by the 
additional presence of TTX(106M). Diagrams in chronological order 
moving downwards.
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Fig 5.21 Histogram showing the response o f control ileum (3 patients, 4 
strips) to EFS (4Hz, 64 pulses, 0.05ms, supramaximal voltage) alone, in the 
presence of L-NAME (10'4M) and in the additional presence o f apamin (5xlO*7M). 
L-NAME alone significantly reduced the response to EFS which was then virtually 
abolished in the additional presence of apamin.
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Fig 5.22 The effects of L-NAME (10'4M), alone and after the addition of apamin
(5xlO'7M) on the inhibitory responses of UC ileum to EFS (4Hz, 64 pulses, 
0.05ms, supramaximal voltage). The 4Hz response was reduced by 
L-NAME alone. Together with apamin the response was abolished. 
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Fig 5.23 Histogram showing the response of ulcerative colitic ileum (3 
patients, 4 strips) to EFS (4Hz, 64 pulses, 0.05ms, supramaximal voltage) alone, in 
the presence of L-NAME (10'4M) and in the additional presence of apamin (5x10' 
7M).
L-NAME alone reduced the response to EFS but not to a significant degree (C f 
control results, see Fig 5.21). The response was abolished in the additional 
presence of apamin.
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Fig 5.24 The effects of oxyhaemoglobin ( •  , HbO, 3xl0 '5M) on the relaxant
responses of SNP ( •  , 10~6M) in control ileum in the presence of carbachol- 
induced tone ( •  , 10'6M). HbO was ineffective in preventing (top trace) or 
reversing (lower trace) the relaxant response to SNP, suggesting that 
extracellular release of NO was not involved in this process.
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Fig 5.25 Schematic diagram of layers o f human small bowel.
a): Control ileum, transverse section (NADPHd, x8): low
magnification to show general appearances.
b): Control ileum, transverse section (NADPHd, xl9).
Fig 5.26 Photomicrographs (a-d) of NADPH-diaphorase staining in control and 
ulcerative colitic samples of ileum. NADPH-diaphorase positive fibres 
have stained dark blue.
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d): UC ileum, transverse section (NADPHd, x77).
Fig 5.26 Photomicrographs (a-d) of NADPH-diaphorase staining in control and 
ulcerative colitic samples of ileum. NADPH-diaphorase positive fibres 
have stained dark blue.
diaphorase reaction were noted in the ganglion cells. In the muscularis extema, 
both the inner circular and outer longitudinal layers contained numerous thin nerve 
fibres which showed strong NADPH diaphorase activity. Interestingly, the 
distribution of NADPH-diaphorase-positive nerve fibres appeared even in both 
layers of the muscularis. This was a constant feature in all patient categories.
Vagotomy did not alter the concentration or distribution of NADPH- 
diaphorase activity; likewise, fulminant UC and previous colectomy for chronic 
UC had no visible effects on the NADPH-diaphorase staining characterisitics of 
terminal ileum. The rare opportunity to stain for NADPH-diaphorase-positive 
activity in 2 established IPAA patients with dysfunction similarly failed to show 
any striking differences with control or pre-pouch tissues.
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5.4 DISCUSSION
5.4.1 SPONTANEOUS ACTIVITY, THE EFFECTS OF TEMPERATURE 
AND PERFUSED DRUGS
Ileal muscle strips under lg  of isometric tension in Krebs solution in 
standard organ bath apparatus elicited a variable degree of spontaneous mechanical 
activity. Using the Golenhofen apparatus, recordings of spontaneous extracellular 
electrical and mechanical activity were made from similar muscle strips but these 
recordings showed marked differences in the frequency and mean amplitude of the 
mechanical contractions. In general, Golenhofen recordings o f spontaneous activity 
in the 3 patient groups showed that, with respect to simple organ bath 
measurements, spontaneous mechanical activity measurements had a greater 
frequency, stronger amplitude and shorter duration. These trends were seen in all 3 
patient groups, reaching statistical significance in 5 of the 9 comparative 
measurements (see Table 5.13). Clearly, absolute values for spontaneous 
mechanical activity measurements relate to the recording method employed, but it 
is difficult to explain why these differences arose. One obvious reason may simply 
be that the Golenhofen apparatus is a more sensitive and accurate way of detecting 
every oscillation in tone generated by pacemaker activity. Organ bath recordings of 
spontaneous activity did not have simultaneous electrical activity measurements to 
verify whether every contraction was an individual mechanical event or instead the 
result of a series of smaller summated contractions. In addition, orientation of the 
ileal muscle strips differed in the two types o f recording apparatus. Perhaps a 
vertically stretched strip of ileum generates different patterns of spontaneous 
mechanical activity to a strip stretched horizontally in the Golenhofen apparatus?
The Golenhofen experiments, together with the organ bath observations 
show that human ileum does not generate any appreciable levels of resting tone. 
Even under lg  of isometric tension, there is almost invariably a spontaneous 
relaxation to baseline levels. However, when carbachol is used to raise it, tone can
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SPONTANEOUS MECHANICAL 
ACTIVITY PARAMETERS
ORGAN BATH GOLENHOFEN
CONTROL 
Number of patients (strips analysed) 
Frequency of spontaneous mechanical 
contractions (min*1)
16 (99) 
4.39±0.66
10 (10) 
9.30+0.96 
**P=0.0005
Isometric tension of spontaneous 
contractions (g)
0.64±0.14 1.88+0.46
*P=0.0065
Duration of spontaneous contractions (s) 11.68±2.23 8.20±1.99
P=0.0853
UC
Number of patients/ strips analysed 
Frequency of spontaneous mechanical 
contractions (min-1)
18 (160) 
3.40+0.61
7(7)
8.57±0.78
*P=0.0010
Isometric tension of spontaneous 
contractions (g)
0.84+0.15 1.14±0.15
P=0.0841
Duration of spontaneous contractions (s) 16.1+2.77 7.86±1.07
*P=0.0423
ISTC
Number of patients/ strips analysed 
Frequency of spontaneous mechanical 
contractions (min'1)
7(37)
4.54±1.16
7(7)
9.14+1.53
P=0.0545
Isometric tension of spontaneous 
contractions (g)
0.56±0.21 1.43±0.13
*P=0.0021
Duration of spontaneous contractions (s) 18.3±4.34 6.07±0.52
*P=0.0205
Table 5.13? Summary of differences in spontaneous mechanical activity of 
human ileum as recorded in organ bath and Golenhofen apparatus.
Mann-Whitney u tests applied to compare UC and ISTC parameters with control 
subjects.
persist for upwards of 2h (see nerve-mediated experiments in section 5.3.2). The 
predominant pattern of contraction seen in organ bath and Golenhofen experiments 
is therefore phasic. The phasic and tonic components of gastrointestinal motility 
have been extensively summarised (see Golenhofen et al, 1992). In basic terms, 
smooth muscle is seen to have two different motor functions. Firstly, to produce 
phasic-rhythmical activity, predominantly for propulsion. Secondly, to produce 
tonic contractions, predominantly for reservoir contractions. The observations from 
the current series of experiments show a uniform pattern of spontaneous 
mechanical activity in the presence of almost zero background tone, in keeping 
with studies from anatomically similar sites in other species (see Golenhofen et al, 
1992). Thus, human ileum used in IPAA has almost entirely propulsive properties 
at the time of ileal pouch construction. Interestingly, the ileal pouch subsequently 
has to adapt to take on the physiological role of a reservoir. The adaptive processes 
which must occur at a smooth muscle level have yet to be elucidated.
In human ileal smooth muscle the effects of cooling reduced the frequency 
of slow wave activity but interestingly did not alter resting tone, which largely 
remained at baseline. Stepwise cooling to 27.5°C never abolished slow wave 
activity in any o f the strips analysed from the 3 patient categories. These 
observations suggest that this tissue, unlike other spontaneously active smooth 
preparations such as guinea-pig trachealis (see Small, 1982), is more resilient to 
temperature change.
The experiments above have noted that spontaneous mechanical activity in 
human ileum is Ca++-dependent and the preliminary studies give some evidence as 
to how this complex process operates at an ionic level. Other workers have shown 
that an increase in the cytosolic concentration of free Ca++ is a fundamental 
requirement for activation of the contractile machinery in smooth muscle (Bolton, 
1989). The source of this activation can be either intracellular or extracellular. 
Bolton proposed that excitatory stimuli promote the cellular influx o f Ca++ either 
through voltage-operated channels (VOCs) or receptor-operated channels (ROCs),
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(Bolton, 1989). Thus, Ca++ entering a smooth muscle cell through these channels 
could simply increase the concentartion of cytosolic free Ca^. Alternatively, it 
could in turn stimulate Ca++ release from intracellular storage (sequestration) sites, 
creating an amplification of the initial excitatory stimulus. Further, a stimulant 
which activated cell surface receptors might evoke intracellular Ca^ release from 
sequestration sites by a process which did not involve VOCs or ROCs. A VOC, by 
definition is a channel which can admit Ca++ into the smooth muscle cell. Opening 
this channel is dependent on the membrane potential o f the cell (Bolton, 1989). The 
VOC opens during the graded depolarization of smooth muscle cells which do not 
normally discharge action potentials. This opening corresponds with the upstroke 
of the smooth muscle action potential. The VOC is also readily blocked by organic 
inhibitors of Ca^ influx e.g. diltiazem and is relatively specific for Ca++. In the 
experiments described above, KC1 produced VOC opening when added to the 
extracellular fluid, and was ineffective when the tissue was pretreated with DTZ. 
From other simple organ bath experiments, KC1 raised tone after prior exposure of 
the tissues to guanethidine, atropine, SNP or TTX. KCl-induced spasm was also 
unaffected when these agents were added to the preparation suggesting that at least 
the action of KC1 was not dependent on adrenergic, muscarinic or nerve-mediated 
processes (traces not shown). This resistance of KCl-induced spasm suggests that it 
has a direct action on human ileal smooth muscle. Moreover, the fact that KC1 
spasm is produced in the presence o f TTX, but not with diltiazem suggests that the 
VOCs which bring about KC1 spasm conduct Ca++ rather than Na+.
Carbachol was seen to operate through muscarinic receptors to raise tone. 
In addition, carbachol could exert an additive effect on background KCl-induced 
spasm (Fig 5.10). In organ bath experiments, carbachol in this tissue still produced 
its spasmogenic effect after pretreatment with diltiazem and was resistant to 
incubation with diltiazem, but not atropine. Both VOCs and ROCs would therefore 
appear to exist in human ileum and when activated can have additive spasmogenic 
effects.
99
The studies with diltiazem and SNP were also useful in suppressing the 
spontaneous mechanical contractions in human ileum. As outlined above, 
Golenhofen and colleagues have categorised phasic and tonic components of 
gastrointestinal motility (Goelhofen et al, 1992). They have described two different 
types of Ca^ channel which exist in the cell membrane and which underlie these 
contractions. Here the nomenclature becomes confusing, suffice to say that the 
Ca++ channels described by Golenhofen and colleagues correspond to the VOCs 
and ROCs of Bolton (Bolton, 1989). Thus, according to the work of Golenhofen 
and colleagues one activation process involves L-type calcium channels (LCA; 
DTZ-sensitive), and the other a non-L-type calcium channel (NLCA; SNP- 
sensitive). The experiments above show that although the pattern of contractions in 
human ileum is almost purely phasic, hence LCA-mediated, this activity can also 
be abolished by SNP, a specific antagonist of NLCA-generated tonic activity. Ca++ 
channels classed as LCA, DTZ-sensitive correspond with VOCs described above, 
while Ca^ channels which are NLCA, SNP-sensitive are thought to be 
predominantly controlled by chemical processes (ligand operated channels) and not 
by membrane potential changes o f the smooth muscle cell. These Ca++ channels 
correspond with ROCs described above.
In the current experiments there appears to be an additive (synergistic) 
effect when VOCs (LCA) and ROCs (NLCA) are activated. Inhibition of  
spontaneous activity by SNP, which suppresses NLCA, also occurs but this effect 
is reversed by the tissue and does not subsequently suppress VOC (LCA) 
stimulation by KC1. The accepted mechanisms by which SNP may operate in this 
tissue are are challenged by the finding that HbO was ineffective in preventing or 
reversing SNP-relaxation in human ileum (see section 5.4.2).
Metronidazole, used commonly in clinical practice to treat pouchitis 
(Mortensen & Madden, 1993) may in theory cause resolution in symptoms not just 
by its antibacterial action, but also by altering or resetting irritable-type patterns of 
motility in the ileal pouch. On the basis of the Golenhofen experiments, in which
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metronidazole was infused, there is no evidence to support this theory, since 
metronidazole had no effect on spontaneous pacemaker activity.
While no statistically significant differences in parameters were detected in 
the UC Golenhofen experiments compared with control measurements, UC strips 
showed a greater mean number of electrical spikes per spike burst, greater duration 
of electrical spike burst and greater mean electrical spike amplitude than control or 
ISTC subjects. The mean duration o f spontaneous contractions in the UC strips was 
also shorter than in controls. Greater patient numbers in these experiments may 
have given data which would have exposed statistically significant differences in 
these parameters between control subjects and UC patients. Clearly, further studies 
are required to explore these aspects (see Section 6.3.2).
Using Spearman's rank correlation coefficients as described in Chapter 3, 
no statistically significant correlates could be demonstrated between the clinical 
features o f the UC illness with regard to duration, patient age and nocturnal stool 
frequency on the one hand and the Golenhofen parameters measured on the other. 
Again, greater patient numbers would be required to investigate this further.
Perhaps the most surprising finding in the Golenhofen experiments was the 
marked differences in the ISTC patients compared with the others. This group had 
statistically fewer numbers of electrical spikes in each spike burst and shorter 
durations of electrical spike burst activity (see Fig 5.27). Thus the extracellular 
electrical activity recordings of the spontaneous pacemaker in ileal smooth muscle 
of ISTC is abnormal. This would support the view that ISTC is a 
pangastrointestinal motility disorder (Watier et al, 1983; Krishnamurthy et al, 
1985; Kumar et al, 1989; Bassotti et al, 1996; Panagamuwa et al, 1994; 
Hemingway et al, 1996). Indeed, in one small bowel manometry study of patients 
with ISTC in vivo assessment of terminal ileal motility confirmed the presence of 
motor abnormalities in both fasting and postprandial states (Panagamuwa et al, 
1994). There was an increase in phase II activity, most significantly during sleep, 
which may have interfered with the passage o f chyme leading to constipation.
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Fig 5.27 A comparison of the electrical (upper traces in each set) and mechanical 
activity in ileal tissue from control (top) and ISTC patients. There were 
fewer electrical spikes per burst in the ISTC patient and electrical spike 
burst activity was of shorter duration (Golenhofen recording).
Phase EH fronts were also found to be of shorter duration in constipated patients 
with approximately one fifth o f phase HI activity fronts showing either retrograde 
propulsion or increased tonic and phasic activity. The constipated patients in this 
study also had a significantly shorter duration of postprandial activity. Whether 
these in vitro small bowel abnormalities are caused by the same process which 
produces delayed transit in ISTC is unclear.
From the above preliminary observations it is interesting to postulate that 
the intestinal pacemaker activity is abnormal in ISTC and modified in UC. In other 
words, these two conditions may be driven by a systemic process which alters the 
function and/ or number of ICC.
5.4.2 INHIBITORY NERVE STIMULATION AND THE EFFECTS OF 
DRUGS
Inhibitory nerve-mediated relaxation to EFS was demonstrated in control 
and UC patients. While these responses were non-adrenergic, the 2 examples of 
relaxations to EFS in the presence of guanethidine (10*6M) and atropine (10 6M) 
confirm that NANC processes nonetheless exist in UC ileum. It is almost certain 
that the inhibitory nerve-mediated responses which were studied throughout the 
remainder o f the experiments were NANC relaxations.
NO, or a related nitroso compound has a role in inhibitory transmission in 
many tissues and species (see section 4 ) and is the main inhibitory transmitter in 
control human ileum (Campbell, 1993; Campbell et al, 1993). NO is synthesised 
from L-ARG by NOS. This process is inhibited by a number o f L-ARG analogues 
with a substituted N-guanidino group (see review by Moncada, 1992). The present 
studies show that one such analogue, L-NAME, effectively blocked inhibitory 
nerve-mediated relaxations produced by EFS in control subjects but had a 
heterogeneous effect in ileum from UC patients awaiting IPAA. Incubation with L- 
ARG partially reversed the effects of L-NAME in the UC tissues examined 
indicating a role for the L-arginine-nitric oxide pathway in inhibitory relaxation of
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the human terminal ileum in UC patients. Likewise, relaxations to SNP were 
unaffected by L-NAME in both controls and UC tissues making it unlikely that L- 
NAME exerts its effect at a location other than NOS.
In control tissues and those UC strips where L-NAME was effective in 
reducing inhibitory nerve-mediated relaxation its effects were identical whether or 
not EFS stimulation continued throughout the 40min incubation period. While a 
thiol derivative o f NO may be stored and released from vesicles (Tottrup et al, 
1992) NO may alternatively be synthesised de novo on nerve stimulation, thus 
precluding the need for storage. NOS may be activated by Ca++ influx into the 
nerve terminal in response to an action potential (Luckhoff & Busse, 1990). The 
observation that L-NAME was effective whether or not EFS stimulation was 
present during the incubation period, therefore, suggests that L-NAME inhibition 
of nerve-mediated relaxation is not use-dependent and implies that NO, at least in 
human ileum is not released from a stored precursor as these stores would need 
time to become depleted before the effects of competitive antagonism of NOS were 
observed.
In the UC tissues, where L-NAME was either ineffective or weakly 
effective in reducing the nerve-mediated relaxation response to inhibitory EFS, one 
may postulate that this may have been due to an alteration in the potencies of other 
putative inhibitory neurotransmitters, such as VIP and ATP. Alternatively the ileal 
smooth muscle may have developed a relative resistance to the effects of NO 
generated by NANC nerve stimulation, perhaps as a result o f the systemic effects 
of either chronic UC or the long-term medications used to treat the colitis. The 
samples in which neuronal responses were absent, yet the tissues still responded to 
carbachol and other exogenous drugs, are difficult to interpret. These tissues may 
simply have been traumatised by surgical dissection or transport, although surgical 
techniques and specimen retrieval procedures were no different than those used to 
obtain the control tissues studied in the same set of experiments. In hindsight, 
electron microscopy o f such UC samples may have helped to exclude neuronal
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damage. On balance, however, it is difficult to imagine that UC patients 
undergoing IPAA, with no unusual gastrointestinal symptoms manifesting 
preoperatively, could have ileal enteric neurons which are non-functioning. 
Nevertheless, these absent responses to inhibitory EFS highlight another difference 
between UC and control tissues.
Using intracellular recording techniques, apamin has been used to 
pharmacologically dissect 2 distinct NANC hyperpolarising responses (Niel et al, 
1983; Bywater & Taylor, 1986). These reponses have been termed the fast and 
slow inhibitory junction potentials (IJPs) respectively (Crist et al, 1991; Crist et al, 
1992). The fast IJP is sensitive to antagonism by apamin and best revealed in the 
presence of atropine. The slow IJP is best revealed when the fast IJP is blocked by 
apamin and a substance P-mediated excitatory potential blocked by substance P 
desensitisation. In guinea-pig ileum circular muscle using apamin and NOS 
antagonists, He and Goyal have suggested that the fast IJP is mediated by ATP; 
that NO is involved in the slow IJP which is mediated by VTP and NO acting in 
series; and that the hyperpolarising effects of VIP and the slow IJP are normally 
masked by overlying depolaristaion due to concomitant release of substance P by 
VEP (He & Goyal, 1993). Apamin was therefore used in the present study, albeit in 
basic organ bath recordings of inhibitory nerve-mediated responses, to investigate 
whether or not an apamin-sensitive component was contributing to the relaxations 
elicited by EFS in control and UC tissues. Clearly these measurements of inhibitory 
response are different from the precise, intracellular membrane potential recordings 
o f single smooth muscle cells used by He and Goyal (He & Goyal, 1993). Also, 
anatomical and species-related differences must be remembered when comparing 
the present studies of human ileum with those of guinea-pig ileum. Nevertheless, 
the sequential incubation of L-NAME followed by apamin in 3 control subjects 
showed that the reponse to 4Hz inhibitory EFS was not abolished, but that a 
residual nerve-mediated component was left (Fig 5.20). This may suggest that 
although NO is the main inhibitory transmitter in control ileum a second apamin-
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sensitive component contributes to the overall relaxation response. In the UC strips 
studied with L-NAME and apamin, the nerve-mediated relaxations in 3 patients 
were abolished after incubation with L-NAME then apamin (Fig 5.22). Thus, at 
least in these 3 UC patients the enteric inhibitory nerve-mediated response would 
appear to be mediated by NO and another apamin-sensitive neurotransmitter (see 
Rae & Muir, 1996).
From these studies NO has been shown to be the main inhibitory 
neurotransmitter in control samples of human terminal ileum. A more complex 
picture emerges in UC ileum. The contributions o f other neurotransmitters to the 
nerve-mediated inhibitory responses in both types o f tissue are as yet unestablished. 
Likewise, the mechanisms which bring about the heterogeneity of inhibitory 
responses in the ileum of UC patients undergoing IPAA are unknown, but are 
presumably related either directly or indirectly to the disease process itself and/ or 
the drugs used to treat UC prior to surgical intervention.
5.4.3 SNP-INDUCED RELAXATION
While inhibitory relaxation in control ileum can be elicited by stimulating 
enteric neurons which synthesise and release NO as the principal inhibitory 
transmitter, SNP does not produce its relaxation through the same nerve-mediated 
mechanisms. Further, SNP relaxation is not dependent on K+ channel opening, as 
demonstrated by the ineffectiveness of K+ depolarising solution or apamin to 
modify its effect. HbO, which has a high affinity for NO and scavenges it from 
extracellular media does not appreciably modify relaxant responses to SNP in 
human ileum.
Although these are only preliminary observations they lend weight to the 
comments made by other workers (Garcia-Pascual & Triguero, 1994), that SNP 
does not produce smooth muscle relaxation through NO released in the 
extracellular medium. The HbO used in these experiments can become unstable 
and ineffective but caution was taken to exclude this factor as a reason for HbO-
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ineffectiveness in preventing SNP-induced relaxation, by using fresh HbO 
preparations for each experiment.
In human ileum, SNP-induced relaxation could potentially occur via other 
pathways distinct from that in which NO activates guanylate cyclase (Fig 4.1). 
Workers have shown that the relaxation produced by SNP may not be solely due to 
a rise in tissue cGMP content (Vidal et al, 1991; Hu et al, 1992). Indeed, different 
mechanisms from cGMP accumulation such as stimulation o f prostaglandin 
synthesis, membrane hyperpolarisation and uncoupling of oxidative 
phosphorylation have been put forward as possible ways in which SNP may cause 
smooth muscle relaxation (Ahlner & Axelsson, 1987). Further studies are required 
to investigate this in human ileum (see section 6.3).
5.4.4 NADPH-DIAPHORASE HISTOCHEMISTRY
Immunohistochemistry, rather than histochemistry per se, would have 
appeared to have been the best method of detecting NOS in human ileum. 
Although other workers have used NOS antibody in rats (Bredt et al, 1990), 
prohibitive cost implications combined with difficulties in obtaining good NOS 
antibody which is sensitive enough to react in fixed tissue specimens, resulted in 
NADPH-diaphorase histochemistry being the technique o f choice for these studies.
Colocalisation of NOS and NADPH-diaphorase in neurons of the guinea- 
pig intestine (Young et al, 1992) and canine colon (Ward et al, 1992) have been 
reported. In addition, several workers have shown that NOS and neuronal NADPH- 
diaphorase are identical (Hope et al, 1991; Dawson et al, 1991; Bredt et al, 1991; 
Grozdanovic et al, 1992; Aimi et al, 1993). Thus, with wide acceptance that the 
existence of NOS can be demonstrated by NADPH-diaphorase histochemistry, 
NADPH-diaphorase-positive neurons may be regarded as NO-producing neurons.
The photomicrographs (Fig 5.26 a-d) show that NO is abundant in the 
myenteric plexus of the human terminal ileum, as well as the mucosa and layers of 
the muscularis. NADPH diaphorase activity was however, notably scarcer in the
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submucosa. Taken together, these results are in keeping with a role for NO as a 
major neurotransmitter in the human enteric nervous system. Similar patterns have 
been reported by other workers studying regions of the human gastrointestinal tract. 
These include the ICJ and caecocolonic junction (Faussone-Pellegrini et al, 1993), 
colon (Hanani et al, 1993) and rectum (O'Kelly et al, 1994).
These histochemistry studies have shown that in the ileal smooth muscle of 
9 UC individuals and 6 other cases of mixed surgical diagnoses, there were no 
appreciable differences in the concentration or anatomical distribution of NO- 
producing neurons. These findings contrast with the differences between the two 
patient groups with respect to NO-mediated enteric nerve relaxation. In particular, 
there was no wide-ranging spectrum of staining in the UC patients, unlike the 
spectrum of responses noted when studying the effects of L-NAME on NO- 
mediated relaxation in the same individuals and in other UC patients. Thus, while 
the facility to generate NO exists in the terminal ileum of UC patients undergoing 
EPAA, the heterogeneity in responses to NO-mediated relaxation, as studied by the 
effects of L-NAME on nerve-mediated relaxation suggests that at some stage 
following generation of NO in ileal neurons, the cascade o f events bringing about 
the relaxation response seen in control ileal smooth muscle is modified in the ileum 
of patients with UC.
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CHAPTER 6 
GENERAL DISCUSSION
6.1 COMMENTS
This thesis has looked at two very different areas of small bowel motility. 
In the first section attempts were made to characterise gross patterns of small 
bowel motility using an ambulatory manometry technique in prospective IPAA 
patients with UC. This contrasts with the second part of the project in which 
specific in vitro aspects of terminal ileal motility were examined in control and UC 
patients at the time o f surgical resection and IPAA. For various practical and 
anatomical reasons which have been discussed in preceding chapters these two 
areas o f study were essentially the only ones which could be pursued in human 
subjects with UC undergoing IPAA.
Although these two approaches are at opposite ends of the spectrum of 
motility investigations (see Chapter 2) and consequently examine small bowel 
motility in ways which are functionally and anatomically distinct, the following 
discussion attempts to evaluate the in vivo and in vitro studies in this thesis in 
terms of design and clinical relevance of the data obtained. The studies are also 
appraised, where applicable, against related work reported by other groups since 
this research began in 1992. Finally, those subjects who underwent both small 
bowel manometry and in vitro studies are re-examined to see if  there are any 
obvious associations which emerge from the motility measurements for each 
individual.
6.1.1 SMALL BOWEL MANOMETRY STUDY
The small bowel manometry study described in Chapter 3 has several 
inherent deficiencies. Firstly, larger patient numbers, including control subjects, 
would have strengthened the validity of the observation that gross patterns of small 
bowel motility do not correlate with nocturnal stool frequency in intact UC patients 
prior to EPAA. To achieve this in reality would require either several years of study 
of consecutive UC patients in the one centre, or alternatively a standardised
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manometry assessment of such patients carried out in several IPAA centres. 
Although not impossible, both of these approaches would require much in the way 
of funding and human resources. Secondly, although small bowel motility was 
assessed by manometry throughout its entire length, closer transducer spacing 
distally would have given more relevant information to compare with the in vitro 
findings of resected portions of terminal ileum. However, to have looked at 
manometry patterns over the entire length o f the small bowel rather than at one 
specific region was entirely reasonable in this study, given the fact that the 
technique had never been used by the author previously, and that gross patterns of 
manometric activity are easier to interpret compared with those obtained from 
regional studies. Nevertheless, both types o f manometric study i.e full length and 
regional (terminal ileum) are required in the study of UC patients undergoing 
EPAA. Longer diurnal periods of recording would have also been desirable to 
enable at least some comment to be made on MMC variables. Analysis was 
impossible in the present study because of the intense phase II activity which 
occurred postprandially, in what was a short overall recording period of 59 hours. 
This highlights the major deficiency of small bowel manometry, and has been 
encountered by other workers examining established IPAA patients (see Stryker et 
al, 1985; Groom et al, 1994). In my opinion, therefore, small bowel manometry 
can only be usefully applied to investigate patterns of nocturnal small bowel 
activity.
Since this research commenced in October 1992, there have been no other 
reports of small bowel manometry studies in prospective or established EPAA 
patients. Although the St Mark's study was published in 1994 (Groom et al, 1994), 
the original work contained in this paper was first presented in March 1992 in 
abstract form (Groom et al, 1992).
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6.1.2 SMALL BOWEL IN VITRO STUDIES
Any in vitro study o f the small intestine, in patients undergoing IPAA, has 
obvious limitations. Firstly, the region o f interest must be confined to the most 
distal portion of terminal ileum which is normally sacrificed at the time of 
mesenteric arcade division in preparation for reservoir construction. Intestine 
proximal to this region is preserved and therefore impossible to obtain for 
laboratory analysis. Secondly, the quantity of ileum which is obtained is 
insufficient to study in apparatus designed to examine the effects of drugs on whole 
tissue peristalsis (see Trendelenburg, 1915; Grider, 1989). Thirdly, any tissue 
obtained in this fashion must be analysed with the knowledge that it has been 
exposed to anaesthetic agents and a variety of long-term anti-inflammatory 
preparations such as 5-aminosalicylic acid derivatives and steroids. Finally, the 
presence of inflammatory sequelae secondary to the disease process, such as 
backwash ileitis (Gustavsson et al, 1987), must be acknowledged. Taking these 
aspects into account, one may make several observations regarding the current 
study.
Although the samples of ileum obtained from patients were small, thus 
making peristalsis studies impossible, adequate quantities were available for 
Golenhofen apparatus, organ bath and histochemical studies. The muscle strips 
represented whole tissue samples, containing both inner cirrcular and outer 
longitudinal layers o f the muscularis propria. While it is possible to dissect these 
two layers and study them independently (see Hara et al, 1986), for preliminary 
assessment of the tissue it was decided to retain both layers, albeit in a longitudinal 
direction. Orientation in the axis of the circular layer, and studies of both isolated 
inner and outer muscle layers would need to be examined in future studies (see 
section 6.3).
All tissues obtained for in vitro analysis in this study were exposed to a 
variety of anaesthetic agents (see Table 5.4), and these must be considered when 
interpreting the data. However, both control and UC patients alike were exposed to
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a broadly similar anaesthetic technique. While certain drugs such as atropine can 
have profound effects on human gut motility when assessed in vitro (A 
MacDonald, personal communication) there were no instances when this drug was 
administered to the cases studied in this thesis. The long-term effects of previous 
systemic steroids and 5-aminosalicylic acid derivatives on ileal motility are 
unknown, but clearly these drugs too may have affected the subsequent motility 
characteristics of the ileal strips examined. From the present study it is clear that 
certain in vitro motility characteristics of the ileum are altered at the time of IPAA 
in patients with UC. Whether this is due to the disease process itself, the anti­
inflammatory medications or a combination of both is clearly clinically relevant 
and will require further investigation. Another factor to consider in this study is 
that all the tissue samples were exposed to diathermy currents prior to resection. 
Thus, for reasons including preoperative medication, anaesthetic agents, drugs 
administered perioperatively and operative factors such as diathermy, inherent 
deficiencies will exist in any studies o f human gut tissue obtained for in vitro 
analysis until a reliable animal model is developed which simulates UC. Animal 
models which have been used to study chronic colitis (Morris et al, 1989; Allgayer 
et al, 1989; Grisham et al, 1991) and chronic ileitis (Miller et al, 1993) have 
debatable relevance to the clinical conditions of UC and CD. Indeed, "most of the 
induced models (of intestinal inflammation) are merely models of induced 
inflammation in the colon, not o f UC", (Warren, 1994).
There were no examples of "backwash ileitis" amongst the patients studied 
in this project. This is a condition seen in up to 11% of patients undergoing 
restorative proctocolectomy (Gustavsson et al, 1987). Larger patient numbers may 
have yielded examples of this condition for examination but there is no evidence in 
the literature to suggest that backwash ileitis is related to pouch function or indeed 
the subsequent development of pouchitis (Gustavsson et al, 1987). Indeed, one 
doubts if the findings of non-specific inflammatory changes in the terminal ileum
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at the time of reservoir construction have any relationship to long-term pouch 
function.
The use of ileum from patients undergoing staged IPAA could also 
represent a relative weakness in this study since patients with ileostomies may have 
possible structural and functional differences relating to their previous surgery and 
not to the residual disease process in their rectal stumps. Further work would be 
necessary to establish if  this is true. Indeed, ideally one would want to study 
samples of tissue from patients with no previous history of gastrointestinal surgery 
and/or colectomy at the time of IPAA. In clinical pactice, however, this is not easy 
and the IPAA patients used in this study represent the typical range of staged and 
intact subjects presenting to an established tertiary referral centre (see Appendix).
Has there been any related research in inflammatory bowel disease carried 
out since this research project commenced? During the last four years several 
groups have examined the role o f the L-arginine-nitric oxide pathway in 
inflammatory bowel disease and in animal models of intestinal inflammation. 
Middleton and colleagues compared NO production in rectal biopsies from patients 
with active UC, quiescent UC and normal controls (Middleton et al, 1993). The 
assay technique employed was based on the simple fact that NO is produced by 
NOS with the liberation of equimolar quantities o f L-citrulline. As noted in 
Chapter 4, NO is highly reactive and very difficult to measure directly in tissue. L- 
citrulline assay was therefore performed as an indirect means of quantifying NO 
production. The study showed that citrulline concentrations were significantly 
increased relative to other amino acids in the rectal biopsy specimens from patients 
with active UC. The authors speculated that increased mucosal NO generation may 
be a contributory factor in the distension seen in severe colitis and at worst, toxic 
megacolon, because the same group had shown previously that NO in low 
concentrations relaxes colonic circular smoth muscle (Middleton & Hunter, 1991). 
Increased NO production and the associated augmented mucosal blood flow seen
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in areas of intestinal inflammation could, however, represent a defensive reaction 
against some unidentified damaging agent (Su et al, 1989).
Further studies investigated the activity o f cNOS and iNOS in colonic 
mucosa and muscle samples from patients with active UC (n=6), CD (n=4) and in 
control, noninflamed subjects (n= ll). (Boughton-Smith et al, 1993). This group 
found that active UC is associated with a substantial elevation of iNOS. Activity of 
NOS was unchanged in the colonic muscle fraction of UC patients when compared 
with control samples, suggesting that iNOS is not expressed in smooth muscle or 
associated neuronal tissue. Thus, the apparent anatomically specific induction of 
iNOS in UC mirrors the mucosal location o f the inflammatory process. Increased 
amounts of NO produced from the mucosa or submucosa after induction could 
diffuse to the muscle layers underneath, akin to NO diffusing from endothelium to 
vascular smooth muscle and hence could relax enteric smooth muscle which would 
contribute to the impaired motility response seen in toxic megacolon. The four 
cases o f CD, on the other hand , failed to show an increase in mucosal levels of 
cNOS and iNOS despite histological evidence of acute inflammation. In addition, 
CD patients had a reduction in the cNOS levels in the muscular layers. Whether or 
not this was due to deficiencies in the concentration or activity o f the enzyme in the 
smooth muscle cells or fibres was not clear. These differences in NOS activity 
between CD and UC patients could contribute to the differences in motility seen 
between the two conditions and the pathological vascular changes seen in the 
former (Wakefield et al, 1989). Furthermore, these differences could be due to 
differences between the two disease states in terms o f composition and penetration 
o f inflammatory infiltrate or to excessive mucosal production of cytokines such as 
interleukin (EL) -4 or IL-10 which have been reported to inhibit induction of iNOS 
activity (Cunha et al, 1992). On this point, the balance of stimulatory to inhibitory 
cytokines may determine the expression of NOS in UC and CD (Boughton-Smith, 
1994). In a review in 1994, Boughton-Smith speculated that if  NOS induction 
occurred in UC but not CD, then the therapeutic potential for selective inhibitors of
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induced NOS in inflammatory bowel disease may be different for the two 
conditions (Boughton-Smith, 1994).
In UC, inhibitors of iNOS may be beneficial where increased NOS could be 
contributing to the mucosal vasodilation and increased vascular permeability. 
Moreover, the obvious benefits of eliminating toxic megacolon which could be 
driven by increased quantities of NO (Guslandi, 1993) would be appealing. These 
agents have been tested in animal models. L-ARG antagonists ameliorated chronic 
ileitis, induced by trinitro-benzenesulfonic acid, in guinea-pigs (Miller et al, 1993a) 
while enhanced generation o f NO promoted mucosal injury, but was anti­
inflammatory under physiological conditions. Under acute conditions, (luminal 
acetic acid and casein in rabbits and luminal deoxycholite in neonatal piglets and 
adult rabbits) NO may contribute to the functional repair o f the epithelial barrier 
(Miller et al, 1993b).
In CD, on the other hand, where there is an underlying vascular pathology, 
removal o f a vasodilator and antiaggregatory substance, such as NO, may 
exacerbate vascular perfusion and be detrimental. NO donors, or agents increasing 
local NO production or stimulating guanylate cyclase activity, may have a 
therapeutic value in CD and are reportedly useful in animal models of acute 
intestinal damage (Boughton-Smith et al, 1990; Boughton-Smith et al, 1992).
Thus, the few human studies carried out to date to evaluate NO in 
inflammatory bowel disease have focussed on colonic NOS activity and enzyme 
isoforms. Importantly, they have contained only small numbers of subjects. In 
patients with UC undergoing IPAA, the role of NO in the NANC neurotransmitter 
mechanisms of the residual ileum from which the reservoir is fashioned was 
unexamined until the work in this thesis was carried out.
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6.1.3 CORRELATES AND PREDICTIONS?
From the preliminary studies descibed in this thesis it would have been 
encouraging to have demonstrated any correlation between the in vivo and in vitro 
data on one hand and the clinical features of the patient on the other. Table 6.1 
shows the individual patients from whom data were available to attempt to 
examine this relationship.
Meaningful analyses were possible only in 6 intact UC patients who had
undergone small bowel manometry and L-NAME studies. The clinical factors
assessed included age, duration of history of UC and nocturnal stool frequency.
The small bowel manometry nocturnal indices were assessed together with an
arbitrary score for whether the patients' tissues were strongly affected by L-NAME
(score 3); weakly affected by L-NAME (score 2); unaffected by L-NAME but
exhibiting neuronal relaxation (score 1); or no demonstrable neuronal relaxations
(score 0). Fisher's exact test showed that of the 9 parameters i.e 8 nocturnal small
bowel manometry parameters, (see Table 3.7) and the score for the tissue response
to incubation with L-NAME, assessed against the patients' clinical features, the
number of nocturnal DCCs and the tissue response to incubation with L-NAME
showed associations with the duration of UC, in both cases P=0.100. While these
data did not reach statistical significance they are nevertheless interesting and could
be investigated in future studies with greater patient numbers. It is interesting to
history
speculate that those patients with the shortest of UC coming forward for IPAA 
have a more aggressive form of colitis which caused the absent neuronal 
relaxations noted in the organ bath, while the more chronic UC patients adjusted to 
their illness by altering the balance of inhibitory neurotransmitters in the non­
inflamed small bowel. On this basis, the absence of DCCs in these patients could 
be similarly explained. Alternatively, and perhaps more plausible, is the possibility 
that the tissues with absent neuronal relaxations were in some way traumatised by 
retrieval for the in vitro experiments (see section 5.4.2).
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The data obtained from the present studies, which were preliminary
investigations of small bowel motility in UC, in an attempt to predict long-term
IPAA function could not be statistically analysed given the small numbers
|no
available. However, while scoring system is currently available to predict long­
term function in prospective IPAA patients, this could be achieved by having 
access to large numbers of patients in the form of a prospective multi-centre trial. 
Such a preoperative scoring system would be particularly useful clinically if it 
included easily measured parameters such as patient age, duration and extent of 
UC, previous colonic resection for UC, response to previous medical therapies, 
number of episodes of UC exacerbation requiring in-patient treatment and if 
female, any significant obstetric history. Simple physiological measurements could 
also be included such as gastric emptying and anal sphincter manometry profiles, 
the latter perhaps being combined with an endoanal ultrasound assessment of the 
sphincter mechanism. However, attempts to develop a scoring system using the in 
vivo and in vitro assessment techniques employed in this thesis would be extremely 
difficult to routinely carry out and to reproduce in other centres.
117
6.2 CONCLUSIONS
This thesis was undertaken to investigate two principal aspects of small 
bowel motility in UC patients undergoing BPAA. Solid state manometry assessed 
the in vivo motility patterns of the small bowel over its entire length in prospective 
patients, while in vitro experiments were confined to the most distal portions of 
terminal ileum discarded at the time of ileal reservoir construction.
Small bowel manometry showed varying patterns of nocturnal motility in 7 
intact patients with no demonstrable correlation between the various motility 
parameters and stool frequency. The former included number o f MMCs, MMC 
cycle length, MMC mean duration, MMC mean velocity, number of non­
propagating MMCs, number o f DCCs and number of PPCs. As in previous 
manometry studies of established IPAA subjects (Stryker et al, 1985; Chaussade et 
al, 1989; Groom et al, 1994) patient numbers in the present study were small; this 
was a major disadvantage but had to be accepted in this pilot study. However, the 
study gave useful information on the small bowel motility patterns of intact UC 
patients prior to EPAA, which have hitherto never been available. The present study 
also demonstrated major weaknesses in the use o f ambulatory manometry as a 
means of assessing motility patterns along the length of the whole small bowel. 
These include patient discomfort, intubation difficulties, length of time required to 
achieve successful catheter positioning, time-consuming analysis of traces and 
considerable expense associated with the catheter plus equipment for data storage 
and analysis.
In vitro experiments, on the other hand, were possible in greater patient 
numbers and allowed a comparison of UC patients with controls undergoing 
elective procedures for non-obstructing, non-inflammatory cancer resections of the 
right colon. Organ bath and Golenhofen apparatus recordings of spontaneous 
activity using controls and UC patients showed that differences in apparatus 
yielded differences in the values recorded. The Golenhofen apparatus was the more
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sensitive and detected subtle oscillations in tone with corresponding extracellular 
electrical activity providing an electrical basis for the contractions seen. Organ bath 
studies showed that UC strips exhibited spontaneous contractions which were 
weaker, but more frequent than controls. A similar pattern was noted in 
Golenhofen experiments. Whether this represents the chronic exposure o f ileum in 
UC patients to the systemic effects of an inflamed colon remains unestablished. 
There was no obvious relationship between the extent of UC (i.e total versus left­
sided UC) and the pattern of spontaneous activity, nor any instances of backwash 
ileitis. Golenhofen experiments confirmed that both control and UC ileal smooth 
muscle specimens have VOC and ROC. Spontaneous activity in both patient 
groups was also temperature-sensitive and blocked by the calcium channel 
antagonist diltiazem as well as SNP. L-NAME had no effect on ileal smooth 
muscle spontaneous activity in either patient group. Golenhofen experiments in 
ISTC patients showed that the intestinal pacemaker generated spontaneous 
mechanical activity via less intense, shorter duration electrical activity than its 
control counterpart. These differences may be due to factors, as yet unestablished 
which modify the number and/ or the function of the ICC.
NO-mediated inhibitory relaxation in carbachol-induced tone (KHM- 3x10' 
6M) and guanethidine (10'6M) was non-adrenergic and was the predominant pattern 
of relaxation under these conditions. In contrast, varied responses to L-NAME 
were noted in 18 UC patients (11 intact, 7 staged). Only 5 of these patients (4 
intact, 1 staged, 10 strips) responded similarly to L-NAME as controls, where L- 
NAME was effective in abolishing neuronal relaxation. In 8 patients (3 intact, 5 
staged, 23 strips) L-NAME was either only weakly effective or ineffective. A 
further 5 patients (4 intact, 1 staged, 25 strips) had no demonstrable neuronal 
relaxation responses to EFS. NADPH-diaphorase staining confirmed NOS 
presence in representative samples from both groups. Thus, while some patients 
with UC have NO-containing nerves mediating relaxation in a similar fashion to 
ileum from control subjects, others appear to have a comparatively defective NO
119
pathway. These latter individuals may be utilising alternative neuronal mechanisms 
and will require future investigation.
Studies to look at how SNP, a classic NO-donor relaxed human ileal 
smooth muscle, challenged the idea that SNP liberates extracellular NO to produce 
its action. HbO, which scavenges NO from extracellular media had no appreciable 
effect on SNP relaxation in samples o f control ileum (3 patients, 3 strips).
The differences noted between control and UC samples of ileum in these in 
vitro experiments merit further investigation and suggest that the visibly "normal" 
ileum from which the EPAA is constructed in UC patients may have different 
motility characteristics from control counterparts i.e FAP pouch patients. Studies to 
investigate small bowel motility in ISTC patients and also the mechanism of action 
of SNP-induced relaxation in ileal smooth muscle are also warranted.
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6.3 FUTURE WORK
Today, small bowel manometry is used only as a research tool. Indeed, as 
recently as March 1997 at the British Society of Gastroenterology Spring Scientific 
Meeting, a symposium on gastrointestinal motility reviewed available techniques 
for investigating every region of the human gut except for the small bowel. This is 
most probably due to the relative inaccessibility of the midgut region to 
catheterisation. In addition, the limited number o f papers available in the scientific 
literature on the in vivo and in vitro properties of the non-diseased human small 
bowel reflect our poor understanding of the motility characteristics o f this region of 
the gut. The motility o f the small bowel in UC is even less well understood and 
much more work is therefore required to investigate this in control subjects and UC 
patients undergoing IPAA. While in vivo studies are dogged by the anatomy of the 
region which makes intubation of the distal small bowel difficult, samples of ileum 
from patients undergoing elective surgical procedures can, on the other hand, be 
obtained for in vitro analysis with relative ease and regularity.
This thesis has reported preliminary studies o f small bowel motility in 
patients with UC undergoing IPAA. It has only touched the surface of a complex 
and largely unknown area of human gut function and much could be written about 
the various directions which future research might take in this field. The following 
is therefore only a precis of specific research areas which would be logical to 
examine in light of the work described above, in both control subjects and UC 
patients.
6.3.1 SMALL BOW EL M ANOM ETRY
While acknowledging the difficulties with small bowel manometry as a 
means of in vivo assessment of motility, the work outlined in Chapter 3 is 
nevertheless only the third study of its kind to investigate IPAA patients, and the 
first to assess such patients preoperatively. One obvious extension o f the work in
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Chapter 3 would be to repeat the study in the same patients once established pouch 
function (more than 12 months following ileostomy reversal- see Appendix) had 
occurred. This would allow assessment of the effects of reservoir construction on 
small bowel motility. Further monitoring of the progression of MMCs into the 
pouch, along with measurements of pouch capacity and emptying characteristics 
may yield comparable values to those reported in the St Mark's study (Groom et al, 
1994). This study would have the added advantage over previous ones of being 
able to use each patient as his/her own preoperative control. However, the 
problems of adhesions preventing catheter migration, which were encountered in 
the present study would have to be borne in mind, although interestingly these were 
not reported by the St Mark's group.
Terminal ileal manometry is possible (Hammer et al, 1993), and as 
mentioned above would be useful in characterising the precise manometric 
properties of the terminal ileum and ileocaecal region in UC patients prior to IPAA. 
The specialised motility characteristics of these regions have been comprehensively 
reviewed by Phillips and colleagues (Phillips et al, 1988) and are well documented 
in control subjects (Kerlin & Phillips, 1982; Quigley et al, 1984; Nasmyth & 
Williams, 1985) but remain unknown in UC patients. Clearly this is an important 
area which requires further investigation.
Fuller evaluation of small bowel manometry as a clinical research tool is 
also required. Studies looking at patient discomfort during this investigation with 
pain score assessment as well as cost analysis o f the technique would help to define 
its role in the evaluation of surgical patients. Assessment of recently introduced 
computer programmes to facilitate data analysis would also be worthwhile.
Finally, if one hypothesises that chronic UC modifies motility in non­
inflamed segments of the gut then it would be reasonable to study oesophageal 
motility using either water-perfused (which is our preferred system at Glasgow 
Royal Infirmary) or solid-state manometry. This would have the advantages of
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being easier to perform than small bowel manometry involving equipment which 
was cheaper and more widely used in hospitals throughout the country.
6.3.2 IN  VITRO STUDIES
The main thrust of any work in the area o f human small bowel motility 
must, in my opinion, be targetted at in vitro assessment of tissue obtained from 
control patients and subjects with pathological conditions.
As mentioned in section 6.1 various types o f tissue orientation have yet to 
be assessed in the investigation of ileal motility in health and in UC. It would be 
particularly interesting to examine the properties o f the isolated inner circular and 
outer longitudinal layers of the muscularis propria given that ICCs are 
predominantly located in the myenteric plexus and circular muscle layer of the 
human small bowel (Hagger et al, 1997).
Most in vitro studies o f the type described in this thesis tend to excise the 
mucosa before muscle strips are suspended in the organ bath. By constructing 
larger electrodes it would be possible to accommodate mucosal-clad strips in the 
stimulating electrode and would permit studies o f the effects o f the presence and 
absence of ileal mucosa on underlying enteric muscle function.
The pilot studies described in this thesis could lead to various other in- 
depth projects. One obvious example would be to progress from the extracellular 
recording techniques described in Chapter 5 to intracellular aspects of spontaneous 
activity and the effects of various drugs on nerve-mediated inhibitory and 
excitatory responses (see review by Bolton, 1989; Hara et al, 1986). This would 
help to clarify the neurotransmitters thought to be contributing to fast and slow IJPs 
in human ileum from controls and UC patients. Thereafter, patch-clamp analysis of 
dispersed human ileal smooth muscle cells from control and UC patients would be 
the state-of-the-art technique to use to examine the ionic mechanisms underlying 
spontaneous and evoked responses in these tissues.
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Biochemical assays of cGMP levels in ileal strips after SNP-induced 
relaxation would help to clarify whether this intracellular messenger was involved 
in processes which would suggest that SNP generates NO p er se (Garcia-Pascual & 
Triguero, 1994).
Other clinical conditions in which ileal samples should be examined at the 
time of surgical resection include CD, in light of work comparing colonic samples 
from patients with UC and CD (Boughton-Smith et al, 1995), and also patients 
with obstructing right colon cancers undergoing emergency right hemicolectomy. 
The latter study would be especially interesting since manometry studies in IPAA 
pouches have raised the suggestion that the ileal reservoir causes a functional small 
bowel obstruction (Chaussade et al, 1989). One could hypothesise that differing 
degrees o f obstruction, produced by the ileal reservoir, could cause varying patterns 
of small bowel motility proximal to the pouch, with functional consequences in 
terms of stool frequency and urgency. In vitro studies o f ileal samples, from 
patients with poor pouch function would be useful but, although access to tissue 
from the most severe cases of pouch dysfunction which ultimately require excision 
or defunctioning would be possible, these occur too sporadically in practice to 
generate large patient numbers for analysis.
The hypothesis underlying this thesis has been that small bowel motility 
may be modified in UC patients undergoing IPAA. In other words, inflammation of 
the colon may in some way bring about motility changes in more proximal, 
histologically normal, non-inflamed areas of the gut. O f great relevance to this 
project have been recent in vitro studies which investigated the immunomodulation 
of enteric neuromuscular function in animal models of gastrointestinal 
inflammation (see review by Collins, 1996). A clear causal relationship now exists 
between the presence of mucosal inflammation and changes in sensory-motor 
function. Notwithstanding the inherent drawbacks o f animal models o f acute 
intestinal inflammation outlined above, one exciting study has shown that in a rat 
model of colitis a marked suppression of release of 3H-noradrenaline (a
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radiolabelled enteric neurotransmitter) occurs not only in the inflamed distal colon 
but also in the noninflamed transverse colon and terminal ileum (Jacobson et al, 
1993). As Collins has pointed out (Collins, 1996), this may provide a possible 
functional correlate of the ultrastructural abnormalities noted in enteric nerves at 
noninflamed sites in patients with Crohn's disease (Dvorak et al, 1979) and the 
altered intestinal motility patterns seen in UC patients (Manousos & Salem, 1965). 
Thus, the relatively new field of immunophysiology may in future years help to 
clarify the effects o f UC on small bowel motility before EPAA. However, extensive 
descriptions o f the various immunological and ultrastructural studies which would 
be of great interest to perform in samples of ileum from UC and CD patients are 
beyond the scope of this discussion.
6.3.3 CLINICAL STUDIES OF POUCH DYSFUNCTION
The Appendix to this thesis, like its anatomical namesake, may on first 
inspection appear unnecessary. However, this thesis evolved from a simple project, 
initiated in 1992, which was designed to audit operative and postoperative 
experience with the technique of TSRP as well as long-term functional outcome. 
The findings of that audit project are summarised in the Appendix. One 
contribution which a database such as the Appendix can make, in terms of 
directing future research, is its ability to identify those established IPAA patients 
with pouch dysfunction.
As experience at Glasgow Royal Infirmary has increased with TSRP, and 
with steadily rising numbers o f IPAA patients who achieve long-term function, it is 
becoming increasingly clear that many patients with problematic pouch function 
cannot be conveniently labelled as having "pouchitis". The Oxford group have 
recently described a problem-solving approach to EPAA dysfunction (Thompson- 
Fawcett et al, 1997). Classification of the non-pouchitis group of conditions 
contributing to functional problems include small bowel dysfunction, pouch 
abnormalities and outlet problems. As patient numbers increase nationwide, a
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multi-centre study incorprating audit databases similar to that summarised in the 
Appendix, would generate adequate patient numbers for meaningful statistical 
analysis and would also provide the opportunity to study the small bowel motility 
and transit characteristics of those individuals falling into the small bowel 
dysfunction category. Retrospective assessment o f preoperative factors in these 
individuals such as age, duration of illness, types and duration o f medical therapies, 
previous surgery, extraintestinal manifestations o f UC, stool patterns and presence 
or absence of IBS would be obvious variables to measure if  attempts were made to 
develop a scoring system which may ultimately predict pouch dysfunction.
Clinical studies including prospective small bowel manometry assessment 
of patients with pouch problems, along the lines of the St Mark's study (Groom et 
al, 1994) could be performed. Small bowel transit and pouch evacuation 
characteristics could be assessed by scintigraphic techniques, along with 
pouchmetrography (Levitt et al, 1992) and standard anal manometry. Although 
difficult to perform, this type of comprehensive clinical assessment is possible and 
has been performed on a small number of IPAA patients at Glasgow Royal 
Infirmary.
The studies described in this thesis shed some interesting new light on 
differences which exist in the so-called "normal" ileum of patients with UC. This 
research project has therefore lent support to the comments of Aufses Jr who stated 
in 1986 that:
"patients who had the operation (IPAA) performed fo r  polyposis (FAP) 
had fewer bowel movements than the patients who had an operation fo r  UC. 
This implies that the function o f  the remaining small bowel is different in the 
two sets o f  p a t i e n t s (see Becker & Raymond, 1986).
The IPAA procedure is no longer in its infancy as a surgical treatment for 
UC. From the foregoing it is clear that little is known, however, about the 
pathophysiology o f pouch function and dysfunction, let alone the motility
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characteristics of the proximal small bowel and terminal ileum used to fashion the 
reservoir. Future in vitro and clinical studies on the functional constituents (i.e. 
proximal small bowel, terminal ileum and anal sphincter mechanism) of the IPAA, 
both before and after reservoir construction are therefore needed if the growing 
population of IPAA patients is to receive effective treatment for pouch dysfunction.
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APPENDIX
TOTALLY STAPLED 
RESTORATIVE PROCTOCOLECTOMY 
AT GLASGOW ROYAL INFIRMARY 1988-1995
BACKGROUND: Totally stapled restorative proctocolectomy (TSRP) has 
simplified IPAA but few reports exist concerning experience with the technique. A 
retrospective study of operative and functional data in a consecutive series of 
patients undergoing TSRP was undertaken.
METHODS: Case-note review with functional assessment by clinical interview 
and/or postal questionnaire.
RESULTS: TSRP with "J" pouch formation was attempted in 103 patients 
between 1988 and 1995 (ulcerative colitis 87; familial adenomatous polyposis coli 
9; slow transit constipation 6; hereditary non-polyposis colorectal cancer 1). Three 
technical failures resulted in 100 patients available for assessment. Average 
operating time was 200 mins, intraoperative blood loss 360ml and hospital stay 12 
days. There was no operative mortality. Loop ileostomy formation and subsequent 
reversal in all but 5 cases (95%) was associated with 29 complication episodes, 
requiring further surgical intervention in 6 (6%). Six pouches were excised and 2 
defunctioned with temporary ileostomy formation (8%). Five patients were 
rediagnosed as Crohn's disease, of whom 4 underwent subsequent pouch excision 
(80%). Pouchitis in the absence of Crohn's disease occurred in 8 individuals (8%). 
In 60 patients with at least 12 months established function, average day/night stool 
frequencies were x5 during the day and x l overnight. Functional evaluation in 49 
(81.7%) revealed 21 using regular antidiarrhoeal medication (42.8%); urgency in 
17 (34.7%); and total continence by day/ night in 37 (75.5%) and 35 (71.4%) 
respectively. Fifty-three patients (88.3%) were satisfied with overall long-term 
outcome.
CONCLUSION: TSRP is safe, has simplified a technically difficult operation and 
gives good long-term functional results.
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Restorative proctocolectomy (RP) is now the treatment o f choice for 
patients with ulcerative colitis (UC) requiring elective surgery (Williams, 1989) 
and is being used increasingly as a surgical option for the management of familial 
adenomatous polyposis coli (FAP), (O'Connell & Williams, 1991).
The initial descriptions o f the operation which were complicated and 
technically demanding (Parks & Nicholls, 1978; Utsunomiya et al, 1980), involved 
retention of a long rectal stump with mucosectomy and a handsewn pouch-anal 
anastomosis. Although the early procedures suffered from high complication rates 
(Parks & Nicholls, 1978; Utsunomiya et al, 1980; Fonkalsrud, 1980) progressive 
simplification of the operative technique (Nicholls et a l, 1984; Johnston et al, 
1987; Keighley, 1987; Pescatori, 1988; Lavery et al, 1989; Slors et al, 1989; Miller 
et al, 1990; Oresland et al, 1990; Mowschenson et al, 1993) has reduced the 
morbidity associated with RP. Arguably the simplest form of RP uses stapling 
instruments to fashion the pouch and pouch-anal anastomosis without performing 
an endoanal mucosectomy. While totally stapled restorative proctocolectomy 
(TSRP) is technically easier to perform than earlier RP procedures, there are few 
reports of its use and little is known about long-term function. We describe our 
operative experience with TSRP and report on the long-term functional outcome.
PATIENTS AND METHODS
Consecutive patients who underwent TSRP with formation o f a pelvic ileal 
J reservoir between 1988 and 1995 were studied. Preoperative diagnosis in these 
103 patients was UC in 87, FAP in 9, idiopathic slow transit constipation (STC) in 
6 and one case of hereditary non-polyposis colorectal cancer (HNPCC). Eighteen 
of the 87 patients with UC underwent semi-urgent surgery to treat fulminant
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disease (21%). Twenty seven patients (26%) had previously undergone total 
colectomy with rectal stump preservation (21 with UC, 2 with FAP and 4 with 
STC).
The operative technique involved diathermy dissection of the rectum, 
including the mesorectum, to the level of the upper anal canal with division 
approximately 1cm above the dentate line using a stapling instrument (Ethicon RL 
30). Care was taken to identify and preserve the presacral nerves. An ileal pouch 
was fashioned in the "J"-configuration using 2-3 firings of a linear stapling device 
(Ethicon PLC 75) ensuring that the apex of the "J" reached the upper anal canal 
without tension. Anastomosis of the ileal pouch to the anal canal was then 
performed by the double-staple technique, using a detached head stapling 
instrument (Ethicon CDH 29). Operative manoeuvres such as mucosal 
proctectomy, endoanal retraction and anal eversion were avoided. In all but 5 cases 
a temporary loop ileostomy was fashioned (5%); ileostomy was avoided when 
technical difficulties prevented formation of a tension-free stoma. Patients received 
intraoperative subcutaneous heparin (5000I.U) and intravenous antibiotics 
(cefotaxime 1G, metronidazole 500mg) for 5 days postoperatively.
All patients were followed at a designated clinic at 3 monthly intervals in 
the first year and 6 monthly thereafter. Patients with functioning pouches for more 
than 12 months after closure of ileostomy underwent detailed functional 
assessment, similar to that used by Weinryb and colleagues (Weinryb et al, 1995), 
by interview at an out-patient clinic and/or by postal questionnaire.
Operative mortality was defined as death within 30 days of surgery. 
Anastomotic leakage was defined clinically with features of pyrexia, lower 
abdominal pain and purulent discharge passed per anum. Contrast studies were 
only performed when clinically indicated. The degree o f continence was graded as
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normal, minor incontinence or major incontinence using standard clinical criteria 
(Nicholls & Pezim, 1985). Urgency of stool was defined as the inability to defer 
defaecation for a minimum of 30 minutes (Nasmyth et al, 1986a). Patients were 
considered to have pouchitis on the basis of diarrhoea with or without bleeding, the 
sigmoidoscopic appearances of pouch inflammation and the absence of specific 
pathogenic organisms in the pouch effluent. Confirmation o f the diagnosis was 
made by histological analysis o f pouch mucosal biopsies (Moskowitz et al, 1986).
RESULTS
TSRP was attempted in 103 cases but in 3 patients double-stapling of the 
reservoir to the anal canal failed, necessitating conversion to a handsewn pouch- 
anal anastomosis. The technical reasons for these conversions are summarised in 
Table A.I.
There were no operative deaths. One patient committed suicide 4 months 
after surgery. The remaining 99 patients (53 males), median age 31 years (range 9- 
59years) were available for assessment (Fig A .l)
The median follow-up was 31 months (range 12-77months). The median 
duration of surgery for TSRP in the 100 patients was 200mins (range 70-285mins), 
median operative blood loss 360ml (range 50-2000ml) and the median duration of 
hospital stay was 12days (range 7-74days). Elective closure of loop ileostomy was 
performed at a median of 85days (range 9-660days) after TSRP.
EARLY COMPLICATIONS
Two pouches were excised during the early postoperative period; one 
because of ischaemia and the other because of haemorrhage.
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PATIENT AGE DIAGNOSIS TECHNICAL REASON
Male 34yrs UC Inadvertent omission to fire 
gun after bowel division
Female 25yrs UC Staple line opened during 
endoanal insertion of CDH 
stapling instrument
Male 45yrs UC Rectal thickening precluded 
satisfactory cross-stapling
Table A.I. Details of attempted totally stapled restorative proctocolectomy 
(TSRP) cases converted intraoperatively to handsewn pouch-anal 
anastomoses. UC, Ulcerative colitis; CDH, Curved detached head
103 attempted TSRP cases
T
3 converted to handsewn pouch-anal anastomosesI
100 successfully constructed TSRP cases
2 early pouch excisions
1 suicide
97 intact TSRP cases followed-up
4 late pouch excisions
2 temporary loop ileostomies
91 functioning TSRP cases
T
60 long-term functioning TSRP cases
53 satisfactory function 7 poor function
TSRP: Totally stapled restorative proctocolectomy
Fig A .l Outcome of 103 patients undergoing totally stapled restorative 
proctocolectomy.
Six patients developed clinical evidence of pouch/anastomotic leakage 
and/or pelvic abscess formation. In 4 of the 6 cases there was no covering 
ileostomy. Two of these 4 patients required formation of a loop ileostomy; the 
remaining 4 healed with antibiotic treatment and nutritional support.
Pulmonary thromboembolism occurred despite prophylaxis in 2 patients; 
both fully recovered.
LATE COMPLICATIONS
Complications associated with formation of a loop ileostomy are given in 
Table A.2. Although 29 complication episodes occurred only 6 patients required 
further surgery.
Pouch-anal stenosis occurred in 5 patients (3 females) and was treated by 
dilation under day-case general anaesthetic. One patient developed a rare 
complication of complete pouch prolapse at the anus which was corrected by 
abdominal "pouchopexy".
Crohn's disease and pouchitis
Five patients (1 male) initially considered to have UC have been shown 
subsequently to have Crohn's disease (CD) in the ileal pouch. Retrospective 
detailed review of the original colectomy specimen showed UC in 4 and 
indeterminate colitis in 1, whilst the anastomotic "doughnuts" showed no evidence 
of CD. In 4 of these patients pouch excision was performed subsequently because 
of poor function and/or pouchitis.
Eight patients developed clinical and histological evidence of pouchitis in 
the absence o f CD. Three individuals had more than one episode. Treatment was 
medical in 7, while 1 patient required a temporary ileostomy.
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COMPLICATION n
POST-POUCH CONSTRUCTION
Intestinal obstruction 3
(conservative treatment)
Ileostomy obstruction (laparotomy) 1
Ileostomy retraction 3
Parastomal abscess 1
Excoriation at stoma site 1
High output ileostomy 7
TOTAL 16
POST-REVERSAL OF LOOP ILEOSTOMY
Anastomotic leak 2
(conservative management)
Anastomotic leak 2
(ileostomy revision)
Intestinal obstruction 7
(conservative treatment)
Intestinal obstruction (laparotomy) 1
Incisional hernia 1
TOTAL 13
Table A.2: Complications associated with loop ileostomy,
n, number of patients.
Pouch function
A temporary ileostomy was created in 1 patient because o f poor pouch 
function. Of the 60 patients who fulfilled the criteria for long-term pouch follow- 
up, 49 completed a detailed questionnaire to assess pouch function. The remaining 
11 patients were assessed, in detail, during regular out-patient review. 
Approximately two thirds of patients with established pouch function were, by 
their own assessment, leading normal lives. In contrast 7% of patients had a poor 
functional result and were unable to work.
Three UC patients (2 males, 5%) had increased pouch frequency, in the 
absence o f both pouchitis and pouch-anal stenosis, on serial examinations under 
anaesthetic. These individuals were labelled as suffering from irritable bowel 
syndrome (DBS), after exclusion of occult small bowel Crohn's disease using 
radiolabelled white cell scans and after measuring haematological/ biochemical 
indices. Small bowel dysmotility, either related to IBS per se or as a result o f UC, 
was suspected to have been a contributing factor in these patients' symptoms.
The long-term functional outcome for the 3 patient subgroups completing 
the detailed questionnaire is shown in Table A.3. Clearly, the majority of the 
patients had a preoperative diagnosis o f UC (39 patients, 79.6%) and hence a 
statistically meaningful comparison of outcome measurements with the 7 FAP and 
3 STC patients is not possible. The data for FAP pouches, however, show that the 
stool frequencies and continence in this group tend to be superior to those of their 
UC counterparts, along with a lower incidence of urgency. Interestingly, the impact 
of EPAA on previously asymptomatic FAP patients creates more lifestyle 
disadvantages, as one would expect, than in UC patients who have longstanding 
chronic symptoms prior to undergoing TSRP. Three UC patients (7.7%) reported
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that TSRP had caused no lifestyle disadvantages and indeed had improved the 
quality of their social and professional lifestyles.
G enitourinary function
Three men developed retrograde ejaculation whilst 1 patient had partial 
erectile failure after TSRP. One female patient noticed reduced libido, whilst a 
further 3 women experienced pouch leakage during intercourse.
It was noted that 76% of the women with established pouch function who 
had regular menstrual cycles detected a marked increase in pouch stool frequency 
just prior to and during menstruation.
Two patients had children following TSRP. Both were delivered by 
caesarian section.
DISCUSSION :
Restorative proctocolectomy has evolved since the first description of the 
procedure in adults in 1978 (Parks & Nicholls, 1978). Initially it was a time- 
consuming and technically difficult operation which involved performing a long 
mucosectomy with excision of the anal transitional zone (ATZ). In addition the 
handsewn pouch-anal anastomosis required prolonged anal dilatation. The 
operation has since been progressively simplified with regard to pouch 
configuration and the avoidance of a long rectal stump. The relatively recent 
availability of stapling instruments has allowed the operation to be further 
simplified. Operative time has been reduced and prolonged anal canal dilatation 
avoided. TSRP might therefore be expected to yield improved functional results 
particularly with regard to continence and night leakage.
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The present study shows that the results o f TSRP for UC are variable. 
Moreover, from the small numbers of FAP pouches available for long-term 
assessment TSRP can be safely performed for this autosomal dominant condition 
with good functional outcome. In general, FAP patients undergoing TSRP have 
lower 24-hour, daytime and nocturnal stool frequencies than UC patients 
undergoing TSRP. Total continence is excellent for both patient groups with a 
lower incidence o f urgency in FAP patients. Like Aufses Jr, we too believe that the 
functional difference amongst the two groups suggests that there is an inherent 
difference in the function of the remaining small bowel in each disease category 
(see Becker & Raymond, 1986). We no longer perform TSRP for ISTC because of 
variable outcome and this experience has been reported by other workers (Keighley 
et al, 1993). Although only 3 ISTC patients were reviewed in this series it is 
interesting to note that 2 (66.7%) had urgency. This may well be a manifestation of 
either a panenteric dysmotility (Bassotti et a l, 1996) or IBS.
The data from the present study confirm that TSRP can be performed safely 
with short operative times, minimal blood loss and low morbidity. Further, there is 
excellent long-term pouch function with a median stool frequency o f x5 per day 
and xl per night. This is in keeping with comparable series of TSRP patients 
(Wexner et al, 1991; Keighley et al, 1993; Reissman et al, 1995). While one would 
not anticipate major differences in pouch frequency between studies of handsewn 
and stapled pouches a difference in continence rates might be expected. In 
particular TSRP appears to avoid the troublesome complication of night leakage 
associated with the traditional operation. In the present series 75% of patients were 
totally continent by day and only 26% reported minor night leakage. In contrast, in 
a study of 389 patients who underwent handsewn pouch-anal anastomosis with
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mucosectomy, Pemberton and colleagues reported nocturnal soiling rates of 56% 
and 44% in females and males respectively (Pemberton et al, 1987).
The leakage rates may be related to either the mucosectomy with excision 
of the anal transition zone or to prolonged anal dilatation. In a prospective pilot 
study comparing stapled and traditional techniques the Leeds group found that 92% 
of patients were completely continent after TSRP compared to only 58% in the 
handsewn group (Johnston et al, 1987). Moreover, whilst anal manometry showed 
normal anal canal pressures after TSRP, these were reduced in the handsewn 
group. Similar results have been reported in a retrospective comparative study from 
the Cleveland Clinic (Tuckson et al, 1991). Others have suggested that TSRP is at 
least comparable to the handsewn operation (Seow-Choen et al, 1994; Gozzetti et 
al, 1994) in terms of functional outcome. In an isolated but important prospective 
randomised trial of 32 patients from St Mark's Hospital, London (Seow-Choen et 
al, 1991), it was suggested that stapled pouches gave an inferior functional result to 
handsewn pouches. This study however, did not comment on the important 
complication o f night leakage which makes patients miserable by irritating the 
perianal skin. Those authors also had considerable experience and skill in the 
handsewn technique of pouch-anal anastomosis.
In the present series the clinical anastomotic leak rate was comparatively 
low at 5%. This compares favourably with other series where the leakage rates 
range from 8-16% (Sugerman & Newsome, 1994; Seow-Choen et al, 1991; 
Luukkonen & Jarvinen, 1993) and may be attributed to the use o f a defunctioning 
ileostomy in the majority of pouch patients. Indeed, in the present series pelvic 
sepsis occcurred predominantly in those patients who were not defunctioned. The 
use of a diverting ileostomy does however, have associated morbidity including 
dehydration, small bowel obstruction and risk of anastomotic leakage at closure.
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These complications have been reported by others (Metcalf et al, 1985; Feinberg et 
al, 1987; Schoetz et al, 1986; Grobler et al, 1992) and occurred in our series (see 
Table 2). It is for this reason that the use of ileostomy has been abandoned or used 
only in selective cases by several groups (Mowschenson et al, 1993a-b; Sugerman 
& Newsome, 1994; Matikainen et al, 1990; Jarvinen & Luukkonen, 1991; Winslet 
et al, 1991; Sagar et al, 1992). While acknowledging these arguments we continue 
to use routine loop ileostomy whenever technically possible, since pelvic sepsis is 
such a serious complication. Indeed, our experience with loop ileostomy for 
temporary faecal diversion after TSRP has, like others (Khoo et al, 1994), been 
favourable with only 6% of patients requiring surgery to correct ileostomy-related 
problems.
Other recognised technical complications of TSRP include the development 
of pouch-anal stenosis (Wexner et al, 1991; Seow-Choen et al, 1991) and pouch- 
vaginal fistula (Groom et al, 1993; Keighley & Grobler, 1993). In the present series 
the division of the upper anal canal was performed with a 30mm diameter stapling 
instrument confirming full mobilisation and resection of the rectum. If the 30mm 
instrument cannot be easily accommodated this indicates inadequate dissection 
with residual rectum and necessitates further mobilisation. In the present series 
there have been no pouch-vaginal fistulae.
The major late complication of restorative proctocolectomy is pouchitis 
which in the present series occurred in 13% of patients (5 with CD). This is 
comparable to other series (Keighley et al, 1993; Sugerman & Newsome, 1994; 
Gozzetti et al, 1994; Lohmuller et al, 1990; de Silva et al, 1991) where the 
incidence varies from 12-30%. Such variability may relate to differences in the 
definition of pouchitis. It has been suggested that pouchitis may be secondary to 
ischaemia (Levin et al, 1992) and since stapled pouch-anal anastomoses are under
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less tension than handsewn anastomoses this may explain our relatively low figure 
for pouchitis. We also found that pouchitis may indicate occult CD (Keighley et al, 
1993) with 5% of patients (38% of all pouchitis cases) having histologically 
confirmed CD. Review of the original colectomy specimens, even with the benefit 
of "hindsight” showed UC in 4 and indeterminate colitis in the fifth. This suggests 
that even if a staged operation had been performed, CD would not have been 
diagnosed. As such these data do not support the suggestion that patients should be 
treated by initial subtotal colectomy to avoid the risk of performing restorative 
proctocolectomy in the presence of occult CD (Keighley et al, 1993; Lucarotti et 
al, 1995). We do however, use a staged approach when the patient has other 
features suggestive, but not diagnostic of CD e.g. mouth ulcers or recurrent 
perianal sepsis. Given the inferior functional outcome after staged procedures 
(Zenilman et al, 1990) the use of on-table retrograde endoscopy of the small bowel 
may be a superior method of identifying occult CD unrecognised by standard 
preoperative investigations (Lescut et al, 1993).
Arguably the greatest putative risk of TSRP is the retention of a short anal 
canal mucosal cuff with the risks o f colitis, dysplasia and carcinoma. In a study 
from the Cleveland Clinic, Florida the incidence of inflammation and dysplasia in 
retained mucosa after TSRP for UC was assessed (Schmitt et al, 1992). In 35% of 
patients the distal doughnut revealed UC at the time of pouch construction. At 
subsequent biopsy 43% of these patients had persistent UC. No dysplasia was 
identified in any of these biopsies. Only one patient with evidence of UC on 
"doughnut" and/or biopsy had symptoms attributable to active UC (2%). In another 
series there have been 3 reported cases of symptomatic colitis from the anal canal 
after TSRP (Curran & Hill, 1992) and this may prove to be the major long-term 
problem with the technique. Leaving a short anal canal cuff in patients with FAP is
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perhaps more controversial. However, this appears to be an academic rather than 
practical argument since the risk o f carcinoma in an easily surveyed 1cm cuff will 
be small when compared with the benefits of superior functional outcome and the 
high risk of premature death in these patients from tumours at other sites. There 
have been no reports to date o f carcinoma arising in the retained cuff o f mucosa 
after TSRP.
Although this is not a randomised comparison of operative techniques the 
results of the present study confirm that TSRP has simplified a difficult operation 
and gives good long-term functional results, with particular regard to night leakage. 
Future careful follow-up is required, however, to ensure that there are no long-term 
complications associated with the short cuff of diseased mucosa which this 
technique leaves behind.
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